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1 Introduction
1.1 TGF-  pathway
Transforming growth factor-  (TGF ) is one of the main signalling
pathways that regulates a plethora of functions inmetazoans, including
many fundamental cellular processes such as cell di￿erentiation, pro-
liferation, tissue homeostasis or regeneration, among many others [1].
￿e control of a multicellular environment in animals rise as the main
objective of TGF  as it has been observed in all the sequenced meta-
zoans, even in Trichoplax adhaerens, the most basal animal sequenced
[2].
One of the best-studied networks activated by the TGF-  family in-
volves the small mothers against decapentaplegic (SMADs) transcrip-
tion factors as the central mediators of the pathway [3]. Brie￿y, ex-
ternal TGF -related cytokines trigger the activation of their receptors
upon binding. Once TGF  receptor I is phosphorylated, R-SMAD pro-
teins get in turn also phosphorylated, favouring the formation of a het-
erotrimeric complex between two R-SMAD and one Co-SMAD. ￿is
complex accumulates in the nucleus and participates in transcriptional
regulation in association with other proteins like transcription factors,
co-activators and co-repressors and also with DNA. Finally, dephos-
phorylation and ubiquitination of the activated SMADs ends the signal
(Figure 1.1).
￿e TGF -related cytokines are divided in two subfamilies; ￿rst: the
TGF-  / Activin / Nodal and second: bonemorphogenetic protein (BMP)
/ growth and di￿erentiation factors (GDF) / Muellerian inhibiting sub-
stance (MIS) subfamily.￿e two groups bind to di￿erent combinations
of receptors I and II, which subsequently activate di￿erent SMAD pro-
teins [3]. Curiously, these are the only cell surface receptors that use
1
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Figure 1.1: General scheme of the TGF  signalling pathway.
serine/threonine kinases, instead of the commonly used tyrosine ki-
nases. Generally, TGF- /Activin/Nodal cytokines trigger the response
of SMAD2/3 while BMP/GDF/MIS activate SMAD1/5/8.￿ese ￿ve pro-
teins are commonly named receptor-regulated SMAD (R-SMAD) be-
cause they are the ones that undergo phosphorylation by the receptor
a￿er the activation of the pathway. Once activated, the R-SMAD pro-
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teins are translocated to the nucleus, where they form a heterotrimer
with SMAD4, also called Co-SMAD, mediator of all R-SMADs.￿e het-
erotrimer is likely to be the functional unit of the pathway. It interacts
with many partners and cofactors to, at the end, bind to the DNA and
regulate the expression of hundreds of genes [4]. Finally, the inhibitory
SMADs (I-SMADs : SMAD6 and SMAD7), act as a negative regulators
of the pathway.
￿e apparent simplicity of the pathway contrasts with the broad vari-
ety of responses that it generates. Indeed, TGF  pathway can cause
contrary outcomes depending on the cellular context. For instance,
DNA-binding protein inhibitor ID-1 is suppressed by TGF  pathway
in mammary epithelial cells [4] but it is induced in metastatic breast
cancer cells [5]. Actually, only few proteins are expressed through all
the cell types, such as SMAD7 [6]. ￿e broad variety of responses is
tightly regulated by several factors, which can be classi￿ed in three
main groups. ￿e ￿rst regulation level describes how and which cy-
tokine signal triggers which receptor. In humans, there are seven type
I and ￿ve type II TGF  receptors. A tetramer of two type I and two
type II receptors is needed to bind the cytokine.￿e availability of cy-
tokine and type I and II receptors will in￿uence on the ￿nal response.
￿e second level includes all the cofactors (activators or suppressors)
and others proteins that could regulate the SMADs-DNA interaction.
Finally, the cell epigenetic status is basic for the ￿nal output.
Moreover, SMAD proteins act as an integrative hub from other cellular
signalling pathways. For example, the interaction with FOXO factors
links TGF  with AKT pathway [7]. In a similar way, activated LEF1
(lymphoid enhancer-binding factor 1) and TCF7L2 transcription factor
are the connection to the WNT pathway [8]. And the cross-talk with
mitogen-activated protein kinases (MAPKs) is centred in the phospho-
rylations of the linker region [9].
3
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1.2 SMAD proteins
1.2.1 SMAD structure
￿e roughly 500 amino acids of the SMAD proteins are structured in
two globular domains connected through an unstructured linker (Fig-
ures 1.2, 1.3, 1.4).￿e N-terminal domain, MAD homology 1 (MH1) do-
main, is conserved in all SMAD proteins with the exception of SMAD6
and SMAD7. A zinc cation (Zn2+) stabilises the DNA binding compact
structure encompassing four ↵ helices, six short  -strands and ￿ve
loops. A  -hairpin between the strands B2 and B3 is responsible for
the interaction with the DNA [10]. All R-SMADs and SMAD4 bind to a
speci￿c sequence of DNA called SMAD binding element (SBE), contain-
ing the sequence 5’-AGAC-3’. SMAD2, which has in its most common
splicing variant a 30-residue insertion next to the DNA binding site, is
believed to have limited DNA binding capacity [3]. In addition to SBE,
SMAD1 and SMAD5 can also recognise GC-rich sequences [11]. On the
other hand, neither SMAD6 nor SMAD7 interact e￿ciently with DNA
[3].
MH2MH
1
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1 MH2MH
1-lik
e
1, 2, 3, 5, 8 4 6, 7
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S
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Figure 1.2: General scheme of SMAD proteins.
￿e C-terminal domain, MH2 domain, is conserved among the SMAD
proteins. It is formed by a central   sandwich surrounded by three
↵-helices and one  -strand in one side and one loop-helix region in
the other side [12].￿is domain is responsible for most of the protein-
protein interactions.￿eMH2 domain of the R-SMADs is characterised
by a conserved C-terminal SXS motif. When phosphorylated by the
type I receptor, these amino acids increase their a￿nity for a basic
pocket located also in the MH2. ￿e interaction between the phos-
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phorylated C-terminal and the MH2 of another SMAD induces the for-
mation of homo- or heterotrimers. ￿e heterotrimer consisting of two
R-SMADs and one SMAD4 is considered as the functional unit of the
pathway. ￿e MH2 in the R-SMAD also contains a hydrophobic corri-
dor that mediates in many protein interactions such as nucleoporins,
cytoplasmatic retention proteins or other transcription factors [3].
MH2MH1
DNA
DNA hairpin
Zinc binding
linker
SXS motif
Hydrophobic corridor
PY motif
Figure 1.3: SMAD3 representation as an example of a R-SMAD. MH1 is la-
belled in light blue, MH2 in dark blue and DNA in orange. DNA hairpin is
highlighted in yellow as well as Zinc binding region. In red are shown the
regions corresponding to the PY motif, the hydrophobic corridor and the SXS
motif, respectively. ￿e structures were taken from PDB id: 1OZJ for MH1
and DNA and id: 1MJS for MH2.
￿e sequences connecting the MH1 and MH2 domains di￿er between
SMADs but are conserved for a given type of SMADs. In particular,
the PY motifs are present in the linkers of both R-SMADs and SMAD7.
Also, the pa￿ern of phosphorylated residues responsible for the regula-
tion of the function and fate of R-SMADs is preserved among di￿erent
SMADs [13, 14].
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SMAD2_HUMAN    1 MSSILPFTPP-VVKRLLG------WKKSAGGSGGAGGGEQNGQEEKWCEKAVKSLVKKLK
SMAD3_HUMAN    1 MSSILPFTPP-IVKRLLG------WKK----------GEQNGQEEKWCEKAVKSLVKKLK
SMAD4_HUMAN    1 MDNMSITNTPTSNDACLS-IVHSLMCH-----------RQGGESETFAKRAIESLVKKLK
SMAD7_HUMAN    1 MFRTKR--SA-LVRRLWRSRAPGGEDE------EEGAGGGGGGGELRGEGATDSRAHGAG
consensus      1 Mssilpftpp vvkrllg      wkk        gggeq GqeEkwcekAvkSlvkklk
SMAD2_HUMAN   54 K-TGRLDELE--------------------------------------------------
SMAD3_HUMAN   44 K-TGQLDELE--------------------------------------------------
SMAD4_HUMAN   49 EKKDELDSLI--------------------------------------------------
SMAD7_HUMAN   52 GGGPGRAGCCLGKAVRGAKGHHHPHPPAAGAGAAGGAEADLKALTHSVLKKLKERQLELL
consensus     61 k tg ldele                                                  
SMAD2_HUMAN   63 -KAITTQN-CN-TKCVTIPSTCSEIWGLSTPNTIDQWDTTGLYSFSEQTRSLDGRLQVSH
SMAD3_HUMAN   53 -KAITTQN-VN-TKCITIP------------------------------RSLDGRLQVSH
SMAD4_HUMAN   59 -TAITTNG-AHPSKCVTIQ------------------------------RTLDGRLQVAG
SMAD7_HUMAN  112 LQAVESRGGTR-TACLLLP------------------------------GRLDCRLGPGA
consensus    121  kAittq   n tkCvtip                              rsLDgRLqvsh
SMAD2_HUMAN  120 RKGLPH----------VIYCRLWRWPDLHSHHELKAIENCEYAFNLKKDEVCVNPYHYQR
SMAD3_HUMAN   80 RKGLPH----------VIYCRLWRWPDLHSHHELRAMELCEFAFNMKKDEVCVNPYHYQR
SMAD4_HUMAN   87 RKGFPH----------VIYARLWRWPDLHKN-ELKHVKYCQYAFDLKCDSVCVNPYHYER
SMAD7_HUMAN  141 PAGAQPAQPPSSYSLPLLLCKVFRWPDLRHSSEVKRLCCCESYGKINPELVCCNPHHLSR
consensus    181 rkGlph          viycrlwRWPDLhshhElkaie CeyafnlkkdeVCvNPyHyqR
SMAD2_HUMAN  170 VETPVLPPVLVPRHTEILTEL-------------PPLDDYTHSI------PEN------T
SMAD3_HUMAN  130 VETPVLPPVLVPRHTEIPAEF-------------PPLDDYSHSI------PEN------T
SMAD4_HUMAN  136 VVSPGIDLSGLTLQSNAPSSMMVKDEYVHDFEGQPSLSTEGHSIQTIQHPPSNRASTETY
SMAD7_HUMAN  201 LCELESPPPP---YSRYPMDF---------------------------------------
consensus    241 vetpvlppvlvprhteiptef             pplddythsi      pen      t
SMAD2_HUMAN  205 NFPAGIEPQ----------------------SNY----------IPETPPPGYISEDGE-
SMAD3_HUMAN  165 NFPAGIEPQ----------------------SN-----------IPETPPPGYLSEDGE-
SMAD4_HUMAN  196 STPALLAPSESNATSTANFPNIPVASTSQPASILGGSHSEGLLQIASGPQPGQQQN-GFT
SMAD7_HUMAN  219 -----LKPT----------------------AD-----------CPDAVPSS--------
consensus    301 nfpagiePq                      sn           ipetpppgyisedge 
SMAD2_HUMAN  232 --T----------S------------DQQLNQSMDTGSPAELSPTTLSPVNHSLDLQPVT
SMAD3_HUMAN  191 --T----------S------------DHQMNHSMDAGSPN-LSPNPMSPAHNNLDLQPVT
SMAD4_HUMAN  255 GQPATYHHNSTTTWTGSRTAPYTPNLPHHQNGHLQHHPPMPPHPGHYWPVHNELAFQPPI
SMAD7_HUMAN  233 ---------------------------------AETGGTNYLAPGGLSDSQ--LLLEPG-
consensus    361   t          s            dhqln smdtgspn lsPg lspvhn LdlqPvt
SMAD2_HUMAN  268 Y--SEPAFWCSIAYYELNQRVGETFHAS--QPSLTVDGFTDPSNSERFCLGLLSNVNRNA
SMAD3_HUMAN  226 Y--CEPAFWCSISYYELNQRVGETFHAS--QPSMTVDGFTDPSNSERFCLGLLSNVNRNA
SMAD4_HUMAN  315 SNHPAPEYWCSIAYFEMDVQVGETFKVPSSCPIVTVDGYVDPSGGDRFCLGQLSNVHRTE
SMAD7_HUMAN  257 ----DRSHWCVVAYWEEKTRVGRLYCVQ--EPSL--DIFYDLPQGNGFCLGQLNSDNKSQ
consensus    421 y   epafWCsiaYyElnqrVGetfh s  qPsltvDgftDpsn erFCLG Lsnvnrna
SMAD2_HUMAN  324 TVEMTRRHIGRGVRLYYIGG-EVFAECLSDSAIFVQSPNCNQRYGWHP-ATVCKIPPGCN
SMAD3_HUMAN  282 AVELTRRHIGRGVRLYYIGG-EVFAECLSDSAIFVQSPNCNQRYGWHP-ATVCKIPPGCN
SMAD4_HUMAN  375 AIERARLHIGKGVQLECKGEGDVWVRCLSDHAVFVQSYYLDREAGRAPGDAVHKIYPSAY
SMAD7_HUMAN  309 LVQKVRSKIGCGIQLTREVD-GVWVYNRSSYPIFIKSATLDNPDSRTL--LVHKVFPGFS
consensus    481 ave tRrhIGrGv Lyyigg eVf eclSdsaiFvqSpn  qryg hp atV KipPgcn
SMAD2_HUMAN  382 LKIFNNQEFAALLAQ---------------S--------------------VNQGFEAVY
SMAD3_HUMAN  340 LKIFNNQEFAALLAQ---------------S--------------------VNQGFEAVY
SMAD4_HUMAN  435 IKVFDLRQCHRQMQQQAATAQAAAAAQAAAVAGNIPGPGSVGGIAPAISLSAAAGI-GVD
SMAD7_HUMAN  366 IKAFDYEKAYSLQR-------------------------------------P-NDHEFMQ
consensus    541 lKiF nqefaallaq               s                    vnqgfeavy
SMAD2_HUMAN  407 QLTRMCTIRMSFVKGWGAEYRRQTVTSTPCWIELHLNGPLQWLDKVLTQMGSPSVRCSSM
SMAD3_HUMAN  365 QLTRMCTIRMSFVKGWGAEYRRQTVTSTPCWIELHLNGPLQWLDKVLTQMGSPSIRCSSV
SMAD4_HUMAN  494 DLRRLCILRMSFVKGWGPDYPRQSIKETPCWIEIHLHRALQLLDEVLHTM--PIADPQPL
SMAD7_HUMAN  388 QPWTGFTVQISFVKGWGQCYTRQFISSCPCWLEVIFNSR---------------------
consensus    601 qltrmctirmSFVKGWGaeYrRQtvtstPCWiElhlngplqwldkvltqmgspsvrcssm
SMAD2_HUMAN  467 S
SMAD3_HUMAN  425 S
SMAD4_HUMAN  552 D
SMAD7_HUMAN      -
consensus    661 s
MH1
MH1
MH1
MH1
MH1
MH2
MH2
MH2
MH2
MH2
Figure 1.4: Sequence alignment between SMAD2, SMAD3, SMAD4 and
SMAD7. MH1 and MH2 domains are indicated in green. Sequence alignment
was done using M-Co￿ee so￿ware [15].
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1.2.2 SMAD interacting proteins
Many SMAD interacting proteins have been characterised in the last
decade [1]. In this section some examples will be introduced with spe-
cial emphasis on the mode of binding to the SMAD proteins.
Smad anchor for receptor activation (SARA) is a protein that serves as
a mediator between the TGF  type I receptor and SMAD2/3 [16]. A￿er
the phosphorylation of the SMAD, the a￿nity of SARA to SMAD2/3
decreases signi￿cantly, allowing the release of the activated SMAD2/3.
SARA interactswith SMAD2/3 through its SMADbinding domain (SBD),
which is accommodated on the hydrophobic corridor of SMAD2/3 adopt-
ing an extended conformation [12].￿e large area of SMAD2/3 covered
by the SBD inhibits the e￿cient formation of SMAD2/3 trimers and thus
SARA only binds to monomeric, unactivated SMAD2/3 [12].
Inside the nucleus, the activated R-SMADs formprotein complexeswith
cofactors and DNA promoter sites. Among these cofactors, one of the
best studied is the forkheadmember FOXH1, a transcriptional co-activa-
tor that recruits the SMAD2/3-SMAD4 complex to the activin response
element (ARE) [17]. Speci￿cally, FOXH1 can bind to SMAD2/3 through
its SMAD interacting motif (SIM), a proline-rich motif that binds to the
↵-helix 2 of SMAD2 MH2 [18]. ￿is motif is not exclusive to FOXH1
related proteins but it is also found in other SMAD2-binding proteins
such as the homeodomain Mixer [19]. In contrast to SARA, the inter-
action between the FOXH1 and SMAD2 does not interrupt the bind-
ing between two activated SMAD2 proteins, allowing the interaction
between FOXH1 and the trimer [20]. In addition, FOXH1 also has a
Fast/FoxH1 motif (FM) that can interact with a hydrophobic pocket of
SMAD/SMAD interface [21]. ￿is novel interacting motif is speci￿c
only to phosphorylated SMAD2, therefore, in contrast to SIMmotif, FM
do not bind to SMAD3. Moreover, this motif is only present in FOXH1
related proteins, which di￿erentiates the interaction between FOXH1
and Mixer versus SMAD2 [21].
Another SMAD2/3 binding partners are the transcriptional co-activators
p300 and cyclic AMP response element-binding protein (CBP). ￿ese
7
1 Introduction
two similar proteins, both with histone acetyltransferase (HAT) activ-
ity, are recruited to chromatin by SMAD2/3 complexes. ￿ere, acety-
lation of the H3 and H4 histone tails promotes a rearrangement of the
nucleosomes, enabling a be￿er access for the transcriptional machin-
ery [22]. Moreover, p300/CBP also acetylates SMAD proteins at their
MH1 to enhance its a￿nity to DNA [23].
In addition to the interaction with co-transcriptional activators, SMAD
proteins can also interactwith transcriptional suppressors. For instance,
SKI and Ski-like proteins bind to the MH2 of SMAD2 and SMAD4 inter-
fering with the formation of the SMAD trimeric complexes [24]. In par-
allel to these mechanisms, SMADs can also recruit the complex formed
by the nuclear receptor corepressor 1(N-CoR), mSin3A and Histone
deacetylase 1 (HDAC1), which suppresses the gene transcription in an
opposite way to p300/CBP [25]. Another examples include 5’-TG-3’ in-
teracting factor 1 (TGIF1) that competes with p300/CBP for SMADs in-
teraction and ecotropic virus integration site 1 protein homolog (EVI1)
that inhibits SMAD3 binding to DNA [20].
1.3 TGIF1
5’-TG-3’ interacting factor 1 (TGIF1)was discovered in 1995 by Bertolino
et al. as a novel protein that binds to the retinoid X receptor responsive
element (RXRE), promoter of the rat retinol-binding protein II (CRBPII)
[26] (Figure 1.5). Homology analysis identi￿ed TGIF1 as a member of
the atypical homeodomain (HD) family of proteins. Further sequence
comparison of TGIF1 and other HD members revealed a three amino
acid insertion between helices 1 and 2.￿ese three residues are shown
to form a common feature among some of the proteins of the growing
atypical homeodomain group.￿us, the authors proposed three amino
acid loop extension (TALE) homeodomain class as a name to this new
group of proteins. Nowadays, this arrangement is still valid as TGIF1 is
classi￿ed as a member of the TGIF family, under the TALE superclass
[27]. Bertolino et al. also determined, by EMSA experiments, the 5’-
TGTCA-3’ motif as the DNA sequence where the homeodomain TGIF1
8
1.3 TGIF1
preferentially binds. Besides, they found TGIF1 mRNA in most tissues,
especially in placenta, prostate, testis and ovary. In contrast, there was
no detection of mRNA in brain neither in muscle tissues [26].
Few years later, in 1999, Wo￿on et al. discovered the corepressor role
of TGIF1 in TGF  pathway [28]. ￿e ￿rst evidence was the identi￿ca-
tion of TGIF1 as an interacting factor of SMAD2 by a two-hybrid library.
Further immunochemistry experiments con￿rmed the binding between
TGIF1 and SMAD2 and SMAD3, weaker with SMAD1 and none with
SMAD4. In all positive cases, the binding was enhanced by the activa-
tion of the TGF  pathway. Moreover, the authors pointed out the nu-
clear localisation of TGIF1 and, for ￿rst time, it was found that TGIF1
inhibits the induced TGF  pathway [28]. Indeed, TGIF1 expression re-
presses the transcription of plasminogen activator inhibitor-1 (PAI-1),
a protein widely used to monitor TGF  signalling. Moreover, when
TGIF1 expression is reduced, the levels of PAI-1 increases again.
In other studies, TGIF1 functionwas also relatedwith holoprosencephaly
(HPE) [29]. HPE is a developmental defect that provokes brain malfor-
mation among many other consequences [30].￿e causes are both en-
vironmental and genetic, including mutations in Sonic hedgehog pro-
tein (SHH) and SIX3 proteins. Further genetic analysis of patients car-
rying this disease led to discover that heterozygous mutations in the
Tgif gene (localised in chromosome 18p11.3 [31]) were also causing
HPE [29]. ￿is result was supported by the fact that TGIF1 has a rele-
vant role during embryogenesis, specially for the formation of the cen-
tral nervous system [32]. Further research found other HPE associated
mutations [33] and linked the disease to TGIF1 regulation upstream of
SHH [34].
￿e implication of TGIF1 with the myelopoiesis (subprocess of hemato-
poiesis) was con￿rmed with the revelation of 1655 direct TGIF1 targets
in HL60 cell line [35]. 35% of those genes were related with cell func-
tion, 18% with hematopoiesis, 16% with organ development among oth-
ers aspects of cell function. Not surprisingly, proteins that are related to
TGF  pathway are among them, as TGF  receptor 2 (TGFBR2), FOXH1
or TGIF2 [35].
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TGIF1_HUMAN    1 MVLAQSRVS--AGVGS----------PHCS---GS-------GGGGSDSFPWPASHPGNP
TGIF2_HUMAN    1 ------------------------------------------------------------
MEIS1_HUMAN    1 MAQRYDDLPHYGGMDGVGIPSTMYGDPHAARSMQPVHHLNHGPPLHSHQYPHTA-HTNAM
PBX1_HUMAN     1 MDEQPRLMHSHAGVGM-----AGH--PGLSQHLQD-------GAGGTEGEGGRKQDIGDI
HXC9_HUMAN     1 MSATGPISNYYVDSLI-------------SH--DN-------EDLLASRFPATGAHPAAA
TGIF1_HUMAN   39 QCSFSTAFLASPRLSRGTLAYLPPAPWSSLATPSALLGSSCAPPPPP-A-----------
TGIF2_HUMAN    1 ------------------------------------------------------------
MEIS1_HUMAN   60 APSMGSSVNDALKRDKDAIYGHPLFPLLALIFEKCEL-ATCTPREPG-VAGGDVCSSESF
PBX1_HUMAN    47 LQQIMTITDQSLDE-----AQARKHALNCHRMKPALFNVLCEIKEK--------------
HXC9_HUMAN    39 RPSG-------------LVPDCSDFPSCSFAPKPAVFSTSWAPVPSQSS-----------
TGIF1_HUMAN   87 ---RCP---QPRALSPELGTKA--------------------------------------
TGIF2_HUMAN    1 ------------------------------------------------------------
MEIS1_HUMAN  118 NEDIAVFAKQIRAEKPLFS---SNPELDNLMI----------------------------
PBX1_HUMAN    88 ---TVL---SIRGAQEEEPTDPQLMRLDNMLLAEGVAGPEKGGGSAAAAAAAAASGGAGS
HXC9_HUMAN    75 ---VVY---HPYGPQPHLGADTRYMRTWLEPLSGAVSFPSFPAGGRHYALKPDAYPGRR-
TGIF1_HUMAN  103 --------------GPRRPHRWELPRSPSQG-----------------------------
TGIF2_HUMAN    1 ------------------------------------------------------------
MEIS1_HUMAN  147 -----------QAIQVLRFHLLELEKVHELCDNFCHRYISCLKGKMPIDLVIDDREGGSK
PBX1_HUMAN   142 DNSVEHSDYRAKLSQIRQIYHTE-------------------------------------
HXC9_HUMAN   128 ------------------------------A-----------------------------
TGIF1_HUMAN  120 ------------AQGPAPRRRLLETMKGI---------------------VAASGSETED
TGIF2_HUMAN    1 ----------------------------------------------------MSDSDLGE
MEIS1_HUMAN  196 SDSEDITRSANLTDQPSWNRDHDDTASTRSGGTPGPSS---GGH------TSHSGDNSSE
PBX1_HUMAN   165 --------------LEKYEQACNEFTTHVMNLLREQSRTRPISPKEIERMVSIIHRKFSS
HXC9_HUMAN   129 ------------DCGPGEGRSYPDYMYGSPGELRDRAPQTLPSPEA----DALAGSKHKE
TGIF1_HUMAN  147 -EDSMDI--PL--D----LSSSAG--SGKRRRRGNLPKE-SVQILRDWLYEHRYNAYPSE
TGIF2_HUMAN    9 -------------D----EGLLSL--AGKRKRRGNLPKE-SVKILRDWLYLHRYNAYPSE
MEIS1_HUMAN  247 QGDGLDN-SVASPSTGDDDDPDKD--KKRHKKRGIFPKV-ATNIMRAWLFQHLTHPYPSE
PBX1_HUMAN   211 IQMQLKQSTCEAVM----ILRSRF--LDARRKRRNFNKQ-ATEILNEYFYSHLSNPYPSE
HXC9_HUMAN   173 EKADLDPSN---------PVANWIHARSTRKKRCPYTKYQTLELEKEFLF----NMYLTR
TGIF1_HUMAN  195 QEKALLSQQTHLSTLQVCNWFINARRRLLPDM--------LRKDGKDPNQFTISRRGAKI
TGIF2_HUMAN   49 QEKLSLSGQTNLSVLQICNWFINARRRLLPDM--------LRKDGKDPNQFTISRRGGKA
MEIS1_HUMAN  303 EQKKQLAQDTGLTILQVNNWFINARRRIVQPMI--------DQSNRAVSQGTPYNPDGQP
PBX1_HUMAN   264 EAKEELAKKCGITVSQVSNWFGNKRIRYKKNIGKFQEEANIYAAKTAVTATNVSAHGSQA
HXC9_HUMAN   220 DRRYEVARVLNLTERQVKIWFQNRRMKMKKMN----------KE----------------
TGIF1_HUMAN  247 SETSSV----ESVMGIKNFMPALEETPFHSCTAGPNPTLGRPLSPKPSSPGSVLARPSVI
TGIF2_HUMAN  101 SDVALPRGSSPSVLAVSVPAPTNVL------------------S------L------SVC
MEIS1_HUMAN  355 MGGFVMDGQQHM--GIRAPGP---------------------------------------
PBX1_HUMAN   324 NSPSTPNSAGSS-SSFN-MSNSGDL------------------F------MSV----QSL
HXC9_HUMAN   254 ------------------------------------------------------------
TGIF1_HUMAN  303 -CHTTVTALKDVPFSLCQSVGVGQNTDIQQIAAKNFTDTSLMYPEDTCKSGPST-NTQSG
TGIF2_HUMAN  131 -SMPLHSGQGEKPAAPFP---RGELESPKPLVTPGSTLTLLTRAEA----GSPT----GG
MEIS1_HUMAN  374 ------------------------------------------------------------
PBX1_HUMAN   354 NGDSYQGAQ-VGANVQSQVDTLRHVISQTGGYSDGLAASQMYSPQGISANGGWQDATTP-
HXC9_HUMAN   254 ------------------------------------------------------------
TGIF1_HUMAN  361 LFNTPPPTPP-DLN-QDFSGFQLLVDVALKRAAEMELQAKLT-----------------A
TGIF2_HUMAN  179 LFNTPPPTPP-EQDKEDFSSFQLLVEVALQRAAEMELQKQQDPSLPLLHTPIPLVSENPQ
MEIS1_HUMAN  374 -------MSGMGMN-MGMEG-----------------QWHY------------------M
PBX1_HUMAN   412 SSVTSPTEGPGSVH-SDTS----------------------------------------N
HXC9_HUMAN   254 -----------KT-------------------------DKEQ-----------------S
Homeodomain
Homeodomain
Arg-rich
TALE
Figure 1.5: Sequence alignment between TGIF1 and TGIF2 (43.1% identity
with TGIF1), MEIS1 (20.3%), PBX1 (18.6%) and HOXC9 (18.3%) proteins. ￿e
￿rst four belong to Homeodomain-TALE super class proteins while HOXC9
is a HOX-nonTALE Homeodomain protein. In green is indicated the home-
odomain, in red is highlighted the arginine-rich region before the home-
odomain and in blue is shown the TALE motif for those TALE proteins. Se-
quence alignment was done using M-Co￿ee so￿ware [15].
TGIF1 is a short-lived protein with a half-life of less than 30 min [36].
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Nevertheless, phosphorylation of threonines 364 and 368 by epidermal
growth factor (EGF) (via ERK kinases) increases the half-life up to 1
h [36]. Interestingly, if these two threonines are mutated to valines,
the half-life is also incremented. ￿ese results led to the conclusion
that both threonines 364 and 368 are critical for the degradation of the
protein, and their phosphorylation or mutation prevents the process
[36]. Indeed, in 2010, F-box/WD repeat-containing protein 7 (FBXW7),
a substrate-recognition factor of SCF ubiquitin ligase, was shown to
interact with TGIF1 [37]. Nevertheless, FBXW7 only recognises phos-
phorylated substrates, meaning the phosphorylated long-lived TGIF1
was the only one to be recognised for degradation.￿is paradox could
be explained by the identi￿cation of a secondway of TGIF1 degradation
by PHD and RING ￿nger domain-containing protein 1 (PHRF1) ubiqui-
tin ligase [38], not related to FBXW7.
In 2000, a second member of TGIF family, named TGIF2 (43.1% iden-
tity with TGIF1, Figure 1.5), was discovered [39]. TGFI2 is shorter than
TGIF1 (237 amino acids long), missing the ￿rst 130 residues plus the
ones between 297 and 347 of TGIF1. Nevertheless, the homeodomain
is conserved with high similarity. Further research revealed that TGIF2
also represses transcription and binds to HDAC1, but because of miss-
ing amino acids, TGIF2 was unable to bind C-terminal-binding protein
1 (CtBP) [40]. Overall, it was suggested that TGIF2 has many over-
lapped functions with TGIF1.
1.3.1 TGIF1 structure
￿e NMR structure of the homeodomain (173-230) was deposited in the
PDB by theNortheast Structural Genomics Consortium (TargetHR4411B;
PDB id: 2LK2). ￿e structure maintains the typical HD shape formed
by three ↵-helices. ￿ere is no structure of TGIF1 in complex with
DNA, but the ↵-helix 3 is considered as the potential DNA binding
site by comparison with the other HD structures.￿e histine-arginine-
tyrosine residues, de￿ned as the TALE element, are localised between
↵-helix 1 and ↵-helix 2, at positions 186-188 (Figure 1.6 A).
11
1 Introduction
α-Helix 1 α-Helix 2
α-Helix 3
TALE
N-terminus
C-terminus
TGIF1 HD (2LK2)A.
α-Helix 1
α-Helix 2
α-Helix 3
TALE
N-terminus 
with Arg-rich region
C-terminus
α-Helix 4
HOX-B1
DNA
PBX1 + HOX B1 + DNA (1B72)B.
PBX1
Figure 1.6: A) Structure of TGIF1 Homeodomain (173-230) by NMR (PDB id:
2LK2). B) Crystal structure of the complex PBX1 - HOX B1 - DNA (PDB id:
1B72).
￿e crystal structure of PBX1, another TALE superclass protein (18.6%
identity with TGIF1, Figure 1.5), in a complex with HOX B1 and DNA
(PDB id:1B72), reveals that the interaction between the two proteins
is mediated through the hydrophobic C-terminal tail of HOX B1 that
binds to the pocket formed between the↵-helix 3 and the three residues
of the TALE in the PBX1 [41] (Figure 1.6 B).￿is interaction suggests
that the three amino acids of the TALE segment might be relevant for a
protein-protein interactions in other proteins that belong to the TALE
superclass. Moreover, the structure of the PBX1 reveals a fourth ↵-
helix, just a￿er the third one in the sequence (Figure 1.6 B). However,
this fourth ↵-helix is not observed in another TALE protein (MEIS1,
20.3% identity with TGIF1, Figure 1.5, PDB id: 5BNG [42]) and may
be speci￿c to the PBC family. Also, in the crystal structure, PBX1 binds
DNA not only through the third ↵-helix (as commonly for HD proteins)
but also through the N-terminal region of the HD, rich in arginines (Fig-
ures 1.5 and 1.6 B).
In contrast, the structure of the rest of TGIF1 is poorly understood. In
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order to have more information about it, we have performed protein
structure prediction using the MetaDisorderMD2 programme [43].￿e
result suggests that the protein is mainly disordered, with the exception
of the HD and a 15 residues segment near to the C-terminus (Appendix
Figure 7.1)
1.3.2 Role of TGIF1 in the TGF  signalling pathway
TGIF1 is a transcription factor that suppresses the transcription of genes
under the regulation of the TGF  signalling [28].￿e interaction with
SMAD2/3, enhanced by the activation of TGF , suggests a regulation
at nuclear level. In addition, it was demonstrated that TGIF1 bridges
between SMAD2 and HDAC1, a known co-suppressor. Based on this
information, a model where activated SMAD2/3 complex could bind ei-
ther to p300/CBP, thus promoting gene expression, or to TGIF1 bridging
HDAC1, suppressing the gene transcription, was proposed [28] (Figure
1.1).
Further experiments revealed that TGIF1 not only represses di￿erent
promoters but also inhibits the gene expression even if the promoters
are localised far away from the beginning of the transcription site [44].
Moreover, TGIF1 is capable to repress without direct binding to DNA.
With these results, it has been suggested that TGIF1 can act as a gen-
eral suppressor factor instead of being speci￿c to one cell response. In
this context, three di￿erent regions were identi￿ed to be able to repress
transcription independently [44] (Figure 1.8 A). One region, located in
237-321, seems to be HDAC1 dependent in order to suppress the tran-
scription. However, the two other suppressing regions (130-171 and
337-401) may not need the presence of HDAC1 to inhibit the gene ex-
pression.
Interestingly, a new study demonstrated that the region 130-171 of TGFI1
binds to CtBP1 through the conserved motif PLDLS located in that re-
gion [45]. ￿e complex TGIF1-CtBP1 can repress independently from
HDAC1 but it was found that HDAC1 can also interact with TGIF1
even when CtBP1 is already bound to TGIF1. Furthermore, it was also
found that the TGIF1 region (337-401) also recruits its own co-repressor,
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mSin3 [46]. mSin3 has been shown to be associated with HDAC1s
forming a suppressor complex. ￿e global picture suggests that TGIF1
serves as a bridge between SMAD2 and the general co-repressor com-
plex HDAC1/mSin3 [46].
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Figure 1.7: Scheme of TGIF1 roles in the TGF  signalling pathway.
Overall, one repressor protein has been identi￿ed to every repressor do-
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main of TGIF1. It is tempting to say that themechanism explaining how
TGIF1 represses the TGF  pathway has been already solved. However,
in another study, the authors tested the inhibition of the TGF  pathway
by TGIF1wild type (WT) and TGIF1with themutations that were found
to cause HPE. Surprisingly, most of the mutants behaved as the wild
type, except for the mutation that, located in the homeodomain, impair
the binding with DNA [29]. Even the mutant that impairs the binding
with CtBP1 (substitution of serine to cysteine on the position 159) had
a similar transcription inhibition. From these results, it seems that the
transcription suppression is performed by di￿erent regions of TGIF1,
being their functions overlapped and that TGIF1 plays more roles in
the cell that the ones already demonstrated.
Indeed, a newTGF  inhibiting pathwaywas discovered, which involves
promyelocytic leukaemia (PML), c-Jun (previously identi￿ed as TGIF1
partner [47]) and TGIF1 [48]. PML is a protein required for the SMAD2
association with SARA and therea￿er activation by type I receptor [49].
But for doing so, PML needs to be located in the cytoplasm. However,
the complex of c-Jun/TGIF1 can bind and sequester PML in the nucleus
and thus avoid SMAD2 activation.
￿e identi￿cation of a PML competitor for TGIF association (PCTA;
also known as IRF2BP1) added more complexity to the pathway [50].
PCTA has the ability to compete with cPML for TGIF1. ￿en, when
PCTA is present, PML will be released and the SMAD2 activation will
proceed. Globally, this new scheme details a novel role of TGIF1 in
the suppression of the TGF  pathway, inhibiting, not only the gene
transcription as it has been studied before [28], but also the activation
of the R-SMADs at the beginning of the signalling cascade (Figure 1.7).
￿ese studies [44, 48, 50] highlight TGIF1 as one of the main suppres-
sors of the TGF  signalling pathway.
1.3.3 Roles of TGIF1 in another pathways
￿e roles of TGIF1 in human cells are not restricted to the TGF  path-
way, but TGIF1 is also involved in the regulation of another pathways.
For instance, TGIF1 also binds to Axin-1 or Axin-2, sequestering them
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in the nucleus [51]. Axin-1 or Axin-2 are the limiting components for
the degradation complex of  -catenin, the ￿nal transductor of the Wnt
signalling pathway [52].￿e function of TGIF1 is to ￿ne tune the levels
of  -catenin in the cell for a correct signal response upon Wnt binding
[53]. TGIF1 has also been associated with p38 MAPK in the context
of proin￿ammatory phenotype of endothelial cells a￿er irradiation or
a￿er TNF-↵ exposure [54]. Moreover, the binding with c-Jun also fa-
cilitates a cross-talk between both pathways [47]. Other functions of
TGIF1 include the regulation mechanism of the mouse axial pa￿erning
[55] and the inhibition of the retinoid signalling via interaction with
the retinoid response elements [56].
Collectively, these discoveries make TGIF1 a key actor in many path-
ways. Although it has not been explored in detail, TGIF1 could also act
as a regulator of the cross talk between di￿erent pathways as a transver-
sal transcriptional suppressor.
1.3.4 TGIF1 - SMADs interaction
￿e discovery of the SMAD2/TGIF1 interaction was performed through
a two-hybrid librarywith a LexA/SMAD2 (100-467) protein.￿is means
that the region of SMAD2 bound to TGIF1 included a fragment of MH1,
the linker and the MH2 [28]. However, SMAD2 and SMAD3 are very
similar in sequence (83.94% of identity, Figure 1.5) and the antibodies
raised against one protein can recognise also the other. ￿erefore, the
results performed with SMAD2 can be extrapolated also to SMAD3.
On the TGIF1 side, the region between the residues 267 and 321, known
as SMAD interacting domain (SID), has been proposed to interact with
SMAD2 [28]. In Figure 1.8 B is displayed where is this region localised
along TGIF1 sequence, together with the other TGIF1 interacting pro-
teins.
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Figure 1.8: Scheme of TGIF1 repression domains (A) [44] and interactions
sites with partner proteins (B). In green are shown the repressor domains, in
orange are drawn the regions where the proteins that interact with TGIF1 bind
and in blue is highlighted the interacting region with SMAD2. ￿e red lines
on TGIF1 sequence represent the phosphorylated residues found in di￿erent
studies [36, 57].￿e ￿rst 130 residues are not considered for TGIF1 study.
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1.4 Peptide ligation
For more than 100 years chemists have been trying to synthesise the
full proteome [58]. ￿e full chemical synthesis of proteins will permit
not only the introduction of post-translational modi￿cations (PTM) (in-
cluding phosphorylation, glycosylation, acetylation, etc. [59]), but also
the incorporation of non natural amino acid and speci￿c labels. Overall,
it will allow a complete protein manipulation at atomic level opening
the door to new strategies regarding protein modi￿cation, protein la-
belling and structure determination [60, 61, 62].
Although it is still a long term objective, many steps in that direc-
tion have been already done. In 1963, the development of the Solid-
Phase Peptide Synthesis (SPPS) by Merri￿eld [63] revolutionised the
way to synthesise peptides allowing a fast and e￿cient synthesis on
solid supports. Many improvements have been incorporated to the
original method such as the development of the Fmoc chemistry, the
adoption of enhanced resins and reagents or the use of peptide synthe-
sisers assisted with microwave technology, among others. However,
incomplete reactions, accumulations of by products and aggregation of
growing peptides are still some of the barriers that limit the synthesis of
long peptides chains [64]. Recently, the use of microwave heating syn-
thesisers have been proved to solve some of the aggregations issues,
enabling to reach more than 100 residues long polypeptides [65, 66].
However, since the average protein length is about 360 amino acids for
Eukarya (270 for Bacteria) [67], it still exists a gap between the main
peptide synthesis technique and the protein world. To overcome this
limitation, many new techniques have been developed that enable the
ligation of two or several peptide fragments to get a longer one.
Generally speaking, there are three basic strategies to ligate two pep-
tides. One involves the use of thiol auxiliary (via cysteine or external
thiol group). Another strategy is based on the direct aminolysis be-
tween the two peptides, without the requirement of a thiol group. Fi-
nally, the last strategy comprise a diverse array of methods that, being
orthogonal, and thus chemoselective, to the most of the peptide and bi-
ological chemistry, can generate an amide bond between two peptides.
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1.4.1 Thiol assisted strategies
In 1989, Kemp and coworkers presented the last part of a new liga-
tion method in which two peptides are bound through a peptide bond
[68]. ￿is method established the basis for the thiol based method-
ology as it was the ￿rst demonstration of a chemoselective ligation
of unprotected peptide fragments. In this reaction, the 4-hydroxy-6-
mercaptodibenzofuran moiety at C-terminus of the ￿rst peptide is used
to react with the sulfenyl derivate at N-terminus of the second peptide
(Figure 1.9 A).￿e reaction, favourable due to the good leaving group
generated, links both peptides. A subsequent acyl transfer reaction cre-
ates a native bond between both peptides. Finally, a reduction with
phosphine reduction yields the desired ligated product. In addition, the
reaction proceed without racemization of the coupled amino acids.
In 1953,Wieland and coworkers demonstrated for the ￿rst time a dipep-
tide ligation between a phenyl thioester valine and a cysteine residue
under aqueous conditions [69]. Based on this achievement, Kent and
coworkers developed in 1994 the most successful peptide ligation, the
Native Chemical Ligation (NCL) [70], between a C-terminal thioester
peptide and an N-terminal cysteine peptide (Figure 1.9 B). It starts with
the a￿ack of the side-chain cysteine to the thioester carbonyl in a re-
versible transthioesteri￿cation step. A subsequent spontaneous intra-
molecular S ! N acyl transfer through a ￿ve-membered ring forms
the amide bond between both peptides. Interestingly, the reaction pro-
ceeds in aqueous medium with all the amino acids unprotected, even
other cysteines; an indication of the high selectivity of the reaction.
Guanidinium chloride or any equivalent chaotrope is usually added to
prevent aggregation during the reaction.
￿e resultant product, however, ends with a cysteine residue in the lig-
ation junction. As cysteine is one of the less common amino acid in
the proteome (between 1-2 %, [71, 72]), it raises as the major limita-
tion. Moreover, back in 1994 there were no methods to prepare peptide
thioesters using Fmoc/tBu chemistry. ￿us, it was mandatory to use
Boc/Bzl chemistry, which prevents the synthesis of phosphopeptides
and glycopeptides due its strong acid conditions. Both conditions plus
the long reaction time of the ligation reaction (48-72 h) limited the prac-
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strategies.
tical applicability of this new ligation method.
Nowadays, most of the above-mentioned are greatly overcome.￿e in-
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corporation of a thiol catalyst, ￿rst thiophenol [73] and later 4-(carboxy-
methyl)thiophenol (MPAA) [74] speeds up the reaction up to 2 h. More
advances include the development of the linker chemistry that allowed
the synthesis of thioesters with Fmoc/tBu strategy at high yields [75,
76]. Finally, post-ligation desulfuration processes of the thiol group
have increased the versatility of the NCL. First, in 2001, Yan and Daw-
son explored the desulfuration of the cysteine to alanine with di￿er-
ent combinations of metal catalysts [77]. Although the use of metals
is inconvenient (peptide absorption on the metal surface, reduction of
methionine and thiazolidine-protected cysteines), this work opened the
door to the expansion of native residues that can be used at the liga-
tion site. Interestingly, in 2007, Wan and Danishefsky presented a new
radical-promoted method for the desulfuration of the cysteine to ala-
nine [78].￿is newmethod requires only tris(2-carboxyethyl)phosphine
(TCEP), radical initiator 2,20-azobis[2-(2-imidazolin-2-yl)propane]dihy-
drochloride (VA-044) and tBuSH in water medium to achieve the se-
lective desulfuration of non-protected cysteines, even in the presence
of methionines, thioesters or glycopeptides. Nowadays, not only ala-
nine, but also valine, lysine, leucine, threonine or proline can be gener-
ated at the ligation junction in metal-free post-ligation reactions. Over-
all, these innovations make the native chemical ligation method much
more a￿ractive.
Since the publication of the Native Chemical Ligation, the peptide liga-
tion ￿eld has expanded with new approaches that complement the NCL
[79].￿e auxiliary-based methods relay on the use of a removable moi-
ety to perform the ligation.￿is auxiliary group mimics the function of
the cysteine and the process proceeds in a similar way as the prior thiol
capture from Kemp and coworkers [68]. In general, the auxiliary motif
contains one thiol group, which carries out the transthioesteri￿cation
step with the thioester at C-terminal of the ￿rst peptide. Similarly to
NCL, an S! N acyl shi￿ generates an amide bond between both pep-
tides. Finally, the auxiliary group is removed.￿is auxiliary group can
be linked to the N-terminal [80] or to the side-chain of some amino
acids, as sugar-assisted glycopeptide ligation (SAL) [81, 82]. Curiously,
Wong and coworkers found inspiration in this reaction to develop the
cysteine-free direct aminolysis [83], when they discovered that the re-
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action could even proceed in the absence of a thiol auxiliary. However,
the multistep auxiliaries preparation and the moiety removal drop the
overall yield of the ligation reaction. Moreover, the ligation rate of the
reactions is always lower than the original NCL, increasing side reac-
tions such as hydrolysis and epimerization.
With the objective to synthesise longer and more complex proteins,
sequentially ligations have been studied. ￿e use of 1,3-thiazolidine-
4-carboxo (￿z) group to protect the N-terminal cysteine opened the
door to sequential C-to-N ligations. ￿z, orthogonal to the main pep-
tide synthesis conditions (including NCL), can be mild removed under
methozyamine at pH 4.0, generating an N-terminal cysteine residue
ready to react [84]. On the other hand, kinetically controlled ligation
(KCL), developed also by Kent and coworkers [85], enables a selective
NCL in the presence of a second thioester. It takes advantage of the dif-
ferent ligation speed depending whether the thioester is aryl (faster) or
alkyl (slower), controlling at the same time the catalysers added (such
as thiophenol or MPAA).
￿e scope of the NCL was further expanded with the development of
the expressed protein ligation (EPL) strategy [86]. EPL takes advan-
tage of the intein proteins to generate a C-terminal thioester that would
proceed with an standard NCL (Figure 1.10). ￿e inteins are the force-
driving proteins in the enzymatic process known as ”protein splicing”.
Analogue to RNA splicing, the intein protein, surrounded by a C and
N-terminal exteins, cleaves itself at the same time that joins both ex-
tremes of the exteins.￿e resulting joined extein does not take part in
the process. Remarkably, a mutation of the C-terminal aspartic acid to
alanine in the intein protein prevents the ￿nal cleave and stops the pro-
cess in the equilibrium between the thioester and the amide form [87].
￿us, a protein of interest can be expressed in a heterologous system
together with the mutated intein. A￿er protein puri￿cation, the addi-
tion of a thiol agent (as 2-mercapoethanesulfonate (MESNA)) generates
the recombinant thioester (now without the intein) ready to react with
an N-terminal cysteine of a synthetic peptide or another recombinant
protein.
￿anks of the EPL, nowadays it is possible to ligate two recombinant
22
1.4 Peptide ligation
proteins (or a mixture recombinant-synthetic) via NCL, broadening the
ligation options to a new high level [88]. However, as common desulfu-
ration techniques cannot be used (all cysteines are unprotected), there
is still the limitation to have a cysteine at the ligation junction. Nev-
ertheless, the use of a photocleavable auxiliary have been already re-
ported [89].
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Figure 1.10: Scheme of Expressed Protein Ligation (EPL) from Muir et al..
1.4.2 Direct aminolysis strategies
Since the￿rst successful direct coupling between two peptides described
byKemp et al. in the 70s [90, 91], many direct aminolysis strategies have
been developed.￿e ￿rst a￿empts were performed with protected pep-
tides dissolved in organic solvents due their poor solubility in water.
However, the reactions su￿ered from epimerization of the C-terminal
↵-carbons.
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One step forward was the method designed by Blake [92], based on a
thiocarboxyl segment condensation strategy in the presence of silver
(Figure 1.11 A). ￿e cations of silver selectively activate the carbonyl
group at the C-terminal of the thiocarboxylic ending peptide.￿e acti-
vated group reacts then with the N-terminal amino group of the second
peptide, binding both peptides through a peptide bond. No protection
groups are needed for side-chain carboxyl but they are for the side-
chain amino groups. However, the reaction causes the epimerization of
the activated thiocarboxyl residue, limiting this protocol to glycine or
proline at the C-terminal position.
An improvement of this method was carried out by Aimoto some years
later [93] (Figure 1.11 B).￿e basic modi￿cation was the exchange of
the thiocarboxyl by a S-alkyl thioester. Because of that, the activation of
the carbonyl group is milder and the nucleophilicity is reduced.￿is re-
duction allows the presence of various protecting groups, including the
acetamidomethyl (Acm) – Cys protecting group, previously discarted
due to the side reactions caused by the activated thiocarboxyl group. In
addition, he found that the addition of 1-hydroxybenzotriazole (HOBt)
or 3,4-dihydro-3-hydroxy-4-oxo-1,2,3-benzotriazine (HOOBt) andN,N -
diisopropylethylamine (DIPEA) to the mixture reaction rises to more
active esters, ending in a e￿cient segment condensation. In his paper,
Aimoto highlights the importance of the peptide thioester synthesis,
as the lower yield obtained stands to be one of the majors limitations
of the method. Other limitations continued to be the racemization at
the C-terminal position and the need of the protecting groups for side-
chain amines and cysteines.
In 2007, Danishefsky and coworkers continued the development of the
ligation method in their research of a reliable strategy for glycopep-
tides ligations [94] (Figure 1.11 C). In their study, they started from
a glycopeptide ending at C-terminus with a phenolic ester bearing a
protected ortho-thio moiety. Apart from Aimoto’s AgCl assisted liga-
tion protocol, they also tried TCEP as a substitute for the Ag cations,
obtaining a similar result. Moreover, the use of TCEP was specially
interesting for orthogonal reactions.￿ey proved that TCEP only acti-
vates acyl donors even in the presence of alkyl thioesters, allowing two
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step ligation. On the other hand, AgCl activates both at the same time.
Nevertheless, the previous limitations were still present. Side-chains
from lysine and cysteine residues were protected by 1-(4,4- dimethyl-
2,6-dioxocyclohex-1-ylidene)-3-methylbutyl (ivDde) and Acm, respec-
tively. Moreover, although they made some e￿orts, they could not ￿nd
any satisfactory condition avoiding the racemization of the C-terminal
amino acid. Hence, all the reactions were performed with a glycine or
a proline at C-terminus.
One year later, Wong and coworkers published the method of a non-
epimerizable cysteine free direct aminolysis [83] (Figure 1.11 D). Based
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on the previous works already explained, they focused their e￿orts on
determining the most suitable bu￿er for a direct aminolysis between
a C-terminal thioester and a free N-terminal peptide without causing
epimerization at the C-terminal residue neither hydrolysis of the thio-
ester. A￿er several trials, they ended with the ligation bu￿er 4:1 v/v
NMP:6 MGuHCl, 1 MHEPES, pH 8,5, where NMP:N -Methyl-2-pyrroli-
done, GuHCl: guanidinium chloride andHEPES: 2-[4-(2-hydroxyethyl)-
piperazin-1-yl]ethanesulfonic acid. Interestingly, the addition of the
peptides prepared in tri￿uoroacetate salts drops the pH to 7.3-7.6, which
actually is the pH that showed less hydrolysis. A￿er the dilution of the
peptides in the bu￿er, 2% thiophenol was added to the mixture in order
to generate a be￿er leaving group at the thioester.￿e reaction was set
at 37ºC with gentle mixing every 12 h.
￿e ligation reactions performed showed an absence of epimerization
at the C-terminal amino acid. Moreover, the hydrolysis observed was
minimal. In order to study the e￿ect of di￿erent combinations at the lig-
ation junction, they synthesised several thioesters and free N-terminal
peptides only changing the last or ￿rst amino acid, respectively. Some
of the combinations, specially those that contain glycine at N-terminal
of the free peptide achieve a quantitative yield. However, those liga-
tions with a tyrosine at N-terminal of the free peptide ended with a
particularly low yield (range 12-39%).￿e authors also ￿gured out that
the N-terminal amino acid of the free peptide seems to be more in￿u-
ential to the reaction yield.
￿e reaction time varied from 48 to 96 h depending on the amino acids
at the ligation junction. However, some additional experiments with
cysteine-containing sequences showed that the native chemical ligation
reaction is faster.￿e same cysteine-containing peptide ligations allow
the authors to prove the chemoselectivity of the reaction when unpro-
tected cysteine was present in the ligated peptides, as they obtained
similar yields with equivalent sequences without cysteines. However,
they could not ￿nd a way to avoid undesired side-reactions with un-
protected lysines.￿us, when lysines are present in the sequence, they
must be protected, e.g. by ivDde. Finally, the authors successfully syn-
thesised a native trimeric 60-mer MUC1 glycoprotein taking advantage
of the described ligation method.
Overall, this work described a great advance to the￿nal goal of a cysteine-
26
1.4 Peptide ligation
free direct aminolysis reaction. It shows for the ￿rst time a chemose-
lective cysteine-free direct aminolysis reaction without epimerization
at the C-terminal residue. In addition, it has already been used in the
synthesis of microcin B17 [95] and polydiscamides B, C and D [96].
Nevertheless, the long reaction times (up to 96 h) and the low yield
exhibit by tyrosine remain the main challenges to be addressed. More-
over, other combinations at the ligation junction, especially those with
relevant di￿culty due to sterically hindrance reasons (e.g. valine or
leucine) [97], need to be studied.
1.4.3 Other peptide ligation strategies
Besides the thiol-assisted and thiol-free peptide ligation reactions, al-
ternative strategies to achieve a native chemical bond between two pep-
tides have been developed [98].
Bode and coworkers presented in 2006 a new strategy to ligate two pep-
tides by the condensation of↵-keto carboxylic acids andN-alkylhydroxy-
alamines (KAHA) [99]. ￿eoretically applicable to any residue par at
the ligation junction, this reaction proceeds in mild conditions and re-
quires no additional reagents or catalyst generating only carbon diox-
ide and water as by-products (Figure 1.12 A). Moreover, the reaction
is ”absolute” chemoselective and thus can be performed with the fully
unprotected peptides. Furthermore, KAHA is completely orthogonal
to NCL.￿e main limitation of the otherwise perfect peptide ligation
method is the generation, precisely, of the ↵-keto carboxylic acid and
N-alkylhydroxy-alamines peptides. ￿e ￿rst have been nicely solved
by the synthesis of the peptide on sulfur ylide linker [100]. A￿er a
fast treatment with oxone, the peptide ends with ↵-keto carboxylic
acid. However, the obtention of the N-alkylhydroxyalamines peptides
has been more problematic [100]. Nevertheless, in 2015, Pusterla and
Bode managed, using an oxazetidine amino acid strategy, to synthesise
S100A4 (metastasin), a remarkably di￿cult molecule to be synthesised
by NCL due to its sequence and properties [101].
Another approach is based on the Staudinger-Meyer reaction between
azides and triaryl phosphanes to form iminophosphoranes [102]. ￿is
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reaction is performed in mild conditions, almost quantitatively, gener-
ating only molecular nitrogen as by-product. More than 80 years later,
in 2000, Bertozzi and Raines and their coworkers – independently –
started a new era of Staudinger reaction [103, 104]. In the non-traceless
ligation, the phosphane ligand designed by Bertozzi, acts as an elec-
trophilic trap containing an ester moiety. A￿er reacting with the azide,
it proceedswith an intramolecular cyclization generating an amide bond.
Just 3 months later, a modi￿cation of the phosphine ligand led to trace-
less Staudingder ligation where the phosphane oxide moiety is cleaved
during the hydrolysis (Figure 1.12 B) [105]. In parallel, Raines and
coworkers ￿rst applied this concept in the peptide ligation [104]. Since
then, this reaction has been applied elsewhere in the chemical biol-
ogy ￿eld because of their orthogonally from in vivo reactions, includ-
ing biotin or ￿uorescence labelling or DNA conjugation, among many
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other examples [106]. Peptide ligation application, however, has been
restricted to glycine amino acid at the ligation junction as it has not
been found a phosphinothiol that proceed with the reaction at e￿cient
rates with other nonglycyl amino acids [107].
Nowadays, click chemistry has became a common term in chemical
biology ￿eld.￿e term, coined by Sharpless [108], refers to those reac-
tions that, achieving high yields, are chemoselective to the biological
reactions and thus could be used in vivo environment without side re-
actions. ￿e already presented Staudinger reaction is considered one
”click” reaction. Nevertheless, the more famous ”click” reaction is the
Huisgen 1,3-dipolar cycloaddition of azides and acetylenes to give 1,2,3-
triazoles.￿is reaction, catalysed by Cu(I), ligates two peptides through
a non native bond. Although it is not a native amide bond, the struc-
ture adopted is very similar to the amide moiety. Plus, triazoles are
more stable against proteolytic degradation than native bonds [109].
Furthermore, its chemoselectivity and easy manipulation makes this
reaction widely employed.
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Figure 1.13: Scheme of ”click” reaction, Cu(I)-catalyzed Huisgen 1,3-dipolar
cycloaddition.
Finally, a completely di￿erent strategy for ligate two peptides is being
developed.￿is novel approach is based on the use of enzymes to catal-
yse an e￿cient peptide ligation. A recent study presented peptiligase, a
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modi￿ed mutant of peptide amide hydrolyse subtilisin BPN’, that could
ligate in high yields a carboxamidomethyl ester (cam-ester) C-terminal
peptide with a free N-terminal peptide in water conditions [110].
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2.1 Characterisation of the interaction
between TGIF1 and SMAD proteins
￿e aim of our project was to elucidate the mechanism of interaction
between TGIF1 and SMAD proteins from an structural point of view.
We ￿rst decided to focus on the interaction between TGIF1 and SMAD2
as it is the most studied interaction. In this sense, we focussed our at-
tention on the TGIF1 region (267-321). ￿is region, named SMAD in-
teracting domain (SID), has been suggested to be essential for SMAD2
binding [28]. Interestingly, mass spectrometry high-throughput analy-
sis have revealed that three serines (286, 291, 294) localised in the SID
are phosphorylated in human embryonic stem cells [57, 111]. In addi-
tion, two mutations (￿r280 and Ser291), also located in the middle of
the interacting region, have been identi￿ed to cause HPE in humans
[29]. Moreover, this region also is essential for the interaction between
TGIF1 and HDAC1 [44], Axin-2 [51] and PHRF1 [38], plus it has been
identi￿ed as one of the repressor domains of TGIF1 [44] (Figure 1.8).
Globally, the region between the residues 267-321 of TGIF1 seems to be
a general region for protein-protein interaction. In addition, the phos-
phorylated serines detected suggest a regulatory mechanism that could
govern the di￿erent interactions.
Our interest about TGIF1 structure also included the characterisation
of the homeodomain region. Recent ￿ndings involving a similar pro-
tein, HOXC9 (18.3% identity with TGIF1, Figure 1.5) suggest that TGIF1
could also interact with SMAD4 through a preserved region rich in
arginines at the N-terminus of the homeodomain. We then planned
to characterise how the complex between SMAD2, SMAD4 and TGIF1
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might be de￿ned.
We also considered if there are certain intramolecular interactions in
the TGIF1 protein that could contribute to de￿ne its global structure
and to regulate its binding properties.
2.2 Study about the cysteine-free direct
aminolysis ligation reaction
Up to date, there are numerous published ligation strategies enabling
synthesis of long polypetides, in some cases even proteins [79]. In this
study we focused our e￿orts on the direct aminolysis ligation strategy
between a C-terminal thioester peptide and a free N-terminus peptide.
￿is strategy has the advantage to ligate two peptides with any combi-
nation of amino acids at the ligation junction. Our project is based on
the previous study done by Wong and coworkers [83], where they re-
ported a direct aminolysis reaction with no detectable epimerization on
a aqueous bu￿er at room temperature. Although several combinations
at the ligation junction were successfully achieved, in the cases where
sterically hindered amino acids, such as aromatic or  -branched, were
present at the ligation junction, additional optimisation were required.
Moreover, the main limitation of this method is the slow ligation rate
in some reactions (up to 96 h), especially in those where sterically hin-
dered amino acids are present.
In this context, the aim of this project was to improve the rate and the
conversion of ligation reactions, at the same time that we check the
applicability of the reaction using  -branched amino acid. With that
objective in mind, we thought that converting the thioester in a be￿er
leaving group should help us to achieve our aim. HOBt is a reagent
widely used in the SPPS for its ability to generate active esters because
the low pKa of HOBt favours the formation of a good leaving group.
￿erefore, we decided that the addition of HOBt to the ligation bu￿er
would be the ideal choice.
Our idea here was to de￿ne a method to prepare phosphorylated frag-
ments of TGIF1 for the binding assays with SMAD2.
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2.3 Determination of six mutant
FBP28-WW2 structures
As a side project and to learn the basics of NMR assignment, we were
also interested in the structural determination of several WW domain
mutants, designed to clarify the folding and unfolding properties of this
domain. We also wanted to understand the key contacts that maintain
the domain folded, using several constructs containing deletions at the
domain termini.
2.4 Thesis objectives
￿erefore, the objectives of this thesis were:
1. Investigate the interactions between SMAD2 and TGIF1 using
mainly NMR and other biophysical techniques.
2. Analyse the e￿ect of serine phosphorylation (at positions 286,
291, 294) in the regulation of TGIF1 and SMAD2 interactions.
3. Determine whether TGIF1 and SMAD4-MH1 also interact with
one another.
4. Characterise potential interactions between the two fragments
of TGIF1, to detect the presence of open and close intramolecular
conformations.
5. Improve the methods of direct aminolysis for the ligation of pep-
tides.
6. Determine the structure of six selected mutants of FBP28-WW2
domain.
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3 Materials and Methods
3.1 Chemistry
In this section, the methods for peptide synthesis and puri￿cation are
explained.
Following the standard protocols, peptideswere synthesised using Solid-
Phase Peptide Synthesis (SPPS) [63] technique.￿e peptides were a￿er-
wards puri￿ed through Reverse Phase-High Performance Liquid Chro-
matography (RP-HPLC), if required. ￿e characterisation of the prod-
uctswas performed byMatrix-Assisted Laser Desorption/IonizationMass
Spectrometry (MALDI-MS) and Liquid Chromatography Mass Spec-
trometry (LC-MS) techniques.
3.1.1 Solid-Phase Peptide Synthesis
Basic principles
Initially developed by Merri￿eld in the 60s, Solid-Phase Peptide Syn-
thesis (SPPS) has nowadays become the main strategy to synthesise
peptides without the use of living beings. ￿e chemical synthesis of
the peptide is achieved through a repetitive loop consisting on: (1)
amino acid coupling, (2) washing and (3) deprotection steps carried on
an insoluble support of porous resin beads where the growing chain of
amino acids a￿aches.￿e anchorage of the peptide to the solid support
allows the use of several equivalents of coupling reagents because a￿er
the reaction the peptide stays and the excess of reagents is removed by
simple washing and ￿ltration.
When the ￿rst ↵-amino protected amino acid is added, it binds to the
linker of the resin via its activated carboxyl group. A￿er one washing
step, the temporary ↵-amino protecting group of the amino acid is re-
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moved. By adding and activating the next ↵-amino protected amino
acid a peptide bond is formed between the carboxyl of the new amino
acid and the free N -terminus from the amino acid a￿ached on the resin
(Figure 3.1). ￿e repetition of this process proceed in a N  C way
until the last amino acid of the sequence is incorporated. Finally, the
peptide is cleaved from the resin together with the side-chain’s protect-
ing groups of the amino acids, yielding the peptide of interest.
SPPS allows the full chemical synthesis of a peptide in a fast and an
e￿cient fashion.￿e versatility of the technique simplify the incorpo-
ration of phosphorylated or non-natural residues, in contrast with het-
erologous systems. However, despite all advantages that SPPS possess,
it faces some limitations as well. For instance, incomplete coupling re-
actions generates byproducts di￿cult to purify and aggregation of the
growing peptides during the synthesis drops the e￿ciency of the cou-
plings. Overall, it is commonly accepted that standard SPPS has a limit
of 40-60 amino acids long [64].
In order to avoid side reactions, SPPS uses two kinds of protecting
groups. While the ↵-amino group of the incoming amino acid has a
temporary protection – removed in each cycle – , the side-chain pro-
tecting groups and the link between the peptide and the resin are per-
manent and resistant to the chemistry used to cleave the temporary
protection group and therefore are only cleaved in the ￿nal step. Fol-
lowing this idea, two main strategies have been developed: Boc/Bzl and
Fmoc/tBu (Table 3.1).
Boc/Bzl relies on the di￿erent behaviour of the protectors groups against
a distinct acid condition. ￿e tert-butoxycarbonyl (Boc), used for tem-
porary protections, is cleaved in the presence of tri￿uoroacetic acid
(TFA). In contrast, benzyl (Bzl) based protecting groups are stable under
TFA conditions and they require the more strong acidic environment
provided by HF to be cleaved from side-chain moieties and resin link-
age. Although this method has high e￿ciency [112], the hazardous
nature of HF and the special equipment needed to handle it led to de-
velop an alternative.
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￿is full orthogonal alternative, Fmoc/tBu system, was developed by
Carpino in 1972 [113]. It takes advantage of the fact that 9-￿uorenyl-
methoxycarbonyl (Fmoc) – protecting↵-amino group – needs base con-
ditions (piperidine) to be cleaved while tert-butyl – protecting side-
chain – and the linkage between the C-terminal residue to the resin
matrix require acid (TFA). As this strategy needs milder cleavage con-
ditions than Boc/Bzl, most labs have adopted it. All the peptides in this
thesis have been synthesised using Fmoc/tBu system and further in this
thesis the explanation will only focus on this strategy.
Table 3.1:Main di￿erences between Boc and Fmoc strategies.
Boc/Bzl Fmoc/tBu
↵-amino protecting group Boc Fmoc
Cleavage ↵-amino protecting group TFA Piperidine
Side-chain protecting group Benzyl tert-butyl
Cleavage side-chain protecting group HF TFA
Cleavage from the resin linker HF TFA
Resins and Linkers
￿e resin is the solid support where the peptide a￿aches during the
synthesis. It exhibits (1) chemical and mechanical stability; (2) high
swelling in several solvents, allowing optimal access for reagents; (3)
uniform and functionalised beads that permits the binding of the linker
and (4) good loading [114]. Polymeric resins ful￿ll these requirements.
Merri￿eld 1% divinylbenzene cross-linked polystyrene (PS) resin was
the ￿rst resin widely adopted in the ￿eld. Inexpensive to produce, it al-
lows an optimal di￿usion of the most used solvents in peptide synthe-
sis.￿is resin has been used extensively although it was found that the
incorporation of some amino acids decreases when the peptide length
increases. To solve this problem, polyethylene glycol (PEG) was intro-
duced in many combinations (TentaGel®, ArgoGel®). Nowadays, total
PEG resin such as ChemMatrix® (CM) are used, achieving superior per-
formance, especially when long peptide sequences need to be synthe-
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sised [115].
￿e linker is the chemical moiety that connects the resin with the C-
terminal of the ￿rst amino acid of the sequence, keeping the carboxyl
group protected. ￿e wide chemistry of the several linkers available
explains the di￿erence in the C-terminal ending of the peptide a￿er
the ￿nal cleavage. For example, Wang resin or 2-chlorotrityl chloride
resin linker provides a free peptide ending in acid group; Rink amide
resin linker yields peptides with amide function at their C-terminal part
while 4-sulfamylbutyryl resin linker gives – through a ”safety-catch”
linker – a peptide thioester.
Reagents and reactions
N,N -Dimethylformamide (DMF) and dichloromethane (DCM) are the
main solvents used in SPPS.￿ey solubilise all the reagents involved in
the reaction such as Fmoc amino acids, coupling reagents, piperidine,
etc..
Activation of the carboxy terminal of the Fmoc-protected amino acid
is required for an e￿cient binding with the growing peptide. Carbodi-
imide based reagents, such as N,N’-diisopropylcarbodiimide (DIC), re-
act, as electrophiles, with the carboxyl acid group to obtain an ester
bond, that is also a good leaving group. However, carbodiimides are so
reactive that can cause side reactions such as racemerization through
the formation of a symmetrical anhydride. To avoid them, an auxiliary
nucleophile as 1-hydroxybenzotriazole (HOBt) is added, generating ac-
tive, but milder, OBt esters. It suppress the racemerization, and at the
same time improves the rate of the reaction. An alternative of it is ethyl
2-cyano-2-(hydroxyimino)acetate (trade nameOxyma Pure), which has
the advantage of being not explosive when is fully dehydrated. Re-
cently, in situ coupling reagents were developed to reduce racemiza-
tion and increase the rate of the reaction. Families of compounds as
acylphosphonium (benzotriazol-1-yloxytris(dimethylamino)phosphonium
hexa￿uorophosphate, BOP; benzotriazol-1-yloxy tris(pyrrolidino)phos-
phoniumhexa￿uorophosphate, PyBOP®) and acyluronium/aminium salts
(N -[(dimethylamino)-1H -1,2,3-triazolo[4,5-b]pyridin-1-ylmethylene]-N -
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methylmethanaminiumhexa￿uorophosphateN -oxide, HATU;N -[(1H -
benzotriazol-1-yl)(dimethylammo)methylene]-N -methylmethanaminium
hexa￿uorophosphate N -oxide, HBTU) have become very popular in
the labs around the world.￿ey convert e￿ciently the Fmoc-protected
amino acid into an active OBt ester in the presence of a base with no
nucleophile component, as N,N -diisopropylethylamine (DIPEA) (Fig-
ure 3.2).
￿e standard procedure includes adding several equivalents of the Fmoc-
amino acid and its activators in order to achieve the completeness of the
reaction. ￿e coupling reaction time depends on the reagent used, the
amino acid that is going to be coupled and the length and aggregation
of the peptide. As a general rule, the combination HATU/DIPEA takes
about 30 min to complete the reaction, whereas DIC/HOBT takes 90
min.
In the deprotection step, the Fmoc group is eliminated via base induced
 -elimination. ￿e most common agent is piperidine that is diluted at
20% in DMF.
￿e ￿nal cleavage of the peptide from its solid support is achieved by
applying acidic conditions. Usually TFA at di￿erent concentrations
(varying from 82 to 97%) is used, which also removes all side-chain pro-
tecting groups. During the removal of the side-chain protecting groups
there is a formation of highly reactive cationic species. ￿erefore, dif-
ferent type of so-called “scavengers” at the concentrations from 3% to
18%, are added together with the TFA in order to prevent side-reactions
between the cleaved side-chain protecting groups and the peptide se-
quence.￿e scavengers used depends on the protecting groups it needs
to react with. Combinations of water, triisopropylsilane (TIPS), 1,2-
ethanedithiol (EDT) and other thiols or phenol are commonly used.
An special case is the cleavage from the 4-sulfamylbutyryl resin linker,
that uses the ”safety-catch” technique, reported by Backes and Ellman
[75], as a modi￿cation of previous Kenner’s sulfoamide ”safety-catch”
[116].￿is linker is stable under base conditions making it compatible
with Fmoc/tBu strategy. ￿e activation proceeds with the reaction of
iodoacetonitrile with DIPEA. In a second reaction, benzylmercaptan is
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Figure 3.2: Chemical structure of the main reagents used in Fmoc/tBu SPPS.
added, cleaving the peptide from the resin in a thioester form (Figure
3.3).
￿ality test
Resin load determination is a test that measures the quantity of Fmoc
release a￿er a treatment with piperidine and thus, gives an exact value
of the coupling e￿ciency. If it is done a￿er the ￿rst coupling it provides
the real quantity of sites (equivalents) able to generate a peptide.
However, for the rest of the couplings, the completeness of the reac-
tion is checked by others methods. Ninhydrin test, conceived by Kaiser
[117], examines the presence of free primary amines. If still some free
amines are present in the analysed beads, the otherwise light yellow
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Figure 3.3: Scheme of cleavage of a peptide thioester from a sulfamylbutyryl
resin. Prior the reaction with iodoacetonitrile, the N-terminus is protected
with Boc2O (temporary protection) or Ac2 (permanent protection).
solution turns dark blue. However, the solution may adopt another
colours if the last amino acid is serine, asparagine or aspartic acid.
Moreover, this detectionmethod has problems detecting secondary amines,
what happens when the last amino acid is proline. In this case, the use
of the chloranil test is recommended [118].
3.1.2 Peptide Purification
Reverse-PhaseHigh Performance/Pressure Liquid Chromatography (RP-
HPLC) is the most commonmethod to purify the crude peptide from its
impurities.￿e peptide is ￿rst dissolved in an aqueous solution with a
minimal percentage of acetonitrile (MeCN) and then injected in a HPLC
with a preparative RP-column. An acetonitrile gradient, typically from
5 to 60%, is applied while the elution is monitored at 220 nm (peptide
bond). TFA is o￿en added to the solvents as ion pair reagent to im-
prove resolution and selectivity. ￿e eluted fractions are collected and
analysed by MALDI-MS.
3.1.3 Experimental procedures
As previously described in Biopolymers (Peptide Science) under the
title ”Addition of HOBt improves the conversion of thioester-amine
chemical ligation” [119].
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General peptide synthesis
All manual synthesis were done in a polypropylene syringes with ￿￿ed
porous ￿lters, allowing a removal of the liquid by a vacuum pump. At
the end of each day, resins were dried and stored at 4ºC ON, swelling
them again with DMF for 30 min at the beginning of the day.￿e amino
acidswere incorporated by using 5 eq of the corresponding Fmoc-amino
acid derivatives activated with 4.9 eq of DIC in the presence of 4.9 eq
of HOBt in DMF for 90 min. All the couplings were done with me-
chanical stirring at room temperature, unless otherwise stated. A￿er
each coupling the resin was washed 6 times with DMF (1 min) and 2
times more with DCM (1 min) before the Kaiser or chloranil test was
performed.￿e e￿ciency of the couplings was veri￿ed with the Kaiser
- or chloranil if the coupled amino acid was proline. If the Kaiser test
was positive, recoupling was performed with 5 eq of Fmoc-amino acid,
4.9 eq of HATU and 10 eq of DIPEA in DMF for 50 min. When the use
of the test was not enough, a mini cleavage was performed. It consist
in a full cleavage of a very li￿le quantity of resin and a￿erwards an
MS analysis. In all cases, the Fmoc was release adding 40% piperidine
in DMF for 5 min, and then 20% piperidine in DMF for 5 min. Both
reactions were done at room temperature.
Synthesis of the peptides thioesters
Peptide thioesters were synthesised using the Fmoc/tBu strategy and 4-
sulfamylbutyryl aminomethyl (AM) resin (substitution: 0.73 mmol/g),
at 100 µmol scale. For the coupling of the ￿rst residue, Fmoc-amino acid
(4 eq), DIC (4 eq) and 1-methylimidazole (4 eq) were dissolved in DCM
(12 µL/µmol). ￿e solution was added to 1 eq of the resin placed in a
glass tube. ￿e mixture, sealed with a septum, was gently agitated for
the next 18 h at 25ºC.Once the reaction is over, the resinwas transferred
to the polypropylene syringes and thenwashed 5 times with DMF and 5
times with DCM before being dried. Coupling e￿ciency was estimated
through resin load determination by UV analysis of Fmoc-release.￿e
remaining amino acids were coupled as previously described.
A￿er completion of the sequences, all peptides were either acetylated
(with 5% acetic anhydride, 8.5% DIPEA and 86.5% DMF (in vol.), 30 min
stirring at room temperature) or Boc-protected (with 20 eq of Boc2 and 5
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eq DIPEA in DMF, 2h stirring at room temperature) at the N -terminus
prior to ￿nal peptide cleavage from the resin. ￿e procedure for the
linker activation was the following: iodoacetonitrile (67 eq) and DIPEA
(13 eq) in DMF (72 µL/µmol) were added to the resin and gently agi-
tated for the next 18 h.￿e resin was then washed six times with DMF,
six times with DCM and then dried. In the next step, the peptide was
cleaved from the activated resin using benzyl mercaptan (50 eq) and
DIPEA (13 eq) in DMF (72 µL/µmol) in an 18 h reaction with gentle
agitation. ￿e peptide solutions were ￿ltered and collected in a round
bo￿om ￿ask. ￿e resin was washed twice with DMF (4 mL each time)
and the combined ￿ltrates were concentrated under vacuum in order
to completely remove DMF.￿e crude product was dissolved in 6 mL
of a TFA/TIPS/water mixture (95:2.5:2.5 by vol.) and stirred at room
temperature for 3 h, yielding the peptide thioester without the side-
chain protecting groups.￿e peptide thioesters were then precipitated
in cold diethyl ether and centrifuged (3,000 g). ￿e pellet was washed
twice with cold ether, dried, and stored at -20ºC.￿e crude thioesters
were analysed by LC-MS and, depending on their purity, some of them
were additionally puri￿ed by preparative RP-HPLC prior to their use in
the ligation reactions.
Synthesis of free N-terminus amide peptides
Peptides containing a free N -terminus were synthesised manually us-
ing a Rink amide AM resin (substitution: 0.68 mmol/g) at 100 µmol
scale with Fmoc/tBu chemistry. ￿e coupling was done as previously
described.
￿e resin-bound peptides were cleaved and deprotected with TFA con-
taining a scavenger mixture of water, thioanisol and EDT (90:5:2.5:2.5
by vol) at RT for 2 h. A￿erwards, the peptides were then precipitated
in cold diethyl ether and centrifuged (3,000 g). ￿e pellet was washed
twice with cold ether, dried and stored at -20ºC. Finally, the crude pep-
tides were puri￿ed by preparative RP-HPLC. Pure fractions were col-
lected, lyophilised, and stored at -20ºC. ￿ey were then analysed by
MALDI-MS and LC-MS prior to their use in ligation reactions.
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Peptide purification
Crude peptides, peptide thioesters, and ligation mixtures were puri￿ed
using an Aqua C18-column (internal diameter 4.6 mm, length 150 mm,
particle size 5 µm, pore size 12.5 nm, Phenomenx) with a linear gradient
from 10 to 24% aqueous acetonitrile (0.1% TFA) over 1.2 min, followed
by a gradient of 24 to 57% for the next 42 min with a ￿ow rate of 1
mL/min using an A¨KTA puri￿er 10 HPLC System (GE Healthcare, Up-
psala Sweden). Fractions were analysed by MALDI-MS and those con-
taining the products were collected, lyophilised, and stored at -20ºC.
Ligation mixtures were analysed on the microbore Aqua C18-column
using a linear gradient from 4.75 to 57% or from 9.5 to 57% aqueous
acetonitrile (0.1% TFA) for 25 min at a ￿ow rate of 1 mL/ min.
Peptide ligation
￿e free N-terminus peptides (1.5 eq or 0.5 eq) were dissolved in 120 µL
of ligation bu￿er (N -Methyl-2-pyrrolidone (NMP) : 6M Guanidinium
chloride (GuHCl) + 1 M 2-[4-(2-hydroxyethyl)piperazin-1-yl]eth-ane-
sulfonic acid (HEPES) at 4:1 (v/v). A bu￿er containing 6 M GuHCl and
1 M HEPES was prepared (50 mL) and adjusted to pH 8.5 using 25%
NaOH solution and degassed. For each ligation trial 100 µL of the bu￿er
was mixed with 400 µL of NMP).￿e resulting solution was used to dis-
solve the thioester peptide (between 0.3 and 1.5 µmol). Depending of
the peptide thioester amount, the ￿nal volume of the ligation bu￿er
was di￿erent (the volume of 80 µL and the described procedure is for
peptide thioester amount of 1 µmol). However, the free NH2 peptide
was always 1.5 eq higher (Table 4.7, combination I, II, V, VI, VII, VIII
and X) or 0.5 eq lower (Table 4.7, combinations III, IV and IX) from
the peptide thioester equivalents). For each reaction, the solution was
separated into two equal parts, and 15 µL of HOBt, dissolved in the
same ligation bu￿er (2 eq based on the amount of peptide thioester),
were added to the ligation series with HOBt, while 15 µL of the liga-
tion bu￿er was added to the other part, for comparison, as a control. For
the ligations, 2 eq of with 1-hydroxy-7-azabenzotriazole (HOAt), 4 eq of
1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) or 4 eq of DIPEA were added
to the ligation mixture, respectively. Finally, thiophenol (2% by volume,
1.5 µL) was added to the reactions in the presence or absence of activa-
45
3 Materials and Methods
tors/bases, and the resulting mixture was incubated at 37ºCwith gentle
agitation until the reaction was completed. At various time points the
reaction was followed by LC-MS, and in some cases by MALDI-MS and
RP-HPLC, depending on the peptide sequences and amino acids at the
ligation junction (Table 4.7). At each time point, 8 µL aliquots of the lig-
ation mixture were taken and quenched by the addition of 0.1% TFA in
water (32 µL) or tris(2-carboxyethyl)phosphine (TCEP) solution (32 µL,
of a 10mg/mL solution) when the products contained cysteine residues.
￿e quenched mixtures were diluted up to 1.5 mL with % MeCN/0.1 %
FA in water and stored at -20ºC.
Reagents
Acetic acid (ACS reagent>99.7%), NaOH (Bioxtra,>98%), 1-methylim-
idazole (>99%), benzyl mercaptan (>99%), HOBt, DBU, and thiophenol
(97% GC) were purchased from Sigma-Aldrich Chemie GmbH (Tau￿ir-
chen, Germany), TFA (HPLC grade, >99,5%) from Alfa Aesar (Ward
Hill, Massachuse￿s, USA). Formic acid (FA, >98%), DIC (>98%) and
NMP from Fluka (Sigma-Aldrich Chemie GmbH). 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES, >99.5%), guanidinium chlo-
ride (GuHCl, >99%) from Melford Laboratories Ltd. (Ipswich, United
Kingdom). Acetonitrile (for HPLC PLUS gradient-ACS-Reag. Ph. Eur-
Reag. USP) and DMF (for peptide synthesis) were purchased fromCarlo
Erba Reagents (Milano, Italy), while DIPEA (for synthesis) and DCM
(99.9%) fromMerck KGaA (Darmstadt, Germany). HOAtwas purchased
fromMedalchemy (Alicante, Spain). Standard Fmoc-amino acid deriva-
tives, supplied by Iris Biotech GmbH (Marktredwitz, Germany), con-
taining tert-butyl protecting groups at serine, threonine and tyrosine,
the 2,2,4,6,7-pentamethyl-dihydrobenzofuran-5-sulfonyl (Pbf) protect-
ing group for arginine, the Boc protecting group for tryptophan, and 1-
(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)isovaleryl (ivDde) protecting
group for the side-chain amine of lysine. Rink amide AM resin (200-
400 mesh) and 4-Sulfamylbutyryl AM resin were purchased from Nov-
abiochem (Merck, Spain). Water was puri￿ed in-house with a Milli-Q
Advantage A10 Ultra PureWater Puri￿cation System (Millipore, Merck,
Spain).
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3.2 Biology
In this section the molecular biology methods are introduced. As most
structural biology techniques require large amounts of highly pure and
concentrated protein, express the protein in some of the di￿erent het-
erologous systems available and a￿erwards purify it is the common
way to obtain it. Nowadays, the most used system is the heterologous
expression in bacteria, and speci￿cally in Escherichia coli (E.coli). ￿e
choice of this organism provides the user plenty of advantages:
• It allows an easy insertion of the DNA sequence of the protein
of interest (compared to di￿erent expression systems, e.g. in in-
sects).
• It permits a high expression of the protein at low cost (especially
important with 15N or 13C labelled samples that are necessary for
NMR experiments).
• It grows fast in a high density cultures.
• E.coli metabolism and genetics are well known.
Several E.coli strains, each of them with a plethora of genetic modi￿-
cations, are available. Every modi￿cation bestows unique characteris-
tics to E.coli, such as protease de￿ciency (avoiding degradation of the
newly expressed protein of interest), T1 Phage Resistant (which gives
E.coli resistance against a virulent phage) or DE3 (containing the T7
RNA Polymerase for induction with the T7 promoter), among many
others.
In this thesis, three main strains of E.coliwere used. DH5-↵, with a very
high e￿ciency in transformation, was used for cloningwhile the strains
BL-21(DE3) and Rose￿a were used for protein expression. Rose￿a dif-
ferentiates from BL-21(DE3) since it has an extra plasmid that contains
rare codons tRNA. If the expressed sequence has codons that are not
normally used by E.coli, Rose￿a may give be￿er expression than BL-
21. Otherwise, it is more recommended the use of BL-21 as it grows
be￿er because it lacks this second plasmid.
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3.2.1 Cloning
￿e E.coli strain expresses the protein that is encoded in the vector we
have inserted in the bacterial cell. ￿e vectors are circular DNA plas-
mids of about 5-7 KDa long. ￿ey contain, at least, all the genetic in-
formation related to: the construct to be expressed and its promoter
region, the antibiotic resistance (that keeps the plasmid in the bacteria
cells through positive selection) and its promoter region, the origin of
replication (which allows the replication of the plasmid) and the multi-
ple cloning site (MCS) (for an easy insertion of the construct of interest).
In order to get the required vector, cloning method may be used. ￿is
method consist of the ampli￿cation of the desired insert (usually ob-
tained from another vector or from a cDNA library) and then the liga-
tion (or recombination) of it with the chosen vector. A￿er the ligation,
DH5-↵ cells are transformed with the ligated vector. Some colonies
are then selected to be sequenced. Only the ones that gives the correct
sequence are stored at -20ºC to be used for further experiments.
Original vector
E.coli amplification
PCR amplification
Ligation or recombination
insert - protein of interest
Promoter region
Antibiotic resistance
Origin of replication
Promoter region
MCS
Cloned vector
Figure 3.4: General scheme of the cloning method.
If only mutations of a certain vector are required, then site-directed
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mutagenesis method is preferred. It requires a whole vector PCR am-
pli￿cation with the primers containing the modi￿ed sequence. In this
PCR, proofreading Pfu polymerase is used to avoid any undesirable mu-
tation. A￿erwards, the PCR solution is transformed in DH5-↵ cells and
the resulting colonies are veri￿ed like the previous cloning method.
Transformation is the process where the plasmid is inserted in the bac-
teria cell. Two main methods are widely used. Heat-shock method
is based on a quick (45 s) thermal shock that creates cell wall pores
from where the plasmid DNA enters into the cell. For a be￿er e￿-
ciency, chemically competent cells are used. In contrast, electropora-
tion method takes advantage of the fact that the cells can be shocked
with an electrical ￿eld of 10-20 kV/cm creating cell wall holes that per-
mit DNA plasmid to enter into it.￿is method requires electroporation-
competent cells for the best performance. In both cases, the bacteria
can repair quickly the weakness of the wall and, a￿er 2 min on ice, su-
per optimal broth with catabolite repression (SOC) medium (Table 3.2)
is added. ￿e cells keep growing at 37ºC for 1 h and ￿nally they are
plated in agar plates (Table 3.2) with the suitable antibiotic.
3.2.2 Protein expression and purification
As milligrams of protein are required for structural experiments, the
growth, induction and expression of the protein is performed in 2 L er-
lenmeyer with 1 L of culture medium. Brie￿y, a colony from a plate is
taken and submerged in the appropriate medium and antibiotic.￿e er-
lenmeyer is then leaved at 37ºC with 220 revolutions per minute (RPM)
to optimise the growth. When the culture reaches OD600 of 0.6-0.8, iso-
propyl  -D-1-thiogalactopyranoside (IPTG, an allolactose mimic that
triggers the expression of the proteins under lac operator; most used
promoter of protein expression) is added to induce the expression of
the protein of interest. ￿e common medium used is Luria Broth (LB)
(Table 3.2), but there are other formulations such as Terri￿c Broth (TB).
However, for someNMR experiments, such asHSQC or 3D experiments
(see section 3.3.1), the protein sample have to be labelled with 15N or
double labelled with 15N and 13C. In these cases, a￿er an overnight (ON)
preculture, 1 L culture is grown in minimal medium containing 15N or
15N and 13C sources (Table 3.2). A￿er the growth, the culture is cen-
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trifuged and the pellet is immediately puri￿ed or stored at -20ºC until
puri￿cation.
To facilitate the protein puri￿cation, the construct is inserted with a
peptide/protein tag (such as His-tag or glutathion S-transferase (GST)-
tag) joined to the protein through a cleavage site. ￿us, the protein
is expressed together with the peptide/protein tag.￿is method allows
the separation of the tag-protein of interest with immobilised metal ion
a￿nity (IMAC) chromatography. In this kind of chromatography, the
high a￿nity between the tagged protein and the resin implies an spe-
ci￿c binding between them. A￿er washing the resin from the rest of the
components with the washing bu￿er, the puri￿ed protein elutes in the
elution bu￿er. Overall, this technique allows a fast puri￿cation under
mild conditions. However, the protein of interest is still ligated with a
non-desire tag. To overcome this, a cleaving protein (such as Tobacco
etch virus protease (TEV) or 3C protease) is added to the eluted protein.
Size exclusion chromatography (SEC) is a widespread technique in pro-
tein puri￿cation. In this kind of chromatography, the protein is puri￿ed
according to its size thanks to the di￿erent porous size of the column
beads. ￿us, the biggest particle do not enter to most of the porous,
making a short itinerary. On the other hand, the smaller molecules are
able to enter in the space between the beads, making a longer itinerary
and thus eluting a￿er the bigger particles.
Ion exchange chromatography is another type of chromatography that
permits the separation of the di￿erent components by their a￿nity to
the ion exchanger. Cation exchange chromatography is used when
cations need to be separated while in anion exchange are the anions
who bind to the column to be separated. ￿us, the relation between
the pI of the protein and the pI of the other non-desired substances de-
termines the chosen column, cation or anion. A￿er the loading of the
sample with low concentration of salts in the column, the gradient with
increasing concentrations of salt elutes the desired protein.
Overall, these techniques allow an easy separation of the protein from
its tag previously cleaved as well as from other proteins not previously
separated.
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Table 3.2: Common solutions composition.
LB (1 L; autoclaved) SOC (0.5 L; autoclaved)
Tryptone 10 g Tryptone 10 g
Yeast extract 5 g Yeast extract 2.5 g
NaCl 10 g NaCl (5 M) 1 ml
Suitable antibiotic: KCl (1 M) 1.25 ml
Ampicillin 100 µg/mL MgCl2 (1 M) 5 ml
Kanamycin 50 µg/mL MgSO4 (1 M) 5 ml
Glucose (1 M) 10 ml
LB Agar (0.5L; autoclaved) M9 medium 1 L (10x)
LB Broth 25 g Na2HPO4 60 g
Bacteriological Agar 15 g KH2PO4 30 g
Suitable antibiotic: NaCl 5 g
Ampicillin 100 µg/mL N15H4Cl 5 g
Kanamycin 50 µg/mL
Minimal medium (1 L) Trace elements 1 L (100x)
M9 medium (10x) 100 ml EDTA 5 g
Trace elements (100x) 10 ml FeCl3 x 6 H2O 0.83 g
20%(w/v) Glucose 20 ml ZnCl2 84 mg
/ or 13C6-glucose / or 2 g CuCl2 x 2 H2O 13 mg
MgSO4 (1 M) 1 ml CoCl2 x 6 H2O 10 mg
CaCl2 (1 M) 0.3 ml H3BO3 10 mg
Biotin (1 mg/ml) 1 ml MnCl2 x 6 H2O 1.6 mg
￿iamin (1 mg/ml) 1 ml
Suitable antibiotic:
Ampicillin 100 µg/mL
Kanamycin 50 µg/mL
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3.2.3 Experimental procedures
TGIF1-SMADs project
Cloning
Since the discovery of TGIF1 [26], up to 12 di￿erent isoforms have been
identi￿ed [120]. ￿e most abundant isoform (number 4, according to
the NCBI nomenclature) was the ￿rst characterized by Bertolino et al.
and the most used a￿erwards by the scienti￿c community [28, 48].￿is
isoform lacks the ￿rst 116 amino acids from the canonical one and the
amino acids corresponding to 116-134 are not conserved. Nevertheless,
since residue number 135 to 401 both canonical and isoform 4 sequences
are identical. Because of the very low expression of the canonical one
respect to the isoform 4, the ￿rst 130 residues are not considered to be
important for the role of TGIF1 and are not treated in this thesis. How-
ever, for consistency with the recommended nomenclature regarding
protein isoforms, in this thesis we are going to use Uniprot canonical
sequence as a reference (Q15583), although most of the studies used the
isoform 4 as a reference.
- TGIF1 sequence was obtained from an pCMV5 Flag-TGIF1 (Isoform
2) clone (Addgene number: 14047) from Dr. Massague´ lab [28]. ￿e
sequences corresponding to amino acids 256-347 & 256-339 (all residue
numbering are referenced to isoform 1) were ampli￿ed by PCR and re-
combined in pETM11 (vector engineered by G. Stier, EMBL, Heidel-
berg, Germany) using RecAf recombinase (New England Biolabs, Mas-
sachuse￿s, USA).￿e vector includes kanamycin resistance, T7-lactose
protein promoter, N-terminal His6 tag and TEV cleaving site between
the His6-tag and the protein.
- TGIF1 (150-248) was ampli￿ed by PCR and recombined in pOPINJ
(vector engineered by Oxford Protein Production Facility, UK) using
RecAf recombinase (New England Biolabs, Massachuse￿s, USA). ￿e
vector includes ampicillin resistance, T7-lactose protein promoter, N-
terminal His6-GST tag and 3C protease cleaving site between the His6-
GST tag and the protein.
- SMAD2-EEE (186-467) (Uniprot entry: Q15796) clone was obtained
as a gi￿ from Dr. Zinn-Justin (CEA, Gif-sur-Yve￿e, France). It was
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cloned in pETM-10 (vector engineered by G. Stier, EMBL, Heidelberg,
Germany). ￿e vector includes kanamycin resistance, T7-lactose pro-
tein promoter, N-terminal His6 tag and no cleaving site between the
His6-tag and the protein.￿e sequence contains three mutations corre-
sponding to the last three serines (464, 465, 467) that were substituted
by three glutamic acids.
- SMAD4-MH1 (10-140) (Uniprot entry: Q13485) and SMAD2-MH1 (10-
174) (Uniprot entry: Q15796) are cloned in pETM-11 (vector engineered
byG. Stier, EMBL,Heidelberg, Germany).￿e vector includes kanamycin
resistance, T7-lactose protein promoter, N-terminal His6 tag and TEV
cleaving site between the His6-tag and the protein.
All clones were con￿rmed byDNA sequencing (Macrogen, Amsterdam,
￿e Netherlands).
- DNA. Two di￿erent DNA were used in this project (Table 3.3). Hav-
ing the same sequence, both are full palindromic and the double stand
(ds) molecule end with both blunt extreme. Each of them contains two
repetitions of the TGIF1 canonical binding DNA sequence, TGTCA (in
red) ([26]). One of them was labelled at the N-terminus with Cy5 [121],
what turns the DNA ￿uorescent and thus able to be used in EMSA ex-
periments. Single stand puri￿ed DNA (Biomers, Germany) were dis-
solved in a minimum quantity of bu￿er (20 mM HEPES, 150 mM NaCl,
1 mM sodium azide, at pH 7.5) and then annealed by heating it at 90ºC
for 3 min and allowed to cold down slowly to room temperature.
Table 3.3: DNA sequences used in this thesis.
Name Sequence ds Mass (mol/g)
DNA1 ATTGACAGCTGTCAAT 9,758
DNA1-Cy5 ATTGACAGCTGTCAAT 11,030
Protein Expression and Purification
- TGIF1 (256-347) & TGIF1 (256-339) were expressed in BL-21 E.Coli
cells (Novagen, Darmstadt, Germany) using LB medium or minimal
medium for isotopical labelling (Table 3.2). ￿e bacteria were induced
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at OD600 0.8 with 1 mM IPTG ON at 20ºC. A￿er resuspension with
guanidinium chloride (GuHCl) (Table 3.5), the bacteria were lysed us-
ing EmulsiFlex-C3 (Avestin, Mannheim, Germany) cell disruptor.￿en
they were centrifuged (30,000 g, 30 min, 4ºC) and the supernatant was
collected.￿e ￿rst step of puri￿cation involved Ni2+ a￿nity resin (ABT
Beads, Madrid, Spain), previously equilibrated with the lysis bu￿er (Ta-
ble 3.5).￿e proteinswere elutedwith 500mM imidazole (elution bu￿er)
(Table 3.5), and a￿erwards TEV protease was added to the protein so-
lution for the cleaving step. A￿er two hours incubating at room tem-
perature (RT), the solutions were dialysed ON at 4ºC against 50 mM
HEPES, 150 mM NaCl, 1 mM TCEP at pH 8.0 in order to decrease the
concentration of imidazole. ￿e cleaved TGIF1 (256-347) was passed
again through Ni2+ a￿nity resin to remove the His-tag. Finally, the
￿ow through that contains the protein was puri￿ed on a Hiload 16/60
Superdex 30 prepgrade column (GE Healthcare, Uppsala, Sweden) in an
A¨kta® Puri￿er10/FPLC system (GE Healthcare, Uppsala, Sweden) equi-
librated with 20 mM HEPES, 100 mM NaCl, 1 mM TCEP at pH 6.8.￿e
elution was collected in 2 ml fractions and those corresponding with
the protein were concentrated in a Amicon® Ultra-15 centrifugal ￿lter 3
KDa (Merck Millipore, Ireland).￿e mass was checked byMALDI-TOF.
- TGIF1 (150-248) was expressed in Rose￿a E.Coli cells (Novagen, Darm-
stadt, Germany) using LB medium or minimal medium for isotopical
labelling (Table 3.2). ￿e bacteria were induced at OD600 0.8 with 0.5
mM IPTG, ON at 37ºC. A￿er resuspension with lysis bu￿er (Table 3.5)
supplementedwith lysozyme, DNAse I and phenylmethanesulfonyl ￿u-
oride (PMSF), the bacteria were lysed using EmulsiFlex-C3 (Avestin,
Mannheim, Germany) cell disruptor.￿en theywere centrifuged (30,000
g, 30 min, 4ºC) and the supernatant was collected. ￿e ￿rst step of
puri￿cation involved Ni2+ a￿nity resin (ABT Beads, Madrid, Spain),
previously equilibrated with the lysis bu￿er (Table 3.5). In the wash-
ing step, a solution of 1M NaCl was added in order to weak the inter-
actions of the homeodomain with the DNA and remove the last one
from the resin.￿e protein was eluted with 500 mM imidazole (elution
bu￿er) (Table 3.5), and a￿erwards 3C protease was added to the protein
solution for the ON cleaving step at 4ºC. Next day, the cleaved TGIF1
(150-248) was puri￿ed on a Hiload 16/60 Superdex 75 prepgrade column
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(GE Healthcare, Uppsala, Sweden) in an A¨kta® Puri￿er10/FPLC system
(GEHealthcare, Uppsala, Sweden) equilibrated with 20 mMHEPES, 150
mMNaCl, 1 mM TCEP at pH 6.4.￿e elution was collected in 2 ml frac-
tions and those corresponding with the protein were concentrated in a
Amicon® Ultra-15 centrifugal ￿lter 3 KDa (Merck Millipore, Ireland).
- SMAD2-EEE (186-467) was expressed in BL-21 E.Coli cells (Novagen,
Darmstadt, Germany) using LB medium (Table 3.2). ￿e bacteria were
induced at OD600 0.8 with 1 mM IPTG ON at 20ºC. A￿er resuspension
with lysis bu￿er (Table 3.5) supplemented with lysozyme, DNAse I and
PMSF, the bacteriawere lysed using EmulsiFlex-C3 (Avestin, Mannheim,
Germany) cell disruptor.￿en they were centrifuged (30,000 g, 30 min,
4ºC) and the supernatant was collected.￿e ￿rst step of puri￿cation in-
volved Ni2+ a￿nity resin (ABT Beads, Madrid, Spain), previously equi-
librated with the lysis bu￿er.￿e protein was eluted with 500 mM im-
idazole (elution bu￿er) (Table 3.5). Without a cleaving step, the pro-
tein was puri￿ed on a Hiload 16/60 Superdex 30 prepgrade column (GE
Healthcare, Uppsala, Sweden) in an A¨kta® Puri￿er10/FPLC system (GE
Healthcare, Uppsala, Sweden) equilibratedwith 20mMHEPES, 150mM
NaCl, 1 mM TCEP at pH 8.0. ￿e elution was collected in 2 ml frac-
tions and those corresponding with the protein were concentrated in
a Amicon® Ultra-15 centrifugal ￿lter 10 KDa (Merck Millipore, Ireland).
- SMAD4-MH1 (10-140) was expressed in BL-21 E.Coli cells (Novagen,
Darmstadt, Germany) using LB medium (Table 3.2). ￿e bacteria were
induced at OD600 0.8 with 0.5 mM IPTG ON at 20ºC. A￿er resuspension
with lysis bu￿er (Table 3.5) supplemented with lysozyme and DNAse I,
the bacteria were lysed using EmulsiFlex-C3 (Avestin, Mannheim, Ger-
many) cell disruptor. ￿en they were centrifuged (30,000 g, 30 min,
4ºC) and the supernatant was collected.￿e ￿rst step of puri￿cation in-
volved Ni2+ a￿nity resin (ABT Beads, Madrid, Spain), previously equi-
librated with the lysis bu￿er.￿e protein was eluted with 500 mM im-
idazole (elution bu￿er) (Table 3.5), and a￿erwards TEV protease and
TCEP (2 mM ￿nal concentration) was added to the protein solution
for the ON cleaving step at 4ºC. Next day, the cleaved SMAD4-MH1
(1-140) was puri￿ed on a Cation Exchange Hi Trap SP HP 5 ml (GE
Healthcare, Uppsala, Sweden) in an A¨kta® Puri￿er10/FPLC system (GE
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Healthcare, Uppsala, Sweden). ￿e gradient was done with a bu￿er A:
20 mMHEPES, 1 mM TCEP at pH 8.0; and bu￿er B: 20 mMHEPES, 1 M
NaCl, 1 mM TCEP at pH 8.0. ￿e elution was collected in 0.2 ml frac-
tions and those corresponding with the protein were concentrated in a
Amicon® Ultra-15 centrifugal ￿lter 10 KDa (Merck Millipore, Ireland).
￿e puri￿cation was done together with more members in the lab.
- SMAD2-MH1 (10-174) was expressed in BL-21 E.Coli cells (Novagen,
Darmstadt, Germany) using LB medium (Table 3.2). ￿e bacteria were
induced at OD600 0.9 with 0.5 mM IPTG ON at 20ºC. A￿er resuspension
with lysis bu￿er (Table 3.5), the bacteria were lysed using EmulsiFlex-
C3 (Avestin, Mannheim, Germany) cell disruptor.￿en they were cen-
trifuged (30,000 g, 30 min, 4ºC) and the pH of the supernatant was ad-
justed to 9.2 adding 1 M NaHCO3. ￿e puri￿cation continues through
a Ni2+ a￿nity resin (ABT Beads, Madrid, Spain), equilibrated with 1 M
NaHCO3. A￿er a washing with the elution bu￿er without imidazole,
the protein was eluted with 300 mM imidazole (elution bu￿er) (Table
3.5). Before the cleaving step, the protein was puri￿ed on aHiload 16/60
Superdex 75 prepgrade column (GE Healthcare, Uppsala, Sweden) in
an A¨kta® Puri￿er10/FPLC system (GE Healthcare, Uppsala, Sweden)
equilibrated with 50 mM 2-Amino-2-(hydroxymethyl)propane-1,3-diol
(TRIS), 100 mM NaCl, 2 mM dithiothreitol (DTT), 2% glycerol at pH
7.0. ￿e elution was collected in 2 ml fractions and those correspond-
ing with the protein were joined and TEV protease was added for the
ON cleaving step at 4ºC. Next morning, more TEV was added and the
sample was le￿ at RT for 3 h. A￿er the cleaving, a second size exclu-
sion chromatography was set in a Hiload 16/60 Superdex 75 prepgrade
column (GE Healthcare, Uppsala, Sweden) in an A¨kta® Puri￿er10/FPLC
system (GEHealthcare, Uppsala, Sweden) equilibratedwith 20mMTRIS,
80 mM NaCl, 2 mM DTT at pH 7.0. ￿e elution was collected in 2 ml
fractions and those corresponding with the protein were concentrated
in a Amicon® Ultra-15 centrifugal ￿lter 10 KDa (Merck Millipore, Ire-
land).￿e puri￿cation was done by others members in the lab.
All proteins were monitored at every step by Sodium Dodecyl Sul-
fate Polyacrylamide Gel Electrophoresis (SDS-PAGE). ￿e concentra-
tions were measured in a NanoDrop-1000 (￿ermo Fisher Scienti￿c,
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Waltham, USA).
￿e theoretical values of molecular weight, isoelectric point and ex-
tinction coe￿cient at 280 nm of each protein were calculated using the
ProtParam tool, hosted by ExPASy portal
(h￿p://web.expasy.org/protparam/).
Table 3.4: Overview of the proteins used in this project.
Protein MW (kDa) Aas pI Samples
TGIF1 (256-339) 9.0 86 7.95 non labelled, 15N
TGIF1 (256-347) 9.9 94 6.05 non labelled, 15N, 15N-13C
TGIF1 (150-248) 11.7 101 10.08 non labelled, 15N, 15N-13C
S2-EEE (186-467) 33.2 297 5.31 non labelled
S2-MH1 (10-174) 19.0 169 8.81 non labelled
S4-MH1 (10-140) 15.2 135 9.07 non labelled
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Table 3.5: TGIF1-SMADs solutions composition.
GuHCl bu￿er TGIF1 (256-347) Elution bu￿er TGIF1 (256-347)
GuHCl 6 M TRIS 20 mM
Imidazole 30 mM NaCl 150 mM
pH 8.0 Imidazole 500 mM
pH 8.0
Lysis bu￿er TGIF1 (150-248) Elution bu￿er TGIF1 (150-248)
TRIS 40 mM TRIS 40 mM
NaCl 300 mM NaCl 300 mM
Imidazole 30 mM TCEP 1 mM
Tween 20 0.2% Imidazole 500 mM
pH 7.4 pH 7.4
Lysis bu￿er S2-EEE (186-467) Elution bu￿er S2-EEE (186-467)
TRIS 20 mM TRIS 20 mM
NaCl 150 mM NaCl 150 mM
Imidazole 30 mM Imidazole 500 mM
pH 8.0 pH 8.0
Lysis bu￿er S4-MH1 (10-140) Elution bu￿er S4-MH1 (10-140)
TRIS 40 mM TRIS 40 mM
NaCl 300 mM NaCl 150 mM
Imidazole 40 mM Imidazole 300 mM
Tween 20 0.2% pH 8.0
pH 8.0
Lysis bu￿er S2-MH1 (10-174) Elution bu￿er S2-MH1 (10-174)
NaCO3 786 mM HEPES 50 mM
NaCl 500 mM NaCl 500 mM
DMSO 10 % Glycerol 20 %
Trace Elements 1x Imidazole 300 mM
TCEP 4 mM TCEP 4 mM
pH 7.0
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WWdomains project. As previously described in PNAS under the ti-
tle ”Folding kinetics of WW domains with the united residue force ￿eld
for bridgingmicroscopicmotions and experimentalmeasurements” [122].
Cloning
￿e FBP28 sequence were cloned from 9-11 days mice embryo cDNA.
￿e WW2 sequence from mice and humans is identical. All variants
were cloned into a pGAT2 vector (vector engineered by M. Hyvo¨nen,
University of Cambridge, UK).￿e vector includes ampicillin resistance,
T7-lactose protein promoter, N-terminal His6-GST tag and￿r protease
cleaving site between the His6-GST tag and the protein. Point muta-
tions of the variants were introduced by site-mutagenesis PCR using
Pfu DNA-polymerase (Agilent Technologies, USA) and the appropriate
primers containing the mutations. A￿er the digestion with DPN1, the
vectors were transformed in DH5-↵ strain (Invitrogen, Carlsbad, CA,
USA) with the heat-shock method. Some colonies were selected, their
plasmids were ampli￿ed by miniPrep (￿iagen, Hilden, Germany) and
a￿erwards veri￿ed by DNA sequencing.
Protein Expression and Purification
All proteins were expressed in E.coli BL21(DE3) (Novagen, Germany)
using LBmedium. WT and Y19L NY11R, N CY11R, N CY11RL26A
mutants were induced at OD600 0.6 with 0.3-0.5 mM IPTG, for 3 h at
37ºC. Y11R andW30F were otherwise induced ON at 37ºC. A￿er resus-
pension with lysis bu￿er A (Table 3.6) supplemented with lysozyme,
DNAse I and PMSF, theywere lysed using EmulsiFlex-C3 (Avestin, Mann-
heim, Germany) cell disruptor. ￿ey were then centrifuged (30,000
g, 30 min, 4ºC) and puri￿ed through Ni2+ a￿nity resin (ABT Beads,
Madrid, Spain), previously equilibrated with the lysis bu￿er. ￿e pro-
teins were eluted with 50 mM ethylenediaminetetraacetic acid (EDTA)
(elution bu￿er, Table 3.6) and then thrombin was added to the solu-
tions and incubated ON in order to remove the tag. ￿e cleaved pro-
teins were puri￿ed from the His6-GST-tag with a Hiload 16/60 Superdex
30 prepgrade column (GE Healthcare, Uppsala, Sweden) in an A¨kta®
Puri￿er10/FPLC system (GE Healthcare, Uppsala, Sweden) equilibrated
with 20 mM sodium phosphate, 100 mM NaCl, 1 mM Azide at pH 6.5.
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￿e elution was collected in 2 ml fractions and those corresponding
with the protein were concentrated in a Amicon® Ultra-15 centrifu-
gal ￿lter 3KDa (Merck Millipore, Ireland). ￿e proteins were moni-
tored at every step by SodiumDodecyl Sulfate Polyacrylamide Gel Elec-
trophoresis (SDS-PAGE) and the masses of each mutant were checked
byMALDI-TOF.￿e concentration were measured in a NanoDrop-1000
(￿ermo Fisher Scienti￿c, Waltham, USA). ￿e theoretical values of
molecular weight, isoelectric point and extinction coe￿cient at 280 nm
of each protein were calculated using the ProtParam tool, hosted by
ExPASy portal
(h￿p://web.expasy.org/protparam/).
Table 3.6:WW domain project solutions composition.
Bu￿er A Elution bu￿er
TRIS 20 mM TRIS 20 mM
NaCl 150 mM NaCl 150 mM
Imidazole 10 mM Imidazole 10 mM
pH 8.0 EDTA 50 mM
pH 8.0
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3.3 Techniques
3.3.1 Nuclear Magnetic Resonance
Nuclear Magnetic Resonance spectroscopy, or simply NMR, is a spec-
troscopy technique that provides information at atomic level ofmolecules
and solids. It is based on the ability of certain nuclei atom to absorb
and emit electromagnetic radiation when they are under a magnetic
￿eld. In the structural biology ￿eld, it is considered as one of the main
techniques, along with X-ray crystallography and cryo-electron mi-
croscopy.
NMRwas born in 1937 when Isidor Rabi measured for ￿rst time the nu-
clear magnetic moment of an atom nuclei [123]. A couple years later, in
1946, Felix Bloch and Edward Purcell, independently, applied the mea-
surement also to liquids and solids, respectively, opening the door for
the study of small molecules [124, 125]. But it was in 1964when Richard
Ernst realised that the replacement of the slow and long radio pulses by
a short but intense ones while processing them by Fourier transform in-
creases dramatically the sensitivity of the NMR. Later on, based on the
ideas of Jean Jenner, Ernst proved the possibility of realising 2D NMR
spectra [126]. Finally, in 1985, Kurt Wu¨thrich solved the ￿rst structure
of a small protein (BUSI) based on the measurement of distances be-
tween atoms by 2D NOESY experiments [127]. Nowadays NMR is a full
established versatile technique capable to determine the full structure
of a protein up to roughly 100 KDa [128], to follow a phosphorylation
reaction in-cell [129], and to provide structural information about large
multi domain complexes in solution [130].
Basic principles
NMR is based on the manipulation of the spin of the atom nuclei. It ap-
pears that some atomic nuclei own a nuclear spin angular momentum.
￿is momentum is an intrinsic property of the atoms nuclei as it is the
charge or the mass. ￿e possession or not of the nuclear spin angular
momentum is speci￿ed by the spin quantum number, I. I can be an in-
teger (0, 1 …) or half-integer (1/2, 3/2 …). Only when I is not equal to 0
(I 6= 0), the nucleus of the atom has spin. For instance, the most abun-
dant H isotope (99.9885%), 1H, has an I = 1/2, making it appropriate for
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NMR spectroscopy. However, the quantum number only states which
nuclei can be manipulated, but not the intensity of the manipulation.
As every nuclei has a positive charge, the spin angular momentum gen-
erates a magnetic momentum. ￿e relation between the spin angular
momentum and the magnetic momentum is given by the gyromagnetic
ratio ( ), which explains the intensity of the magnetic momentum gen-
erated and thus, the intensity of the manipulation:
~µ =  ~I (3.1)
where ~µ is the nuclear magnetic moment and ~I the nuclear spin mo-
ment.
￿e 1H nuclei has a   of 267.513 106 rad s-1 T -1. ￿is high value of  
in conjunction with the fact that it is the most abundant nuclei in bio-
logic samples, makes 1H themost suitable atom for biological NMR.￿e
other abundant nuclei in living being, 12C (98.93% isotope abundance),
with a I = 0, thus no spin angular momentum; and 14N (99.632%) with a
I = 1, integer spin (that introduces high quadrupole interferences mak-
ing inviable the measurement) are not capable to be used in NMR.￿is
problem is solved enriching arti￿cially (labelling) the samples with 13C
and 15N, respectively, both with an adequate I of -1/2. However, their
  is not so high as 1H, and so less signal is acquired if the experiment
is recorded with 13C or 15N atoms nuclei. For this reason, most of the
NMR experiments are actually acquired in 1H.
When a nuclei is under the in￿uence of an external magnetic ￿eld (B0),
the spin adopts di￿erent conformations, each of them with di￿erent
energy in a process known as Zeeman e￿ect (Figure 3.5). ￿e number
of the conformations is regulated by the quantic number m, that adopt
m = I, I -1, … -I, with a total of 2I + 1 conformations.￿e energy of each
con￿guration is explained by:
Em =   ~IB0 =  mh¯ B0 (3.2)
If we apply this formula for I = 1/2; then m adopt the values +1/2 (↵)
and -1/2 ( ).
E↵ =  1
2
h¯ B0 E  = +
1
2
h¯ B0 (3.3)
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E
B0
α (m = +1/2)
β (m = -1/2)
ΔE          B0
I = 1/2
Figure 3.5: Zeeman e￿ect in a atom nuclei with I = 1/2.￿e external magnetic
￿eld B0 splits the otherwise one conformation into two energetic levels.
And so the energy di￿erence between both levels is,
 E↵!  = +
1
2
h¯ B0   ( 1
2
h¯ B0)
= h¯ B0
(3.4)
Applying Plank’s law E = hv, the frequency of the transition between
the two spin states, also known as the Larmor frequency, is,
w0 =   B0 in rad s-1
v0 =   B0
2⇡
in Hz
(3.5)
Considering a commonly used 14.0921 T external magnetic ￿eld, the
di￿erence of energy between alpha and beta for 1H turn out to be 3.97555
10-25 J, or as Larmor frequency, 599,985,479.179 Hz, or 600 MHz (located
in the Ultra high frequency, UHT, radio spectrum band).
In thermal equilibria, the energy levels are occupied following the Boltz-
mann distribution.
N 
N↵
= e
   EkBT = e 
h¯ B0
kBT (3.6)
For 1H, in the same external magnetic ￿eld and at room temperature (T
= 298 K), N  is 0.99990 times N↵, meaning that the lower state is only
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0.01% more occupied than the higher energetic level.￿is small di￿er-
ence in population is the reason why NMR has low sensitivity. Apart
from decreasing the T and increasing the B0, scientists have commonly
employ two techniques to overcome the low signal. First, use high con-
centrated samples; the more atoms are, the strongest the signal. And
second, acquire the same spectrum many times. ￿e idea is to accu-
mulate several spectra and process them altogether. ￿e signal from
the sample is added linearly, so a￿er N spectra the signal is N times
stronger. However, the noise, as randomly, only increases by a factor
of
p
N . Considering both factors, the signal-to-noise ratio (SNR) in-
creases the by a factor of
p
N , meaning that doubling the number of
scans (spectra acquired) the signal increases 1.41 times. As doubling
the number of scans also means doubling the time required for acquir-
ing it, there is a practical limit of using this technique, that depends on
every experiment.
So far, one can imagine that if all atom nuclei are equal, there will be
only one signal per atom nuclei and thus it will be impossible to dis-
tinguish between the atoms with di￿erent connectivity. However, it
happens that the electron density that surrounds the nuclei is di￿erent
from nucleus to nucleus. ￿e di￿erent electron density shields the nu-
clei from the external magnetic ￿eld in a di￿erent way, resulting that
every nucleus provides a slightly di￿erent frequency depending of the
environment. ￿is phenomena links the 3D structure of the molecule
with the signals that are acquired in the NMR.
Having di￿erent chemical environments, the nuclei have slightly dif-
ferent Larmor frequencies. As the transition between the two states
depends on the strength of the external magnetic ￿eld, the frequency
di￿erences between the same nucleus are di￿erent for each spectrom-
eter.￿e concept of chemical shi￿ ( ), de￿ned as,
 (ppm) =
v   vref
vref
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overcome this limitation. Due to this, the same spin have the same
chemical shi￿ regardless the magnet used to measure it. ￿e huge dif-
ference between the absolute frequency range (in 14.0921 T; 600 MHz
for 1H) and the relative frequency range between the most and the less
64
3.3 Techniques
shielded nuclei (in 14.0921 T, 10 kHz for 1H) makes part per million
(ppm) the units of reference for the chemical shi￿.
As well as the nuclei spins are a￿ected by the external magnetic ￿eld,
they are also altered by the other nuclei that surround them. In other
words, one nucleus spin has a di￿erent Larmor frequency depending if
the spin, to which it is connected, is aligned or not with the external
magnetic ￿eld. ￿is interaction between the spins is called J-coupling
(also known as scalar coupling). Although the J-coupling have a low af-
fection to the total frequency (it is in the rage of 1 to 100 Hz), it causes
the spli￿ing of the signal, which lead to the broadening of the peak. Fur-
thermore, the J-coupling allows the transfer of magnetisation between
nuclei, including heteronuclear nuclei, being the basis of the multidi-
mensional experiments.
Vector model
￿e vector model is a simple framework that although it do not explain
a full NMR experiment (only quantum mechanics does it) it helps to
understand the basics of it. ￿e vector model will be used to explain
brie￿y how a spectrum is actually acquired.
￿e vector model is based on the simpli￿cation that the atom nuclei
is like a positive charged particle that spins on its axis. When a non-
zero radius charged nucleus spins, generates a tiny magnetic ￿eld, ~µ.
Under the in￿uence of an external magnetic ￿eld (B0), such as the one
generated by an NMR spectrometer, the ~µ aligns with it along the same
z-axis. However, this is an oversimpli￿cation. Actually, as the spinning
tiny magnet has also angular momentum, the nuclei actually precess
around the z-axis at precisely the Larmor frequency before explained.
Plus, quantum mechanics shows us that the angle of precession (✓) for
the 1H nuclei can only be 54.7º. As mentioned before, when I = 1/2,
the energy is split in two levels. In the vector model this is represented
with the lower levels corresponding to the precession around +z while
the higher is precessing around -z (Figure 3.6).
Moreover, the thermal motion – much greater than the interaction be-
tween the tiny magnet and the strong external one – randomise the
direction of each nuclei. Overall the net magnetisation is equal as if
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θ = 54.7º
μ
B0  (z)
Net magnetisation
Individual nucleus 
magnetisation
A B 
B0  (z)
μ
lower energy
higher energy
Figure 3.6: A) Under the in￿uence of an externalmagnetic ￿eld (B0), a charged
nucleus not only spins around its axis, but precess around the direction of B0.
B)￿e sum of the individuals magnetisations results in an overall magnetisa-
tion aligned with the external ￿eld.
only 1 spin over 10,000 is perfectly aligned with the external ￿eld while
the other become totally random. For this reason, the magnetisation of
each nuclei is summed and only the total magnetisation is considered.
NMR can only record the displace of the total magnetisation, being im-
possible to detect each one of the tiny magnets. At equilibrium, the net
magnetisation is stable on the +z axis, so no record can be done. To do
so, the magnetisation has to move to the xy plane and record the pre-
cession movement when the magnetisation return to the equilibrium
state at +z.
A simple NMR experiment starts with a strong but short (around 10 µs
for 1H) radio pulse (radio frequency, RF) applied at +x. ￿is pulse, in
the Larmor frequency, shi￿s the net magnetisation towards the -y axis,
on the xy plane. In most of the NMR experiments the magnetisation
is transferred to another atoms and ￿nished usually on 1H nuclei (be-
cause as explained before, this nuclei gives the highest signal). Finally,
the magnetisation returns to the +z axis in a process known as relax-
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Figure 3.7: Scheme of a very simple NMR experiment. A) Under the B0 ￿eld,
the net magnetisation at equilibrium points toward +z axis. B) A short RF
pulse on B1 (x) shi￿s the magnetisation towards -y axis. C) Once the pulse is
over, relaxation process start, recovering the equilibrium. D) While the mag-
netisation is oscillating, recovering the equilibrium, the FID is recorded. E)
￿e FT is applied to the FID, obtaining an standard NMR 1D spectrum.
ation. In this moment, the probe records the precession around +z as a
free induction decay (FID) signal. Applying the Fourier Transform (FT)
the oscillating voltage versus time function recorded is transformed in
intensity versus frequency plot, the common axis of an NMR spectrum
(Figure 3.7).
￿e relaxation process is one of the most important parameters in NMR
as it has a direct in￿uence on the signal recorded. It can be divided
in the sum of two di￿erent processes. ￿e spin-la￿ice relaxation, also
called longitudinal, refers to the recovery of the magnetisation on the
+z axis and is characterised by the time constant T1. On the other hand,
the spin-spin relaxation, also called transverse, explains the recovery of
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the randomness on the xy plane and is de￿ned by the time constant T2.
Experiments used
In this thesis, all the NMR samples were dissolved in aqueous bu￿ers.
￿e 2 1H of water also are a￿ected by the NMR and the pulses. As
the quantity of molecules is several times higher than any protein we
dissolved in it, many techniques (as watergate or presaturation) have
been developed to suppress the otherwise gigantic water peak at ⇠4.7.
All the experiments recorded in this thesis have proteins as sample to
be analysed. From this point, all the explanation will be focused in pro-
teins.
1D experiment
1H one dimension (1D) experiment is the most simple experiment and
the ￿rst executed in any structural biology project (Figure 3.8). ￿is
experiment requires only an enough concentrated sample containing
1H. It is a fast experiment (less than a minute) that shows all the peaks
related to 1H of the sample. ￿e range from -2 to +12 ppm allows the
observation of all kinds of shielded 1H of a protein. It provides infor-
mation about (1) the presence of protein in the tube (2) the fold of the
protein (3) the good suppression of the water (required if we want to
perform more complex experiments) (4) the presence of any impurity
that is a￿ecting the spectrum.
However, the utility of this experiment is limited to check how is the
protein globally because it contains all the peaks from 1H in only 1D,
making impossible to distinguish and assign them.
2D experiments
￿e two dimension (2D) experiments represent the correlation between
two di￿erent nuclei spins, indicating how two di￿erent spins are con-
nected between themselves.￿ese experiments are based on the trans-
fer of magnetisation between di￿erent nuclei through J-coupling or an-
other spin interaction. ￿e 2D experiments are displayed in a two di-
mension plot (every axis correspond to the   of each nuclei) with the in-
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Figure 3.8: 1D 1H spectrum of a folded protein. ￿e highest peaks are cut to
allow be￿er visualisation of the smaller ones. ￿e two peaks located below 0
ppm indicate the folding of the protein. In the region from 0 to 4 the aliphatic H
are located.￿e negative peaks at⇠4.7 refers to the suppressed water. Finally
a￿er 6 and until 10, the aromatic H and the H bound to N are localised.
tensity given by isopleths.￿ere are two main kinds of 2D experiments
used in this thesis: homonuclears (TOCSY/NOESY) and heteronuclears
(HSQC).
￿e homonuclear experiments are those that transfer themagnetisation
between the same type of nuclei, in most cases 1H. In all the homonu-
clear experiments done in this thesis both nuclei are 1H, thus the further
explanation is based only on 1H -1H experiments. In these 2D spectra,
both axis corresponds to 1H.￿e spectra show two kinds of peaks, the
ones in the diagonal, like in the 1D spectra; and the cross-peaks, that are
symmetrical le￿/right of the diagonal peak and represent the link be-
tween two protons with di￿erent  .￿e nature of the link distinguishes
which kind of experiment is. Total correlation spectroscopy (TOCSY)
provides information about the 1H that are connected by a chain of cou-
plingswhile Nuclear Overhauser e￿ect spectroscopy (NOESY) show the
1H that are close in space with an intensity that drops 1/r6 with the dis-
tance.
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TOtal Correlation SpectroscopY (TOCSY) is an evolution of the pre-
vious correlation spectroscopy (COSY) experiment. As mentioned pre-
viously, a cross-peak indicates an unbroken chain of couplings between
two protons. For example, in a threonine the HA proton is coupled to
HB, and the HB is coupled to the three HG. So, in TOCSY, there is a
cross-peak not only between HA and HB or HB and HG but also be-
tween HA and HG. TOCSY is then very useful in order to see the con-
nection of all the protons in the same spin system. As every amino acid
is an isolated spin system (the peptide bond breaks the coupling chain),
this spectra is very useful in the assignment.
 10  8  6  4  2  0 
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1 H
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Figure 3.9: NOESY spectrum. ￿e positive peaks are displayed in red and
the negative in green. It can be seen as 1D spectrum in the diagonal that is
expanded with the cross-peaks symmetrically located at both sides.￿e broad
vertical line in the middle of the spectra is the water peak.
Nuclear Overhauser E￿ect SpectroscopY (NOESY). However, only
with a TOCSY is very di￿cult to assign completely a protein as many
amino acids are repeated in the sequence and some of them have similar
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pa￿erns of  . For this reason, the NOESY spectra result very helpful
(Figure 3.9). NOESY cross-peaks represents the link between those 1H
that are close in the space (up to 5 A˚) and so, not only the cross-peaks
from the same spin system are seen but also some cross-peaks from 1H
from di￿erent spin systems. Specially interesting are the cross-peaks
from the 1HN. As the 1HN is very near in the space from the 1H of the
-1 residue, the two di￿erent system couplings can be connected. ￿us,
all the protein can be sequentially connected, identi￿ed and assigned
with the only exception of proline that do not have 1HN.
A second crucial advantage of the space-linked cross-peaks that NOESY
provides is those connections close in space but far in sequence. If we
have discarded aggregation, the only reason that two atoms far in se-
quence are together in space is because the protein is folded in a such
way that these two atoms are in proximity. In addition, as the NOE
e￿ect depends 1/r6 on the distance, it also provides information about
how close in the space are both atoms. With the information of these
cross-peaks, so￿ware such as Crystallography & NMR System (CNS)
[131] or Ambiguous Restraints for Iterative Assignment (ARIA) [132]
can calculate the structures with the sequence of the protein that ful￿ll
the NOESY restrictions.
￿e heteronuclear experiments are those that transfer the magnetisa-
tion between di￿erent kind of nuclei.￿e most used nuclei are 1H, 13C
and 15N. ￿is implies that the sample must be labelled in 13C or 15N,
being this the main drawback of the experiment.
￿e most prominent 2D heteronuclear experiment is the Heteronu-
clear Single-￿antumCorrelation/Coherence spectroscopy (HSQC)
[133]. It records the correlation between the chemical shi￿ of 1H and
13C (more used for organic molecules) or 1H and 15N (more used for bio-
logic molecules) through the J coupling interaction between the nuclei.
Focusing on the 1H-15N HSQC experiment, it shows a peak for every
15N-1H bound in the protein. Every amino acid have one 15N-1H bound
with the exception of the proline (that lacks the 1HN). Also some side
chains contains 15N-1H and give a peak too. Overall, the spectrum, with
the x-axis for 1H and the y axis for 15N, allows a general vision of almost
all amino acids in a fast and easy way (Figure 3.10). Such vision allows
a quick analysis of the position of the peaks. If they are too close (from
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7.5 to 8.5 1H (ppm)) may indicate that the protein is unfolded.￿e other
way around, a good dispersion (from 6 to 10 1H (ppm)) means proper
folding. Moreover, if some disruption is a￿ecting the amino acid such a
phosphorylation or any binding of a ligand, the correspondent a￿ected
peakwill shi￿ from the reference position. However, this information is
much more relevant if the assignment of every 15N-1H peak is known.
Unfortunately, with only an HSQC is impossible to known to which
amino acid corresponds to each peak, as 3D experiments are needed
for the assignment. HeteronuclearMultiple-￿antumCorrelation
(HMQC) is another 2D experiment that, similarly to the HSQC, also
correlates the chemical shi￿, via the J coupling, between the 1H and
the 13C or 15N, giving very similar kind of spectra and information. It
is based on a di￿erent pulse sequence compared to HSQC, that overall
give worse resolution but higher signal-to-noise ratio.
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Figure 3.10: Figure of a typical 1H-15N HSQC spectrum, where each peak
represents one 15N-1H correlation. ￿e good dispersion observed indicates
that the protein is well folded.
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3D experiments
￿e three dimension (3D) experiments provide information about the
link between three di￿erent spin nuclei. ￿ere are many types of 3D
experiments, but in this thesis only the ones needed for assignment
were used.
CBCA(co)NH. It provides information about the link between the 1HN
and 15N of the i amino acid and the 13C↵ and 13C  of the previous i-
1 amino acid. In the practice is like a 1H-15N HSQC with a new 13C
on the third dimension. In this experiment, the magnetisation from
the 1H↵ and 1H  is transferred to the corresponding 13C, where they
evolve together. Because of this, both 13C appear in the same dimension.
A￿erwards the magnetisation goes through the 13C’ and evolves in the
15N of the i amino acid to ￿nally end in the 1HN for detection (Figure
3.11) [134].
CBCANH. It is similar to the CBCA(co)NH. In this experiment the
magnetisation goes over the 13C’ allowing the 15N to receive the mag-
netisation not only from the previous amino acid (i-1) but also for the
same amino acid (i). ￿is crucial change allows the link between the i
and the i-1 amino acid (Figure 3.11) [135].
hN(coca)NH.￿e hN(coca)NH experiment connect the chemical shi￿
of an 15NHi with the following 15NHi+1, allowing a ”backbone NHwalk”.
￿is results very useful in the assignment process as provide informa-
tion about which 15NH peak is a￿er which other peak. ￿e magneti-
sation is transferred from the 15NHi+1 to the 15NHi (evolving in dif-
ferent dimensions) through 13C↵ and 13C’. Finally the magnetisation
is recorded in 1HN (Figure 3.11) [136].
Overall, the protein is assigned following the amino acid sequence, in
a similar way as NOESY/TOCSY works. While the CBCANH is main
spectrum used for the assignment, the CBCA(co)NH and hN(coca)NH
spectra help to distinguish the di￿erent spin systems.
Ligand binding principles
NMR is a tool that allows monitoring a binding reaction when a ligand
is added to a given sample. As explained before, 1H-15N HSQC is the
most common experiment used due to the broad spectrum of peaks that
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Figure 3.11: Scheme of CBCA(co)NH, CBCANH and hN(coca)NH 3D experi-
ments.￿e graph show the way of the magnetisation. In blue are represented
those nuclei where the magnetisation goes through while in orange, yellow
and green are those nuclei where the magnetisation evolve and thus are a di-
mension of the spectra.
it provides (one for each amino acid excepting proline) in a fast man-
ner (20-40 min each experiment). As the protein is labelled in 15N, the
ligand can be unlabelled and so, do not appear in the spectrum. If the
ligand interacts with some region of the protein, the nuclei atoms that
are in that region will be a￿ected by changes in the electronic environ-
ment and so their   will shi￿ generating a chemical shi￿ perturbation
(CSP).￿e usual way of work includes a titration of the ligand versus
the protein in a way that several spectra are acquired while equivalents
of ligand are added.
￿e way the peak is shi￿ed depends on how fast is the exchange of
the protein-ligand interaction in comparison with the di￿erence be-
tween the v of both states ( v). When the interaction exchange is
much faster than the di￿erence in Hz between the bound and the un-
74
3.3 Techniques
bound state, there are several binding and unbinding processes during
the same NMR experiment.￿is situation lead to a mixture of both sit-
uations in one single peak that shi￿s from the unbound   to the bound
  without losing intensity (Figure 3.12 B).
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Figure 3.12: 1H-15N HSQC titration. A)￿e peak does not shi￿ upon the ad-
dition of the ligand. B) Example of fast exchange. ￿e unbound peak moves
towards the ￿nal bound peak. C) Slow exchange.￿e unbound peak progres-
sively disappears while the bound peak appears.
On the other hand, if the exchange rate is much slower than the di￿er-
ence of  , then some molecules will be bound with the ligand and some
no, leading to the appearance of two smaller peaks, from the bound and
unbound state respectively. As the proportion of ligand increases, the
peak related to the unbound state drops while the peak from the bound
state increases at the same proportion (Figure 3.12 C).
In the intermediate state (when exchange rate is similar than  ) some-
thing in between is observed.￿emixture peak shi￿s but with lower in-
tensity in the middle region, plus both peak at the bound and unbound
state are also seen but also at lower intensity as the same quantity of
spins have to be shared by all peaks.
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Experimental procedures
TGIF1-SMADs project
- TGIF1 (256-339) & TGIF1 (256-347)
￿e experiments regarding TGIF1 (256-347) 2DHSQC, and 3DCBCANH-
BEST, HNCANH-BEST assignment experiments were done at 200 µM
in 20 mM HEPES, 100 mM NaCl, 2 mM DTT, 1.5 mM EDTA, 100 µM
PMSF at pH 6.4. 5% of D2O was added to a ￿nal volume of 350 µl in a 5
mm shigemi tube.￿e temperature was set at 277 K.
Generally, the phosphorylation reaction with p38↵ kinase was done
adding ATP 2 mM (￿nal concentration), MgCl2 5 mM (￿nal concentra-
tion) and 10 µl of p38↵ at 0.1 µg/µl (SignalChem, Richmond, Canada)
for every 100 µl of protein solution.￿e reaction was incubated at 25ºC
ON without stirring.
￿e further phosphorylationwith Casein Kinase I (CK1)was done adding
ATP 2 mM (￿nal concentration), 1x protein kinase bu￿er (provided by
the manufacturer) and 8 µl of CK1 at 1,000,000 U/ml (New England Bi-
olabs, Massachuse￿s, USA) for every 100 µl of protein solution. ￿e
reaction was incubated at 25ºC ON without stirring.
￿e experiments regarding pTGIF1 (256-347) with p38↵, 2D HSQC, and
3DCBCANH-BEST,HNCANH-BEST assignment experimentswere done
at 200 µM in 20 mM HEPES, 100 mM NaCl, 2 mM DTT, 1.5 mM EDTA,
100 µM PMSF at pH 6.4. 5% of D2O was added to a ￿nal volume of 320
µl in a 5 mm shigemi tube.￿e temperature was set at 277 K.
2D SOFAST-HSQC and SOFAST-HMQC experiments before and a￿er
phosphorylations with p38↵ and CK1 were done with 50 µM TGIF1
(256-347) in 20 mM HEPES, 100 mM NaCl, 2 mM DTT (or 1 mM TCEP)
at pH 6.8. 5% of D2O was added to a ￿nal volume of 150 µl in a 3 mm
tube.￿e temperature was set at 277 K.
Real-timeNMR experiment following p38↵ phosphorylationswere done
with 80 µM TGIF1 (256-339) in 20 mM HEPES, 100 mM NaCl, 2 mM
DTT at pH 6.8. For the phosphorylation were added MgCl2 5 mM (￿-
nal concentration), ATP 1 mM (￿nal concentration), 8 µl p38↵ at 0.1
µg/µl (SignalChem, Richmond, Canada). 5% of D2Owas added to a ￿nal
volume of 150 µl in a 3 mm tube. 21 non-stop SOFAST-HMQC experi-
ments (34 min 42s each) were recorded at 298 K.￿e intensities of every
1H-15N unambiguously assigned peak were ￿￿ed to mono-exponential
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equation (y = y0 ⇤ (1  exp( K ⇤ x)) in GraphPad Prism so￿ware.
In the NMR 1H-15N HSQC titrations between 15N TGIF1 (256-347) (un-
phosphorylated (75 µM) and with phosphorylated S286 and S291 (45
µM)) and SMAD2-EEE (186-467), the common bu￿er used was 20 mM
HEPES, 100 mM NaCl, 1 mM TCEP at pH 6.8.￿e temperature was set
at 277 K.
TGIF1 (256-347) HSQC titrations with SMAD2-MH1 (10-174) at around
200 µM in 20 mM PO4, 80 mM NaCl, 1 mM TCEP at pH 6.4. 10% of D2O
was added to a ￿nal volume of 154 µl in a 3 mm tube.￿e temperature
was set at 277 K.
TGIF1 (256-347) HSQC titrations with TGIF1 (150-248) at around 200
µM in 20 mM PO4, 80 mMNaCl, 1 mM TCEP at pH 6.4. 10% of D2O was
added to a ￿nal volume of 148 µl in a 3 mm tube.￿e temperature was
set at 277 K.
- TGIF1 (150-248)
￿e experiments regarding TGIF1 (150-248) 2DHSQC experimentswere
done at 100 µM in 20 mM PO4, 150 mM NaCl, 1 mM TCEP at pH 4.9.
10% of D2O was added to a ￿nal volume of 270 µl in a 5 mm shigemi
tube.￿e temperature was set at 298 K.
￿e 3D CBCANH-BEST, CBCA(CO)NH-BEST assignment experiments
were done at 166 µM in 20 mM PO4, 80 mM NaCl, 1 mM TCEP at pH
5.25. 10% of D2O was added to a ￿nal volume of 160 µl in a 3 mm tube.
￿e temperature was set at 298 K.
TGIF1 (150-248) HSQC titrations with DNA were done at 231 µM in 20
mM PO4, 80 mM NaCl, 1 mM TCEP at pH 5.25. 10% of D2O was added
to a ￿nal volume of 160 µl in a 3 mm tube.￿e temperature was set at
298 K.
TGIF1 (150-248) HSQC titrations with SMAD4-MH1 (10-140) at 65 µM
in 20 mMHEPES, 150 mMNaCl, 1 mM TCEP at pH 6.4. 10% of D2O was
added to a ￿nal volume of 140 µl in a 3 mm tube.￿e temperature was
set at 298 K.
TGIF1 (150-248) HSQC titrations with SMAD2-MH1 (10-174) at 200 µM
in 20 mM PO4, 80 mM NaCl, 1 mM TCEP at pH 5.25. 10% of D2O was
added to a ￿nal volume of 154 µl in a 3 mm tube.￿e temperature was
set at 298 K.
￿e experiments regarding the TGIF1 (256-339) & TGIF1 (256-347) 2D
77
3 Materials and Methods
HSQC, SOFAST-HMQC; 3D CBCANH-BEST, HNCANH-BEST assign-
ment experiments and Real-Time NMR following kinase phosphoryla-
tion, were recorded with a 600MHz or 750 MHz Bruker Avance spec-
trometer both equipped with a cryogenically cooled triple resonance
1H13C/15NTCI probe located in theDepartment of NMR-supported Struc-
tural Biology, Leibniz Institute ofMolecular Pharmacology (FMPBerlin),
Robert-Ro¨ssle Strasse 10, 13125 Berlin, Germany. All other experiments,
including all the titrations, were recorded in house Bruker Avance III
600-MHz spectrometer equippedwith a cryoprobe (CPQCI 1H-31P/-13C/15N/D
Z-GRD).
￿e spectra were processed with TopSpin v3.5 Bruker So￿ware. Real-
time NMR experiments were evaluated with Sparky [137] and the as-
signment and the titrationswere analysedwith CcpNMRAnalysis [138].
For every titration, the change in the displacement as well as in the
intensity of every chemical shi￿ was analysed. In all cases the last
titration point was compared with the ￿rst point with no ligand. ￿e
movement in the chemical shi￿ was evaluated with the equation:
d =
r
1
2
[ 2H + (0.14 ·  2N)] (3.8)
where d is the averaged Euclidean distance moved, as is stated in [139].
Only the peaks above 2 standard deviation   and with a d higher than
0.02 ppm are considered as shi￿ed. ￿e intensity ratio was calculated
as the height of the peak at bound state divided by the height at free
state. A uniform scaling number averaged from the ratio of 4 di￿er-
ent non-interacting residues was applied to normalise the values. ￿is
value compensate the decrease of intensity due to dilution or precip-
itation of the 15N sample. Again, only those values above or below 2
standard deviation   were considered.￿ose values with a normalised
intensity more than 2.5 times were not considered in order to calculate
the average and the standard deviation.
Chemical shi￿ index (CSI) was calculated using the random coil values
provided by the Biological Magnetic Resonance Data Bank (BMRB). For
those phosphorylated serines, the random coil values for C↵ and C 
were calculated from [140].
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WWmutants project
As previously described in PNAS under the title ”Folding kinetics of
WW domains with the united residue force ￿eld for bridging micro-
scopic motions and experimental measurements” [122].
1D-1H, 2D-NOESY and 2D-TOCSY were acquired at 285 K unless oth-
erwise stated.￿e mixing time for 2D-NOESY was 120 ms.￿e spectra
were acquired on a Bruker Avance III 600-MHz spectrometer equipped
with a z-pulse ￿eld gradient unit and a triple (1H, 13C, 15N) resonance
probe head and further processed with TopSpin v3.5 Bruker So￿ware.
NOEs were manually assigned using CARA so￿ware and integrated
using the batch integration method of XEASY package [141]. Crystal-
lography & NMR system (CNS) vs 1.1 was used for structure calcula-
tion [131] using the unambiguously assigned intra and inter-molecular
NOEs. 200 structures were calculated with the calculation protocol us-
ing 100,000 cooling steps. ￿e protocol includes a water re￿nement
so￿ware [132] with a modi￿ed protocols developed in house, which
include all experimental restraints during re￿nement. ￿e 20 lowest
energy structures for each mutant were selected and their quality was
checked with iCing [142] and PROCHECK-NMR [143] so￿ware. Fi-
nally, the structures represented in this thesiswere depicted usingUCSF
Chimera [144].
3.3.2 Mass Spectrometry
Basic principles
Mass spectrometry (MS) is a analytical technique that determines the
mass of a particle (isolated or as mixtures). A mass spectrometer sepa-
rates previously ionised particles by its mass to charge ratio to ￿nally
record them in a ion detector.
￿ere are many kinds of MS techniques, di￿ering basically in the way
how they perform these three steps. Firstly, it can ionize the particle by
Matrix-Assisted Laser Desorption/ionization (MALDI) or electrospray
ionizationmethod (ESI), amongmany others. Later, MS sorts the result-
ing ions based on their mass/charge (m/z) ratio. Time-of-￿ight (TOF),
quadrupole, ion traps or Fourier transform (FT) analysers are some of
the most used ways to sort them. In the last step a MS detects the ions
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thanks of an electron multiplier, micro-channel plate detectors (MCP)
or other methods. An important aspect of MS is that it requires few
sample to work despite the sample is not recovered. In this thesis only
MALDI-TOF and ESI-quadropole devices were used, and so from now
the explanation will focus on these kind of MS spectrometers.
￿e idea behind MALDI is to shoot the sample with a laser to desorb
them from a suitable matrix, at the same time that they are ionizated by
being protonated or deprotonated. It is considered a so￿ technique as it
can ionize, without major fragmentation, many kinds of biomolecules
such as proteins, DNA or sugars. A￿er the sample have been ionized,
the di￿erence of time of ￿ight (TOF) of the electrical accelerated par-
ticles sorts the particles through their m/z ratio. MALDI-TOF con￿g-
uration is very common as they both works in a batch mode and they
allow the measurement of a wide mass range.
ESI is also considered a so￿ technique. It generates the ionswhen a high
voltage is applied to a ￿owing liquid creating an aerosol. At the time
that the li￿le drops loses their liquid, the particle is being charged until
no liquid remains and the particle stays ionized. ￿adropole analyser
is made by four parallel cylindrical rods that creates an electrical ￿eld
so that only particles with the right m/z ratio passes through it to the
detector. ESI-quadropole can work in a continuous mode and thus it
can be coupled to an HPLC as a ￿nal detector to check the mass of the
eluted fractions.
Experimental procedures
Peptide ligation project. As previously described in Biopolymers
(Peptide Science) under the title ”Addition of HOBt improves the con-
version of thioester-amine chemical ligation” [119].
MALDI-MS. Mass spectra were acquired on a 4700 Proteomic analyser
or on a 4800 Plus MALDI TOF/TOF Analyser (AB Sciex, Framingham,
USA) calibrated with Calmix (Calmix 4700 Proteomics Analyser Cali-
brating Mixture). ￿e mass spectra were recorded in positive re￿ector
TOF mode in the m/z range 500–2000 or 1500–4500 at a ￿xed laser in-
80
3.3 Techniques
tensity of 4800 using alpha-cyano-4-hydroxycinnamic acid (ACH) as a
matrix. Spectra were analysed by Data Explorer so￿ware (Version 4.6,
Applied Biosystems GmbH).
LC-MS.￿e ligation mixtures (30 µL, at ￿nal concentration of approx.
60 µmol/L for each time point) were injected into the HPLC-MS sys-
tem (Waters, model Alliance 2796 with a quaternary pump and UV/Vis
dual absorbance detector Waters 2487 connected with ESI-MS model
Micromass ZQ).￿e separation was achieved on a Sun￿re C18-column
(internal diameter 2.1 mm, particle size 3.5 µm, length 100 mm) using a
linear gradient from 10% or 20% to 100% aqueous acetonitrile (0.1% FA)
in 8 min at a ￿ow rate of 0.3 mL/min. ￿e mass spectra were acquired
for a mass range from m/z 500 to 2000 in positive ion mode using ￿ve
di￿erent cone voltages ranging from 5 to 70 V. ￿e TIC spectra used
for peak integration corresponds to the cone voltage of 30 V and were
analysed by Masslynx 4.0 so￿ware (Waters, Milford, USA).
WWmutants project. As previously described in PNAS under the ti-
tle ”Folding kinetics of WW domains with the united residue force ￿eld
for bridgingmicroscopicmotions and experimentalmeasurements” [122].
And TGIF1-SMADs project.
MALDI-MS. Mass spectra were acquired on a 4700 Proteomic analyser
(AB Sciex) calibrated with Calmix (Calmix 4700 Proteomics Analyser
Calibratingmixture).￿e spectra were recorded in positive linear mode
or at positive re￿ector, when possible. 0.4 µl of sample were mixed with
the same quantity of a sinapinic acid (SA) matrix solution. Spectra were
analysed by Data Explorer so￿ware (Version 4.6, Applied Biosystems
GmbH).
3.3.3 MicroScale Thermophoresis
Basic principles
MicroScale￿ermophoresis (MST) is a technique used for quantifymolec-
ular interactions. It is based on the measurement of the displacement of
a molecule caused by a gradient of temperature, an e￿ect called ”ther-
mophoresis”.￿is e￿ect depends on the hydration shell, charge or size
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of the molecule. If the molecule is bound to a ligand, the bound com-
plex will have a di￿erent hydration shell, charge and size in comparison
with the unbound one.￿erefore both molecules will be displaced in a
di￿erent rate when there is a gradient of temperature. ￿is technique
allows the determination of molecular interactions in their native state
in a wide range of concentrations (nm to mM) [145].
￿e experiment works as following: the ￿uorescent sample is intro-
duced in a narrow capillary by capillarity. ￿en the device start mea-
suring the basal ￿uorescence by standard methods. A￿erwards, an IR-
laser is switched on and creates the temperature gradient. Because of
the thermophoresis e￿ect, the molecule moves away from the heat. As
previous described, the molecule moves away in a di￿erent rate de-
pending if it is bound to a ligand or not. ￿is process is repeated with
increasing equivalents of ligand. A￿er the experiment, the normalised
￿uorescence (Fnorm) is calculated from the ￿uorescence values with and
without the IR laser. Finally, the (Fnorm) is plo￿ed versus the increasing
concentrations of ligand and the KD is derived.
Experimental procedures
As pTGIF1 (256-347) is not ￿uorescent, NT-647 ￿uorescence dye (Nan-
oTemper Technologies, Mu¨nchen, Germany) was bound to it. ￿is dye
only binds to cysteines (there are 3 in pTGIF1 (256-347) fragment) and
only one cysteine permolecule is labelled. However, the cysteinewhere
the dye binds varies from molecule to molecule. Following manufac-
turer instructions, 100 µl at 20 µM of pTGIF1 (256-347) reacted with
100 µl at 60 µM of dye in 20 mM NaPO4, 80 mM NaCl at pH 6.4 bu￿er.
A￿er 35 min of reaction at room temperature in the dark, the free dye
was separated from the resin with a PD-10 (General Electric, UK).￿e
MST experiment was carried out mixing 5 µl of pTGIF1 (256-347) at 20
nM and 5 µl of SMAD2 at increasing concentrations doubling from 5.6
nM to 186 µM in 20mMNaPO4, 80 mMNaCl, 1 mMTCEP, 0.05% Tween
at pH 6.4. 16 capillaries were analysed. Excitation power was set at 40%
while MST was set at 20%.
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3.3.4 Electrophoretic Mobility Shi￿ Assay
Basic principles
Electrophoretic Mobility Shi￿ Assay (EMSA) is a technique that de-
tect the interaction between two molecules in a easy and fast way. It
consists on a gel electrophoresis, similar to the SDS-PAGE, where the
molecules (commonly DNA or RNA) are moved due to their size and
charge. When a protein is added to the solution two things can happen:
(1) the DNA do not bind to the protein and so, the DNA band is equal
as the one without protein (2) the DNA actually binds to the protein.
In this case, as the complex DNA-protein is bigger and has a di￿erent
charge as the original DNA, the band shi￿s from its original position
to a new one upper in the gel. In this experiment, only the DNA is
labelled and thus the protein remains invisible. ￿ere are di￿erent la-
belling methods, radioactivity, ￿uorescence dye or biotin. In this thesis,
only the ￿uorescence labelling was used because its security and sim-
plicity. Overall, EMSA is a very sensible technique that requires li￿le
amount of DNA and protein allowing competition experiments at very
reduced concentrations.
Experimental procedures
TGIF1 Homeodomain (150-248) mother solution was 114 µM in 20 mM
NaPO4, 150 mM NaCl, 1 mM TCEP, at pH 6.4 while the DNA was an-
nealed in 20 mM HEPES, 150 mM NaCl, 1 mM sodium azide, at pH
7.5. All protein dilutions were done in 20 mM HEPES, 150 mM NaCl, 1
mM sodium azide, at pH 7.5.￿e protein concentration gradients were
done in a serial dilution fashion. In each sample, 10 µl of protein were
mixed with 3 µl of DNA and 10 µl of Orange dye. A￿er the mixing, the
samples were incubated for 30 min. ￿en, they were loaded in a 12%
polyacrylamide gels under non-denaturating conditions.￿e bu￿er for
the electrophoresis was 25 mM TRIS, 200 mM Glycine, pH 8.2. ￿e gel
was run 1h 15 min at 80V at room temperature, until the orange dye
reach the bo￿om. Finally, the gels were revealed at the wavelength of
678/694 nm (excitation/emission) using a Typhoon imager (GE Health-
care, Uppsala Sweden). ￿e EMSA assays were carried out together
with Dr. Guca.
83

4 Results
4.1 Deciphering the binding of TGIF1
(256-347) to SMAD2
4.1.1 TGIF1 (256-347) is unstructured
￿e ￿rst step in the project was to design a fragment of TGIF1 that
includes the region described to interact with SMAD2 (SID), between
the residues 267 and 321 of TGIF1 [28]. We decided to perform our ex-
periments with the TGIF1 fragment (256-347), which not only includes
the SMAD2 binding region but also the contact region of HDAC1 [44],
Axin-2 [51] and PHRF1 [38] (Figures 1.8 B and 4.1).
TGIF1 (256-347)
1 401
HD
SID (267-321)
TGIF1 (1- 401)
173 230
130
256 347
Figure 4.1: Scheme of TGIF1 (256-347) fragment in relation with the full-
length TGIF1 protein.￿e SID region is shown in blue while the serine phos-
phorylations found in the region are indicated with a red stick.
In our ￿rst experiment, we prepared a 15N labeled sample and recorded
an 1H-15N HSQC of it (Figure 4.2).￿e spectrum shows a narrow distri-
bution of the peaks, indicating that this region of TGIF1 lacks a stable
tertiary structure. We proceed then to prepare a double labelled sample
(15N-13C) in order to assign the amide resonances. With the informa-
tion obtained combining the pair of CBCA(CO)NH and HNCANH ex-
periments we could assign up to 78 of the 83 (94%) non-proline amino
acids of the fragment (94 total amino acids).
85
4 Results
 9.0  8.5  8.0  7.5 
 125 
 120 
 115 
 110 
1H δ(ppm)
15
N
 δ
(p
pm
)
 7.0 
TGIF1 (256-347)
Figure 4.2: 1H-15NHSQC of TGIF1 (256-347).￿e poor dispersion of the peaks
indicates a lack of stable tertiary structure. 91.6% of the expected peaks can
be observed (76 of a total of 83 peaks).
￿e assignments of the carbon resonances also allowed us to compare
the C↵ and C  chemical shi￿ ( ) of each amino acidwith its random coil
value (Chemical shi￿ index (CSI)) (Figure 4.3). ￿e lack of a tendency
towards a positive (↵-helix) or negative ( -sheet) di￿erence versus the
random coil values indicates the absence of di￿erentiated ↵-helix or
 -sheet structures, in agreement with the previous data obtained.
4.1.2 TGIF1 (256-347) does not interact with
SMAD2-EEE (186-467)
In our next experiment we investigated the interaction between the
TGIF1 (256-347) and SMAD2 protein using NMR. As explained in the
introduction, SMAD2 binds to TGIF1 through part of MH1 and the full
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Figure 4.3: Chemical shi￿ representation of  C↵- C  of TGIF1 (256-347).
Tendency to negative values indicates the presence of  -sheet while a positive
tendency re￿ects ↵-helix.
linker and MH2 domain [28]. Plus, as most of the proteins that inter-
act with SMAD2 bind to the linker or MH2 domain of SMAD2 [20], we
decided to start our titrating experiments with the linker-MH2 frag-
ment of SMAD2 (amino acids 186-467). In addition, as previous experi-
ments demonstrated [28], in vivo interaction is enhanced when TGF- 
is present, or in other words, when SMAD2 is activated, hence, phos-
phorylated in the last three serines (464, 465, 467). In order to facilitate
its obtention, glutamic acids can be used to mimics the e￿ects of the
phosphorylated serines [146].￿erefore, in our experiments we used a
clone of SMAD2 (186-467) with the three serines 464, 465, 467 substi-
tuted by glutamic acid (from now, stated like SMAD2-EEE (186-467)).
￿eHSQC titration between the 15N TGIF1 (256-347) with up to 7 equiv-
alents of the ligand SMAD2-EEE (186-467) showed no variation in the
  neither in the intensity of the peaks, indicating that there is no inter-
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action between them under the experimental conditions used (Figure
4.4 and Appendix Figure 7.3).
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Only TGIF1 (256-347)
+ 1 eq SMAD2 (186-467)
+ 7 eq SMAD2 (186-467)
Figure 4.4: Superimposition of several 1H-15N-SOFAST-HSQC of TGIF1 (256-
347) with increasing equivalents of SMAD2-EEE (186-467). Red colour refers
to TGIF1 (256-347) alone; green to TGIF1 (256-347) + 1 equivalent of SMAD2-
EEE (186-467) and blue to TGIF1 (256-347) + 7 equivalents of SMAD2-EEE
(186-467).
4.1.3 p38↵ phosphorylates Ser286 and Ser291 of
TGIF1 (256-347)
￿e negative result led us to think that the serines 286, 291 and 294,
which have been found phosphorylated in vivo ([57], [111]) and are
located in the middle of the TGIF1 region that interacts with SMAD2,
may have a role in the regulation of the interaction. In particular, we
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wanted to know if the presence of the phosphate groupsmay have some
in￿uence in the binding (Figure 4.5).
256 347
ETPFHSCTAGPNPTLGRPLSPKPSSPGSVLARPSVICHTTVTALKDVPFSLCQSV
267 321
286 291268
SID
P P P
294
TGIF1 (256-347)
Figure 4.5: Detail of the TGIF1 sequence that is proposed to interact with
SMAD2. In red there are the serines/threonines that are theoretically phos-
phorylated by p38↵ as they are before proline (in green). ￿ere are no more
serines or threonines before proline in the rest of the construct sequence not
shown.￿e phosphorylations that were found by HTP-MS methods are indi-
cated by a P. Ser294, not theoretically phosphorylated by p38↵ but found in
vivo with the phosphate group is labelled in purple. ￿e arginines present in
the fragment are highlighted in yellow.
In order to get the phosphorylated TGIF1 fragment, we ￿rst planned to
apply the peptide synthesis strategy. As the fragment is too long (94
amino acid) to synthesise it by a single SPPS, we designed a ligation
strategy with the improved cysteine-free direct aminolysis we have de-
veloped in our lab (Section 4.3). However, as explained in the subsection
4.4.4, the strategy for this particular peptide was unsuccessful.
￿en we considered the possibility to phosphorylate the TGIF1 (256-
347) fragment in vitro with speci￿c kinases. In this sense, p38↵ kinase
is known to phosphorylate serines or threonines before prolines [147].
In the TGIF1 (256-347) fragment there are three serine/threonines that
could be phosphorylated by p38↵ as they are situated before a proline
(￿r268, Ser286, Ser291; Figure 4.5). Two of them, Ser286 and Ser291,
are two of the three serines that have been found phosphorylated in
vivo [57]. ￿us, we investigated the in vitro phosphorylation reaction
by p38↵ kinase on a sample of TGIF1 (256-347) by NMR (Figure 4.6 A,
B).
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Figure 4.6: A) Superimposition of 1H-15N-SOFAST-HMQC spectra of TGIF1
(256-347) before (red) and a￿er (green) the phosphorylation with p38↵. ￿e
most relevant changes in   and the unchanged position of threonine 268 are
labelled. Surrounded by a dashed line are the side-chain peaks of the arginines:
In yellow before phosphorylation and in light green a￿er phosphorylation. B)
Shi￿ of every backbone 1H-15N   caused by p38↵ phosphorylation. Prolines
and non-assigned amino acids have a value of 0.
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Interestingly, we found a great shi￿ of the 1H-15N  relative to the Ser286
and Ser291 (but not to the￿r268) and smaller changes relative to the
amino acids surrounding them. As it has been reported previously
([129], [140]), a large shi￿ of a serine to higher chemical shi￿ (mean-
ing less shielded spin nuclei) indicates its phosphorylation. We there-
fore conclude that the addition of the p38↵ causes the speci￿c phos-
phorylation of Ser286 and Ser291. Curiously, Ser286 and￿r268 have
a very similar chemical shi￿ and they appear superimposed in the 1H-
15NHMQC spectrum before the phosphorylation.￿erefore, in order to
con￿rm the assignment, we also assigned the backbone 1H-15N peaks
of TGIF1 (256-347) a￿er p38↵ phosphorylation by performing 3D ex-
periments (Appendix Figure 7.2).
Another shi￿ can be observed in Figure 4.6 A. Located at low   of
both dimensions, a couple of negative peaks shi￿ their positions due
to the phosphorylation event (indicated by dashed line in Figure 4.6 A).
￿ese peaks likely belong to the 1H-15N side-chains of the two arginines
present in the sequence of TGIF1 (256-347) (their peaks actually res-
onate at around 15N 87 ppm but as the spectrum frequency is too nar-
row, the spectrum is folded, and this feature is re￿ected by the neg-
ative sign of the resonances). ￿ese shi￿s may indicate the presence
of salt bridges between the phosphate group and the side-chain of the
arginines [148]. ￿is interpretation is supported by the fact that both
arginines are situated just before and a￿er the phosphorylated serines,
speci￿cally at -3 of Ser286 and at +7 of Ser291 (indicated in yellow in
the Figure 4.5).
To investigate if the serines are ge￿ing phosphorylated at the same time
or if the reaction is sequential, we performed a Real-Time NMR ex-
periment. In this assay, we followed the appearance of the new peaks
forming (and the disappearance of the old peaks) in the course of the
phosphorylation reaction. We determined that the Ser286 was phos-
phorylated ￿rst (with half of population phosphorylated a￿er 50.0 min)
while the Ser291 took 191.8 min to be half phosphorylated (Figure 4.7).
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Figure 4.7: Kinetic of the appearance of the phosphorylated serines 286 and
291 peaks. ￿e intensity versus time peaks are ￿￿ed to a mono-exponential
equation.
pTGIF1 (256-347) by p38↵ does not change its secondary
structure a￿er phosphorylation.
As shown in Figure 4.6 A, the peak distribution in the 1H-15N HMQC
spectra of pTGIF1 (256-347) by p38↵ did not change signi￿cantly, al-
though some peaks have shi￿ed due to the phosphorylation. Moreover,
the CSI values of the phosphorylated TGIF1 (256-347) by p38↵ expose
a similar distribution (Figure 4.8). Overall, we can conclude that TGIF1
(256-347) does not undergo any big structural rearrangement a￿er the
phosphorylation and it remains essentially unstructured.
4.1.4 pTGIF1 (256-347) by p38↵ spectrum does not
change significantly a￿er the addition of
SMAD2-EEE (186-467)
To investigate the binding of phosphorylated TGIF1 (256-347) by p38↵
and SMAD2-EEE (186-467), we performed a NMR titration experiment
on a 15N-pTGIF1 (256-347) by p38↵ sample (100% phosphorylated at
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Figure 4.8: Superimposition of chemical shi￿ index (CSI) values ( C↵- C )
of TGIF1 (256-347) before and a￿er being phosphorylated by p38↵. Tendency
to negative values indicate the presence of  -sheet while a positive tendency
re￿ects ↵-helix.￿e circled P represents the phosphorylated serines. Labelled
in red are all three serines found phosphorylated in vivo.
S286; 50% at S291) titrated by SMAD2-EEE (186-467).￿e results of the
titration, showed in Figure 4.9 and Appendix Figure 7.4, revealed three
chemical shi￿ perturbations (CSPs): pSer286 and pSer291 are shi￿ed an
average distance of 0.021 ppm and 0.022 ppm, respectively, just above
the cut-o￿ and the third shi￿ of 0.056 ppm, corresponds to one peak
located at the bo￿om le￿ region. ￿is peak, and the one next to it, did
not appear in the assignment spectra and therefore we do not know
to which amino acid refers to. We speculate that they refer to some
of the histidines that we could not observe (and assign) before. ￿ese
two new peaks also change their intensity (1.70 and 0.78 times, com-
paring the ￿nal and the initial points of the titrations) as new peak 1
moves and overlaps the second one during the addition of SMAD2-EEE
(186-467). Finally, Arg283 also increases its intensity (1.47 times) during
the titration. All the changes are summarised in table 4.1. Overall, the
small shi￿s of the   and the intensity could indicate a weak interaction
between pTGIF1 (256-347) by p38↵ and SMAD2-EEE (186-467).
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Table 4.1: List of the assigned peaks that changed in the titration between
pTGIF1 (256-347) by p38↵ and SMAD2-EEE (186-467).
Peak Intensity variation (times) CSP, d (ppm)
New peak 1 1.70 0.056
New peak 2 0.78 -
Arg 283 1.47 -
pSer 286 - 0.021
pSer 291 - 0.022
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Figure 4.9: Superimposition of several 1H-15N-SOFAST-HSQC of pTGIF1
(256-347) by p38↵ with increasing equivalents of SMAD2-EEE (186-467). Red
colour refers to pTGIF1 (256-347) alone; green to pTGIF1 (256-347) + 1 equiv-
alent of SMAD2-EEE (186-467) and blue to pTGIF1 (256-347) + 5 equivalents
of SMAD2-EEE (186-467). ￿e verticals peaks located at 1H 7.0 are related to
an excess of PMSF added.
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4.1.5 A direct interaction between pTGIF1 (256-347)
by p38↵ and SMAD2-EEE (186-467) was not
detected by MST
In order to con￿rm the interaction between pTGIF1 (256-347) by p38↵
and SMAD2-EEE (186-467) we proceed to analyse the interaction by
MST technique.￿e ￿at curve of the normalised ￿uorescence indicates
an absence of interaction between the two proteins. However, the last
point, at very high concentration of SMAD2-EEE (186-467) may suggest
some interaction at mmolar range (Figure 4.10).
101 102 103 104 105 106
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Figure 4.10: MicroScale￿ermophoresis (MST) result on the interaction be-
tween pTGIF1 (256-347) by p38↵ and SMAD2-EEE (186-467). ￿e ￿at curve
of the normalised ￿uorescence (Fnorm) versus increasing concentration of
SMAD2-EEE (186-467) point out an absence of interaction.
4.1.6 pTGIF1 (256-347) by p38↵ is further
phosphorylated by CK1
As mentioned earlier, High-throughput (HTP)-MS experiments found
three phosphorylations in the TGIF1 (256-347) fragment [57], [111]. We
have reproduced in vitro two of them (Ser286 and Ser291) using p38↵
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Figure 4.11: A) Superimposition of 1H-15N-SOFAST-HSQC spectra before
(green) and a￿er (blue) the phosphorylation with CK1 on a pTGIF1 (256-347)
by p38↵. ￿e most relevant changes of   are labelled. ￿e most relevant
changes in   are labelled. Surrounded by a dashed line are the side-chain peaks
of the arginines. In light green are labelled the negative peaks before phospho-
rylation while in purple are labelled the negative peaks a￿er phosphorylation.
B) Shi￿ of the backbone1H-15N   from the surrounding Ser294 amino acids.
Prolines have a value of 0.
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kinase, but still we lacked the phosphorylation over Ser294. To explore
whether Ser294 could also be phosphorylated, we employed Casein Ki-
nase I (CK1). CK1 is a kinase that has pSXXS/T as it most e￿ective
recognition motif [149], where the target serine or threonine is located
at +3 of an already phosphorylated serine. Since Ser294 has the phos-
phorylated Ser291 at -3 (286-pSPKPSpSPGS-294) we decided to use CK1
to phosphorylate Ser294. ￿us, we added CK1 kinase to a previously
double-phosphorylated 15N-pTGIF1 (256-347) by p38↵. ￿e ￿gure 4.11
A shows a superimposition of a 1H-15N-SOFAST-HSQC spectrum be-
fore and a￿er the phosphorylation by CK1. ￿e shi￿ from the Ser294
and the amino acids that surrounded it con￿rm the selective phospho-
rylation of Ser294 (Figure 4.11 B). Besides, we can also observe a shi￿
from the side-chain of the arginines, indicating that some contacts have
changed due to the presence of the phosphate group, in a similar way
as explained before.
4.1.7 TGIF1 (256-347) spectrum does not change
significantly a￿er the addition of SMAD2-MH1
(10-174)
￿e absence of a strong direct contact between TGIF1 (256-347) or its
double phosphorylated version and SMAD2-EEE (186-467) led us to test
whether the MH1 domain of SMAD2 was participating in the interac-
tion. Accordingly, we titrated the SMAD2-MH1 (10-174) fragment on
15N-TGIF1 (256-347) using NMR (Figure 4.12 and Appendix Figure 7.5).
￿e addition of 5 equivalents of SMAD2-MH1 (10-174) decrease the in-
tensity of three peaks: Cys273 (to 0.66 times), Cys303 (0.60) and Leu317
(0.75) while all others keeps constant their intensity and their position
(Table 4.2). ￿is result indicates a weak interaction of both molecules,
similarly to pTGIF1 (256-347) by p38↵ and SMAD2-EEE (186-467).
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Table 4.2: List of the assigned peaks that changed in the titration between
TGIF1 (150-248) and SMAD4-MH1 (10-140).
Peak Intensity variation (times)
Cys 273 0.66
Cys 303 0.60
Leu 313 0.75
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Figure 4.12: Superposition of several 1H-15N-SOFAST-HSQC of TGIF1 (256-
347) with increasing equivalents of SMAD2-MH1 (10-174). Red colour refers
to TGIF1 (256-347) alone; green to TGIF1 (256-347) + 1 equivalent of SMAD2-
MH1 (10-174) and blue to TGIF1 (256-347) + 4 equivalents of SMAD2-(10-174).
￿e peaks that are a￿ected by the addition of SMAD2-MH1 (10-174) are la-
belled.
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4.2 Investigating the interaction between
TGIF1 homeodomain (150-248) and
SMAD proteins
4.2.1 Characterisation of the TGIF1 homeodomain
(150-248)
In our project we were also interested in the role of the TGIF1 home-
odomain in the interactions with the SMAD proteins. As explained
before, recent ￿ndings showed an interaction between the N-terminal
region of the HOXC9 HD and SMAD4-MH1 [150]. Using NMR and
EMSA techniques, we wanted to explore if this interaction also occurs
with TGIF1 andwhether this contact may be essential for the TGIF1 and
SMAD2 interaction. In this sense, we designed a construct of TGIF1 that
contains the homeodomain and the N-terminal region, TGIF1 (150-248),
Figure 4.13.
SGKRRRR
162 168
150 248
HD TGIF1 (150-248)
1 401
HD
SID (267-321)
TGIF1 (1- 401)
173 230
130
Arg-rich region
Figure 4.13:Construct of TGIF1 (150-248) with the detail of the homeodomain
and the N-terminal arginine-rich region.
First of all, we compared the 1H-15N-HSQC spectrum of TGIF1 (150-248)
with the resonances of the already published NMR structure of TGIF1
homeodomain (171-248) (PDB id: 2LK2, BMRB Entry 17971). As we can
see in Figure 4.14, most of the peaks superimpose with the 2LK2 struc-
ture.￿e di￿erence in the chemical shi￿s can be a￿ributed to di￿erent
bu￿er conditions of both samples. Moreover, we can also distinguish
new peaks that are not present in the resonances corresponding to the
sample deposited in the BMRB. In particular, three new peaks appear
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Figure 4.14: Superimposition of 1H-15N-SOFAST-HSQC of TGIF1 (150-248)
(in red) with the peaks taken from the already published TGIF1 HD struc-
ture (171-248) (black crosses; PDB id: 2LK2).￿e assignment of those isolated
peaks is shown.
in the glycine region (< 113 ppm of   15N), in agreement with the three
new glycines that our construct has in the N-terminal region, missing
in the 2LK2 structure. Finally, the wide distribution of the peaks (6.5 to
10.0 in 1H   dimension) indicates the presence of a well-folded struc-
ture.
In order to further con￿rm the activity of the TGIF1 (150-248) fragment
we titrated it with a 16-mer DNA that contains two copies of the TGIF1
binding DNA canonical sequence [26] (Table 3.3). ￿e ￿nal spectrum
with 3 eq of DNA reveals a strong interaction between the protein and
the DNA as most of the TGIF1 resonances shi￿ and vary their intensity
of the peaks (Figure 4.15).
Although we have not assigned the construct, we can deduce several
residues –mainly from the isolated peaks – by comparing our spectrum
with the already published 2LK2. Still, wemiss the assignment of the N-
terminal region that our construct has and it is not present in the 2LK2
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Figure 4.15: Superimposition of 1H-15N-SOFAST-HSQC of TGIF1 (150-248)
with increasing equivalents of DNA1 (ATTGACAGCTGTCAAT). Red colour
refers to TGIF1 (150-248) alone; green to TGIF1 (150-248) + 0.75 equivalents
of DNA and blue to TGIF1 (150-248) + 3 equivalents of DNA.
construct. ￿us, in the next sections only the change of the deduced
peaks are described.
4.2.2 TGIF1 homeodomain (150-248) interacts with
SMAD2/4-MH1
Our next step was to explore by NMR titration experiment if TGIF1
(150-248) also interacts with SMAD4-MH1 as HOXC9 does [150].￿us,
we titrated SMAD4-MH1 (10-140) domain on 15N-TGIF1 (150-248) (Fig-
ure 4.18 and Appendix Figure 7.6). A￿er the addition of 1.6 equivalents
of SMAD4-MH1 several changes have been observed. Two peaks be-
longing to￿r208 and the side-chain of Gln210 changed their positions,
0.121 ppm and 0.062 ppm, respectively. Interestingly, the peak inten-
sity of some resonances was also signi￿cantly a￿ected by the addition
of SMAD4-MH1. ￿e peak corresponding to the H✏-N✏ of the Trp214
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Table 4.3: List of the assigned peaks that changed during the NMR titration
between TGIF1 (150-248) and SMAD4-MH1 (10-140).
Peak Intensity variation (times) CSP, d (ppm)
H✏-N✏ Trp 214 3.32 -
Glu 174 2.68 -
H✏22 Gln 210 1.86 -
Lys 173 1.75 0.046
Ile 178 1.75 -
Ser 175 1.70 -
H 22 Asn 217 1.61 -
￿r 208 - 0.121
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Figure 4.16: Superimposition of 1H-15N-SOFAST-HSQC of TGIF1 (150-248)
with increasing equivalents of SMAD4-MH1 (10-140). Red colour refers to
TGIF1 (150-248) alone; green to TGIF1 (150-248) + 0.5 equivalents of SMAD4-
MH1 (10-140) and blue to TGIF1 (150-248) + 1.6 equivalents of SMAD4-MH1
(10-140).￿e peaks that are a￿ected by the addition of SMAD4-MH1 (10-140)
are labelled.
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Thr 208
Gln 210
Trp 214Asn 217
Lys 173
Glu 174
Ile 178
Ser 175
C-terminus
Arg-rich region
N-terminus
Figure 4.17: Structure of TGIF1 HD with the residues a￿ected upon the pres-
ence of SMAD4-MH1 (10-140) highlighted. ￿e red labelled amino acids are
those with higher variation (214Trp, 174Glu , 208￿r) while in orange are la-
belled all the others modi￿ed residues. ￿e residues are shown on the previ-
ously solved TGIF1-HD structure (PDB: 2LK2). With a dashed line is repre-
sented the extra region at N-terminus that the TGIF1 construct (150-248) has
in comparison with the 2LK2.
increased its intensity by 3.32 times while the Glu174 increased 2.68
times. ￿e table 4.3 summarises the others peaks a￿ected more than
the threshold values. All residues that varied during the titrations are
localised in the same N-terminus region of the protein, which led to the
conclusion that the interaction between TGIF1 homeodomain (150-248)
and SMAD4-MH1 (10-140) a￿ects to an speci￿c region of the home-
odomain (Figure 4.17).
￿e evidence of the interaction between the TGIF1 (150-248) and SMAD4-
MH1 (10-140) made us to consider whether this interaction could also
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Table 4.4: List of the assigned peaks that changed in the NMR titration be-
tween TGIF1 (150-248) and SMAD2-MH1 (10-174).
Peak Intensity variation (times)
H 22 Asn 217 2.04
Ser 175 1.90
H 22 Asn 213 1.80
Asn 217 1.78
H 21 Asn 213 1.72
H✏22 Gln 210 1.72
Glu 174 1.72
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Figure 4.18: Superposition of several 1H-15N-SOFAST-HSQC of TGIF1 (150-
248) with increasing equivalents of SMAD2-MH1(10-174). Red colour refers to
TGIF1 (150-248) alone; green to TGIF1 (150-248) + 1.0 equivalent of SMAD2-
MH1(10-174) and blue to TGIF1 (150-248) + 2.4 equivalents of SMAD2-
MH1(10-174).￿e peaks that are a￿ected by the addition of SMAD2-MH1(10-
174) are labelled.
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occur between the TGIF1 (150-248) and SMAD2-MH1 (10-174). Subse-
quently, we titrated SMAD2-MH1 (10-174) on 15N-TGIF1 (150-248) (Fig-
ure 4.18 and Appendix Figure 7.7). ￿e analysis of the 1H-15N HSQC
revealed that no peak was shi￿ed during the titration. However, up
to seven peaks varied their intensity (see Table 4.4) upon the addition
of SMAD2-MH1 (10-174). Interestingly, some of these peaks (Glu174,
Ser175, H✏22 Gln210, H 22 Asn217) are the same as the ones that varied
in the TGIF1 (150-248) - SMAD4-MH1 (10-140) titration (Figure 4.19).
￿is evidence led to the conclusion that both proteins interact similarly,
a￿ecting at the same N-terminus region of TGIF1 (150-248). Moreover,
the overall intensity shi￿s are higher in the SMAD4-MH1 (10-140) titra-
tion, which maybe is related to a higher a￿nity of the SMAD4-MH1
(10-140) in comparison with the SMAD2-MH1 (10-174).
Gln 210Asn 217
Glu 174
Ser 175
N-terminusC-terminus
Asn 213
Arg-rich region
Figure 4.19: Structure of TGIF1 HD with the residues a￿ected upon the pres-
ence of SMAD2-MH1 (10-174) highlighted in orange.￿e residues are shown
on the previously solved TGIF1-HD structure (PDB: 2LK2). With a dashed
line is represented the extra region at N-terminus that the TGIF1 construct
(150-248) has in comparison with the 2LK2.
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A￿er the observation of the interaction of TGIF1 homeodomain (150-
248) with SMAD4-MH1 (10-140) and SMAD2-MH1 (10-174), we wanted
to analyse these interactions with a complementary technique. Taking
advantage of the binding of TGIF1 HD with its canonical DNA, we per-
formed electrophoretic mobility shi￿ assays (EMSA) in order to con￿rm
the interactions between proteins already seen. In the ￿rst experiment
(Figure 4.20 A) we increased the concentration of TGIF1 homeodomain
(150-248) while keeping constant the Cy5-DNA concentration at 3.75
nM.￿e shi￿ produced by the complex between the DNA and the pro-
tein starts to be visible at 31.3 nM of protein. Increasing the protein
concentration, the complex is formed by two molecules of protein by
one of DNA, in agreement with the two protein binding sites present
in the palindromic DNA.￿is assay was fundamental to determine the
best protein concentration of the protein for the following experiments.
For these experiments we choose a TGIF1 homeodomain (150-248) con-
centration between 54 and 212 nM because in this range we can see all
four bands (ssDNA, dsDNA, complex 1:1 and complex 2:1) in equilib-
rium with each other. ￿erefore, any slight change in the binding be-
tween TGIF1 HD and the DNA will a￿ect greatly in the abundance of
all four bands.
In our next assay, keeping constant the DNA and the TGIF1 home-
odomain (150-248), we added increasing concentrations of SMAD4-MH1
(10-140) (Figure 4.20 B). At both constant concentrations of TGIF1 (150-
248) (54 and 212 nM), the bands corresponding to the 2:1 complex al-
most disappeared a￿er the addition of two equivalents of SMAD4-MH1
(10-140) over TGIF1 (150-248). As SMAD4-MH1 (10-140) alone with the
DNA did not interact, we can conclude that the presence of SMAD4-
MH1 (10-140) interferes with the formation of the complex between
the TGIF1 homeodomain and the DNA by interacting with the TGIF1
(150-248).
We obtained equivalent results when we tested the e￿ect of the addi-
tion of SMAD2 (10-174) to TGIF1 HD (150-248) (Figure 4.20 C). In this
case the binding between TGIF1 (150-248) andDNA is already disrupted
with one equivalent of SMAD2 (10-174). ￿ese results added evidence
about the interaction between SMAD2/4-MH1 with TGIF1 (150-248) al-
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ready observed by NMR.
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Figure 4.20: EMSA assays carried out with TGIF1 (150-248) and its canonical
DNA labelled with Cy5 (Cy5-ATTGACAGCTGTCAAT) (at constant concen-
tration of 3.75 nM in all assays). A) Simple assay with increasing concentra-
tions of TGIF1 (150-248) (from 0.97 nM to 4 µM, doubling at each line) with
while keeping constant the DNA concentration. A cross on a line indicates
an error on the sample loaded. B) Competition assay with increasing concen-
trations of SMAD4-MH1 (10-140) while keeping constant the concentrations
of TGIF1 (150-248) and DNA. Two di￿erent competitions assays were done
at 54 and 212 nM concentrations of TGIF1 (150-248). ￿e concentration of
SMAD4-MH1 (10-140) in the control line with only the DNA was 500 nM. C)
Competition assay with increasing concentrations of SMAD2-MH1 (10-174)
while keeping constant the concentrations of TGIF1 (150-248) and DNA.￿e
concentration of SMAD2-MH1 (10-174) in the control line with only the DNA
was 180 nM, equivalent to 3 times 60 nM.￿e DNA alone control was taken
from a sample of a previous day, and presents degradation, smirring along the
line. ss and ds DNA stands for single and double stranded DNA, respectively.
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4.3 TGIF1 (256-347) binds to TGIF1
homeodomain (150-248)
In order to decipher a possible intramolecular interactions in TGIF1
protein, we performed NMR titration experiments between the two
fragments of the protein. ￿e titration, represented in Figure 4.22 and
Appendix Figure 7.8, revealed the   displacement of three peaks (Table
4.5) and the decrease of intensity of two more peaks, up to 0.5 times
in the case of Cys303. Altogether, these results pointed out an inter-
action between the two fragments of TGIF1. Engrossingly, Cys273,
Cys303 and Leu317 were also disturbed when SMAD2-MH1 (10-174)
was added to 15N-TGIF1 (256-347), indicating a similar mode of inter-
action between these two proteins and TGIF1 (256-347).
Additionally, we also tested by EMSA whether TGIF1 (256-347) could
also disturb the interaction between DNA and TGIF1 homeodomain
(150-248). Indeed, a￿er the addition of 4 equivalents of TGIF1 (256-
347), the band corresponding to the 1:1 complex disappeared, similarly
as with the addition of SMAD2/4-MH1, previously reported.
TGIF1 (150-248) @ 60 nM
TGIF1 (256-347) 
Cy5-DNA @ 3.75 nM +
+
+
-
+
-
+
1 2 3 4 6
TGIF1:DNA 2:1
TGIF1:DNA 1:1
ds DNA
ss DNA
TGIF1 (256-347) : TGIF1 (150-248)
TGIF1 (150-248) vs TGIF1 (256-347) 
+
-
-
+
+
8 12
Figure 4.21: EMSA competition assay with increasing concentrations of
TGIF1 (256-347) while keeping constant the concentrations of TGIF1 (150-248)
and DNA.￿e concentration of TGIF1 (256-347) in the control line with only
the DNA was 720 nM, equivalent to 12 times 60 nM. ss and ds DNA stands for
single and double stranded DNA, respectively.
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4.3 TGIF1 (256-347) binds to TGIF1 homeodomain (150-248)
Table 4.5: List of the assigned peaks that changed in the titration between
TGIF1 (256-347) and TGIF1 (150-248).
Peak Intensity variation (times) CSP, d (ppm)
Cys 303 0.50 -
Leu 317 0.58 -
*Ser 272 or￿r 306 - 0.026
Cys 273 - 0.025
￿r 274 - 0.023
*￿e assignment was confusing for this peak.
 9.0  8.5  8.0  7.5 
 125 
 120 
 115 
 110 
1H δ(ppm)
15
N
 δ
(p
pm
)
 7.0 
Cys303
Leu317
Cys273
Thr274
Ser272 or Thr306
TGIF1 (256-347)
+ 1.0 eq TGIF1 (150-248)
+ 2.9 eq TGIF1 (150-248)
Figure 4.22: Superposition of several 1H-15N-SOFAST-HSQC of TGIF1 (256-
347) with increasing equivalents of TGIF1 (150-248). Red colour refers to
TGIF1 (256-347) alone; green to TGIF1 (256-347) + 1.0 equivalent of TGIF1
(150-248) and blue to TGIF1 (256-347) + 2.9 equivalents of TGIF1 (150-248).
￿e peaks that are a￿ected by the addition of TGIF1 (150-248) are labelled.
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4.4 Study about the cysteine-free direct
aminolysis ligation reaction
￿is project was done together with Dr. Todorovski and the result is
published in Biopolymers (Peptide Science) under the title ”Addition of
HOBt improves the conversion of thioester-amine chemical ligation”
[119] (Appendix).
￿e ￿rst step towards our aim was to synthesise the peptides that will
be used in the peptide ligation trials. As mentioned in the introduction,
the direct aminolysis cysteine-free ligation reaction requires that the N-
terminal peptide ends in an thioester on its C-terminus. On the other
hand, the C-terminal peptide do not have this requisite and thus can
end in amide or acid moiety at its C-terminus (Figure 4.23).
S
O
+
Peptide 1 Peptide 2
O
Peptide 1
H
N
O
N
H
R
in 4:1 (v/v) NMP:6 M GuHCl
 +1 M HEPES, pH 8,5  
2% vol. PhSH
O
N
H
NH2
R Peptide 2
Figure 4.23: Direct aminolysis cysteine-free peptide ligation scheme.
In total, we synthesised 13 peptides (Tables 4.6). Five of them (1-5) were
synthesised in sulfamylbutyryl resin in order to get the peptides end-
ing with a benzyl mercaptan group at their C-terminus.￿e rest of the
peptides (6-13) were synthesised in a common Rink-Amide resin. Be-
cause of the more complex procedure of cleaving the peptide from the
sulfamylbutyryl resin, the yields of the thioesters peptides are consid-
erably lower than those peptides ending with an amide group.
￿e peptide sequences were selected in order to test di￿erent amino
acids combinations at the ligation junction while keeping all the other
reaction parameters constant. ￿us, peptides 1-3 only di￿er in the last
amino acid and sequences 6-9, 10-12 in the ￿rst one. Seven of these
peptides (1-3, 6-9) are 10 amino acid long as we also wanted to check
the e￿cacy of the ligation method in longer sequences. Moreover, we
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Table 4.6: List of the peptides synthesised. SB stands for Sulfamylbutyryl and
RA for Rink-Amide AM.
Peptide sequence m/z m/z Yield* Resin
theo. exp. (%) used
1 Ac-GASATVSPLG-SC7H7 1007.46 1007.50 30 SB
2 Ac-GASATVSPLV-SC7H7 1049.51 1049.58 63 SB
3 Ac-GASATVSPLS-SC7H7 1037.49 1037.55 64 SB
4 Ac-LYRAG-SC7H7 727.87 727.53 20 SB
5 Ac-PSpSPGSV-SC7H7 858.87 858.25 48 SB
6 NH2-GGPSPLGFLG-CONH2 900.49 900.57 96 RA
7 NH2-VGPSPLGFLG-CONH2 942.54 942.61 92 RA
8 NH2-LGPSPLGFLG-CONH2 956.56 956.62 75 RA
9 NH2-CGPSPLGFLG-CONH2 946.48 946.46 50 RA
10 NH2-GSPGYS-CONH2 566.25 566.47 89 RA
11 NH2-ASPGYS-CONH2 580.26 580.48 59 RA
12 NH2-YSPGYS-CONH2 672.29 672.55 86 RA
13 NH2-LARPSVI-CONH2 754.49 754.44 59 RA
*￿e yield was calculated before the HPLC puri￿cation, except for 10
to 13, which were calculated a￿er HPLC puri￿cation.
synthesised standard peptide sequences (4 and 10-12) [83, 76]. Finally,
we also synthesised a phosphorylated thioester (5) that corresponds to
the TGIF1 protein sequence (289-295; serine 291 phosphorylated) and
the C-terminal amide (13) related C-terminal TGIF1 sequence (296-302).
Notice that this sequence of TGIF1 is placed in the central interaction
region with SMAD2 and the phosphorylated 291 serine is one of those
found phosphorylated by MS experiments (See 4.1.3). All the thioester
sequences are C-terminus acetylated to avoid intramolecular reaction.
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4.4.1 HOBt increases the conversion, but not the
rate, of peptide ligation reactions
In order to check if the addition of HOBt may improve the conversion
or the rate of the ligation reactions, we performed the following series
of experiments: for every combination of thioester and amide peptide,
we did two parallel experiments. Starting from the same reaction so-
lution, we divided the volume in two tubes. In one tube we added two
equivalents of HOBt (based on the amount of peptide thioester) while
in the second we added the same volume of ligation bu￿er. At each
time point (di￿erent depending of the amino acid combination), we col-
lected a li￿le fraction of each tube, stopped the reaction and analysed
it by LC-MS. We then integrated the area of the peak corresponding to
the expected product. ￿e area was plo￿ed against time, obtaining a
kinetic representation of the reaction (Figures 4.24 and 4.25).
We started with the Gly-Gly combination (in all cases, the ￿rst amino
acid is the thioester and the second is the C-terminal peptide) (Figure
4.24, A; Table 4.7, I). Based on the kinetic plot, we can see that in both
conditions (with and without HOBt) the reaction ended with a similar
amount of product a￿er 36 h, although in the ￿rst hours the reaction
without HOBt generatedmore product. However, considering standard
Gly-Gly sequences (C, III), the presence of HOBt increases the amount
and the rate of the product formed. We continued the experiments with
Ser-Gly combination (B, II). In this case, the total amount of product
clearly increases when we added HOBt in the reaction solution. We
observe similar result in the combination Gly-Ala (D, IV) with standard
sequences although in this peptide combination the reaction without
HOBt generated more product at the ￿rst hours of reaction. In contrast,
the presence of a cysteine in the C-terminal peptide (E, V) enhances the
speed of the ligation reaction (at 8 h the reaction was already ￿nished)
but the addition of HOBt, in this reaction, decreases the conversion.
In another set of experiments, we analysed the presence of HOBt when
 -branched or aromatic amino acids are present at the ligation junc-
tion. ￿ese amino acid are known to have a lower conversion and a
slower reaction rate most probably due to sterical hinderance [97]. Re-
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Figure 4.24: Kinetics of the ligated product formation in ligation reactions
with HOBt (solid line) or without (dashed line). A) Ligation I; between pep-
tides 1 and 6. B) Ligation II; between peptides 3 and 6. C) Ligation III; between
peptides 4 and 10. D) Ligation IV; between peptides 4 and 11. E) Ligation V;
between peptides 3 and 9.￿e error bars were calculated from duplicate injec-
tions in the LC-MS. In the Appendix Table 7.1 are listed the product ligation
cations of every reaction.
markably, when we reacted Ser-Val (Figure 4.25 A; Table 4.7 VI), the
presence of HOBt increases dramatically the conversion, but not the
rate of the reaction. We got the same outcome when the combinations
were Val-Val (B, VII), Val-Leu (C, VIII) or Gly-Tyr (D, IX).
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Table 4.7: Summary of the peptide ligation results in di￿erent amino acid
combinations.
Ligation Combinations Yield (Y) / Conversion (C) (%)
without HOBt with HOBt
I Ac-GASATVSPLG-SC7H7 + n.d n.d
NH2-GGPSPLGFLG-CONH2
II Ac-GASATVSPLS-SC7H7 + n.d n.d
NH2-GGPSPLGFLG-CONH2
III Ac-LYRAG-SC7H7 + 83 (Y) 89 (Y)
NH2-GSPGYS-CONH2
IV Ac-LYRAG-SC7H7 + n.d n.d
NH2-ASPGYS-CONH2
V Ac-GASATVSPLS-SC7H7 + n.d n.d
NH2-CGPSPLGFLG-CONH2
VI Ac-GASATVSPLS-SC7H7 + 10 (Y) 36 (Y)
NH2-VGPSPLGFLG-CONH2
VII Ac-GASATVSPLV-SC7H7 + 5 (Y) 34 (Y)
NH2-VGPSPLGFLG-CONH2
VIII Ac-GASATVSPLV-SC7H7 + 17 (C) 37 (C)
NH2-LGPSPLGFLG-CONH2
IX Ac-LYRAG-SC7H7 + 33 (Y) 57 (Y)
NH2-YSPGYS-CONH2
X Ac-PSpSPGSV-SC7H7 + 19 (C) 32 (C)
NH2-LARPSVI-CONH2
To con￿rm our results further, we performed the ligations reactions in
a large scale, which it allowed us to purify the products and quantify
the reaction yields (Figure 4.26 and Table 4.7, combinations III, VI, VII
and VIII). For the rest of the reactions, we calculated, when possible, the
conversion based of the integrated ions ratio (in the TIC spectra from
the LC-MS) between the ligated product at the last point of reaction
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Figure 4.25: Kinetics of the ligated product formation in ligation reactions
with HOBt (solid line) or without (dashed line). A) Ligation VI; between pep-
tides 3 and 7. B) Ligation VII; between peptides 2 and 7. C) Ligation VIII;
between peptides 2 and 8. D) Ligation IX; between peptides 4 and 12. ￿e
error bars were calculated from duplicate injections in the LC-MS. In the Ap-
pendix Table 7.1 are listed the product ligation cations of every reaction.
versus peptide thioester at the beginning of the reaction. In all cases,
the yield/conversion obtained was higher when HOBt was present in
the ligation, increasing in most cases more than 20 points, although in
any case the ￿nal yield/conversion reaches more than 60%. Con￿rming
our previous results, the e￿ect of HOBt is limited in the combination
Gly-Gly (III) but it is more intense when hindered amino acids such as
valine or tyrosine (VI, VII, VIII and IX) are present in the ligation junc-
tion.
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Figure 4.26: Example of an RP-HPLC of two peptide ligation reactions. In
both cases the last point of the reaction was taken. A-B) Ligation VI (Table
4.7) without (A) and with HOBt (B); at 96 h of reaction. C-D) Ligation VIII
(Table 4.7) without HOBt (C) and with HOBt (D) at 98 h of reaction.
4.4.2 Improving the aminolysis ligation reaction
Looking for further improvements in the conversion and rate of the
peptide ligation reactions, we tested several variations of the ligation
conditions (Figure 4.27). An increase of the number of equivalents of
HOBt, up to 10, does not enhance the quantity of product formed, but
decreases it (Figure 4.27 A).￿is e￿ect could be explained by the drop
of the pH caused by the acidic nature of HOBt.
We then focused our a￿ention on the thiophenol. It is known that in
the cysteine based ligations reactions the replacement of thiophenol
by 4-(carboxymethyl)thiophenol (MPAA) can augment the rate and the
conversion of the reaction [74]. However, in our system, the mentioned
substitution causes a notorious drop in the conversion (Figure 4.27 B).
One possible explanation is that the rate of the transthioesteri￿cation
step was very low in this case (Appendix Figure 7.9) and therefore the
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observed conversion rate was worse than in the case of thiophenol.
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Figure 4.27: Kinetics of the ligated product formation in ligation reactions
(A-C). A) Ligation I. Comparison between 2 equivalents of HOBt (solid line)
and 10 equivalents HOBt (dashed line). B) Ligation II. Comparison between
2 equivalents of thiophenol (solid line) and 2 equivalents of MPAA (dashed
line). C) Ligation VII. Comparison between HOBt + DIPEA (red solid line);
HOBt + DBU (black do￿ed line); HOBt (green short dashed line) and HOAt
(blue long dashed line). D) Same as C but following the kinetics of the phenyl
thioester. In the Appendix Table 7.1 are listed the product ligation cations of
every reaction.
In peptide synthesis, the addition of a base activator can improve the
rate of a reaction [151]. We therefore tested whether the presence of
N,N -diisopropylethylamine (DIPEA) or 1,8-diazabicyclo[5.4.0]undec-7-
ene (DBU) could increase the rate of the reaction (Figure 4.27 C). Our
results show that although both bases improve the conversion up to
certain point (50 h of the reaction), for a reaction times longer than 50
h, only the presence of DIPEA had notable in￿uence on the conversion
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rate.￿e di￿erent behaviour of both bases can be explained by the dif-
ferent presence of the intermediate phenyl thioester, formed a￿er the
transthioesteri￿cation step (Figure 4.27 D).￿e plot indicates that in the
case of the DIPEA the formed phenyl thioester lasts longer in the reac-
tion mixture while when DBU is present, this intermediate disappears
a￿er 50 h, at the same point where the conversion of the product stops.
￿is observation highlights the importance of the thiophenol interme-
diate in the reaction because, without the presence of it, the ligation
reaction stops.
Finally, we tested the potential role of 1-hydroxy-7-azabenzotriazole
(HOAt) as an alternative of HOBt. Indeed, HOAt has been demon-
strated superior than HOBt in coupling reactions [152] because com-
bines in one molecule the e￿ect of HOBt itself and a tertiary amine, en-
hancing altogether its catalytic e￿ect. In addition, its lower pKa (3.28
versus 4.60 of HOBt) and thus, potentially be￿er leaving group, makes
HOAt a good candidate to improve the e￿ect of HOBt in the ligation re-
action. However, our results indicate that the ￿nal conversion is similar
using either HOAt or HOBt (Figure 4.27 C, D). Interestingly, the product
appears much later in the presence of HOAt than when we use HOBt
and thus can be hypothesised that with more reaction time the conver-
sion will be higher with HOAt, although more reaction time would also
increase side reactions.￿is phenomena could be a￿ributed to the fact
that HOAt requires more time to react with the thioester intermediate
keeping the thiophenolic ester more time in the solution, as shown in
Figure 4.27 D.
Overall, only the addition of 4 equivalents of DIPEA improves slightly
the previous results obtained using HOBt only while the use of the oth-
ers reagents turn out to be a worse option.
On the other hand, we were wondering whether the ligation reaction
would be feasiblewith a freeN-terminus thioester, that is, being chemos-
elective to the N-terminus of the other peptide. ￿e logic behind this
idea is to use the ligated product as an input to a second ligation reac-
tion using a new thioester containing peptide, allowing the synthesis
of longer and more complex peptides in a stepwise manner. To test this
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hypothesis, we synthesised three more thioester peptides (Table 4.8)
with the same sequence as their homologs 1, 2, 3 (to 14, 15, 16, respec-
tively) but with a free N-terminus. In this set of experiments we evalu-
ated the presence of the ligation product respect to the intramolecular
cyclisation product. In the combinations we tried, shown in Figure 4.28,
the formation of the cyclisation product overwhelms the obtention of
the ligation product.￿erefore, we dismissed this option.
Table 4.8: List of the peptides synthesised. SB stands for Sulfamylbutyryl.
Peptide sequence m/z m/z Yield* Resin
theo. exp. (%) used
14 NH2-GASATVSPLG-SC7H7 965.54 965.58 15 SB
15 NH2-GASATVSPLV-SC7H7 1007.53 1007.55 48 SB
16 NH2-GASATVSPLS-SC7H7 995.49 995.46 44 SB
*￿e yield was calculated before the HPLC puri￿cation.
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4.4.3 Proposal of a mechanism of reaction
￿e results we have obtained led us to propose a plausible reaction
mechanism for the direct aminolysis peptide ligation in the presence
of HOBt (Figure 4.29).
In our proposed mechanism, the reaction starts with a transthioester-
i￿cation step where the thiophenol substitutes the benzyl mercaptan
at the C-terminus of the peptide thioester. ￿e presence of the phenyl
thioester intermediate in all our reactions con￿rms its existence (Figure
4.30).￿e lower pKa of thiophenol compared to benzyl mercaptan (6.6
versus 9.67, respectively) make this thioester a be￿er leaving group,
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Figure 4.29: Scheme of the proposed mechanism for the ligation reaction.
conditioning the following steps. In fact, this step is crucial for the
reaction, demonstrated by the absence of product when thiophenol is
missing (data not shown) due to the poor leaving group that the alka-
nethiols generate. However, when thiophenol is substituted by MPAA
(with a similar pKa of 6.6) (Figure 4.27 B, Appendix Figure 7.9), the prod-
uct formed drops dramatically. ￿e low formation of the intermediate
thioester by MPAA reveals to be the key reason of the low conversion
obtained. In this aspect, the ligation bu￿er used (more suitable to thio-
phenol exchange) could be the explanation for this fact. HOBt, how-
ever, seems that does not have a big in￿uence on this step, as the phenyl
thioester intermediate formation is similar regardless HOBt presence.
￿e fact that we could detect the phenyl thioester intermediate in the
solution demonstrates the slower rate of the second part of the reac-
121
4 Results
tion.￿is part is composed by two separated steps. Firstly, HOBt reacts
with the phenyl thioester intermediate, generating an HOBt ester that
is more prone to be reactive with the N-terminus of the second pep-
tide, due to the be￿er leaving group of HOBt ester over phenyl ester
(lower pKa of the HOBt, 4.6 versus 6.6 of thiophenol). Finally, the nu-
cleophilic a￿ack performed by the amine at the N-terminus ends the
reaction generating the native peptide bond between the two peptides.
Overall, we believe that although most of the reaction may follow this
mechanism, we cannot discard another alternativemechanism that could
be happening at the same time as, for instance, the reaction mechanism
without HOBt.
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Figure 4.30: Same kinetic plot as Figure 4.25 but with the thiophenolic es-
ter formation represented too in red, with HOBt (solid line) or without HOBt
(dashed line). In the Appendix Table 7.1 are listed the product ligation cations
of every reaction.
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4.4.4 Ligation with TGIF1 phosphorylated peptides
One of the aims of the peptide ligation project was to ￿nd an easy
method to synthesise long fragments of phosphorylated peptides se-
lected from the TGIF1 protein sequence. To test the feasibility of this
hypothesis, we synthesised two peptides: a serine phosphorylated thioester
and anN-terminus free peptide ( Table 4.6, 5 and 13). Once ligated, these
peptide fragments would generate a sequence corespondent to 289-302
of TGIF1 that we plan to use in the analysis of the interactions with
SMAD2.
In Figure 4.31 there is the kinetic plot for the reaction. Again, the
presence of HOBt in the reaction increases the conversion of the reac-
tion. However, the ￿nal product does not reach one third of the initial
thioester quantity (Table 4.7, X).
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Figure 4.31: Kinetics of the ligated product formation of the X combination,
with HOBt (solid line) or without (dashed line).
Lastly, the fact that we did not observe a clear interaction between
TGIF1 and SMAD2 made the synthesis of the peptide less a￿ractive as
we have thought to use the peptides in order to investigate the impor-
tance of the various phosphorylation sites on the binding with SMAD2.
However, we ￿nally discarded the peptide synthesis approach because
the yield obtained was too low, not only regarding the peptide liga-
tion itself, but also with the peptide thioester synthesis. In conclusion,
in our system the protein expression plus kinase phosphorylation strat-
egy appears to be easier to generate andmore powerful than the peptide
synthesis approach.
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4.5 Determination of six mutant structures
of FBP28-WW2
4.5.1 Introduction
Computing simulations have been developed during the last 60 years
as a useful tool to study molecular processes, otherwise impossible
to analyse by experimental techniques. Speci￿cally, all-atoms force
￿elds have recently facilitated the study of the folding of small pro-
teins [153]. However, the validation of these methods remains uncom-
pleted because the di￿erent timescale between the computational (from
hundreds of nanoseconds to microseconds) and the experimental stud-
ies (from several microseconds to seconds). ￿anks to their accessible
quantitative observables, the study of folding and unfolding kinetics
have been used as a model to connect microscopic – theoretical – and
macroscopic – experimental – world. In order to achieve the millisec-
ond scale in the molecular dynamics simulations, it is required the use
of a coarse grained force ￿eld. ￿us, several coarse-grained methods
have been developed. One of them, designed by the group of Dr. Harold
Scheraga (Cornell University), makes use of a physics-based united-
residue (UNRES) force ￿eld, being able to simulate the folding of small
proteins in the millisecond timescale [154].￿e objective of this project
was to validate the use of the UNRES force ￿eld for the study of protein
folding mechanism using the FBP28-WW2 domain as a model.
￿e WW domain of the Formin Binding Protein 28 (FBP28, also known
as Transcription elongation regulator 1 (Tcerg1), Uniprot: O14776, Fig-
ure 4.32) has been used as a model for the validation of the molec-
ular dynamics methods thanks to the availability of its structure, its
fast-kinetics folding, biological relevance and small size (is one of the
smallest monomeric triple-stranded antiparallel  -sheet protein known
[155]).￿us, many e￿orts have been made in order to study its folding
via experimental and theoretical methods. Still, there is some contro-
versy about whether FBP28-WW2 follows a two or three-state mecha-
nism during its folding [156].
In order to study the folding mechanism of the FBP28-WW2, UNRES
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Tyr11 Tyr19Leu26
Pro33
Trp30
Trp8Nter
Cter
Figure 4.32: Wild-Type FBP28-WW2 domain structure. ￿e structure was
solved by Macias et al. in 2000 [155]. PDB id: 1E0L. ￿e main amino acids
are represented with their side-chain. Among them, the most relevant are
labelled.
force ￿eld simulations introducing speci￿c point mutations were per-
formed to detect the presence or absence of some potential intermedi-
ates. To do so, canonical Langevin simulations with the UNRES force
￿elds were performed for the WW2 wild-type domain and six mutants:
Y11R, Y19L, W30F,  NY11R,  N CY11R,  N CY11R/L26A (Figure
4.33). For each protein, 512 independent folding trajectories were calcu-
lated, starting from an extended structure. A￿erwards, each trajectory
was classi￿ed as native (N), intermediate (I) or unfolded (U) based on
the root-mean-square deviation (RMSD) from the respective reference
structure. To obtain the rate constant, the fractions of the N, I and U
states were averaged over the 512 trajectories at each time interval and
were ￿￿ed to exponential kinetics equations. Lastly, the results were
comparable with the experimental data previously determined [156].
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GATAVSEWTEYKTADGKTYYYNNRTLESTWEKPQELK
GATAVSEWTERKTADGKTYYYNNRTLESTWEKPQELK
GATAVSEWTEYKTADGKTLYYNNRTLESTWEKPQELK
-  WT
-  Y11R
-  Y19L
GATAVSEWTEYKTADGKTYYYNNRTLESTF EKPQELK
SEWTERKTADGKTYYYNNRTLESTWEKPQELK
SEWTERKTADGKTYYYNNRTLESTWEKP
SEWTERKTADGKTYYYNNRTAESTWEKP
-  W30F
-  ΔNY11R
-  ΔNΔCY11R
-  ΔNΔCY11RL26A
β-strand β-strand β-strand
Figure 4.33: Sequence of all six mutant compared with the wild-type (WT)
sequence. In red are distinguished the mutated amino acids. For simplicity, all
the amino acid number are referenced to the WW2 domain of 37 amino acids
total, where the ￿rst glycine (1) corresponds to the amino acid number 428 of
the full length protein and the last lysine (37) to the number 464, respectively.
4.5.2 Results
My participation in this project was (together with Dr. Todorovski
and Dr. Macias) to express, purify and determine the structure of the
six mutants of the FBP28 WW2 protein: Y11R, Y19L, W30F,  NY11R,
 N CY11R and  N CY11R/L26A (Figure 4.33). ￿e election of the
six mutants was based on the previous experimental results done by
Nguyen et al. [156]. As described in the materials and methods sec-
tion, a￿er the puri￿cation of each mutant we carried out 2D-NOESY
and TOCSY NMR experiments in order to determine the structure of
every mutant.￿e structures of each mutant are represented in Figures
4.34, 4.35, 4.36, 4.37, 4.38 and 4.39. In the table 4.9 are summarised the
statistics of every structure we determined.
Overall, in all mutants the main three- -strand structure is maintained
thanks to the interaction between the proline 33 and the tryptophan 8,
which act as a ”staple” keeping the folding of the domain. Nevertheless,
near the mutations there are minor changes a￿ecting the position of
some side-chains.
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Arg11
Tyr19
Leu26
Pro33
Trp30
Trp8
Nter
Cter
Figure 4.34: Experimental NMR structure of the mutant Y11R (Y438R). ￿e
main amino acids are represented with their side-chain. Among them, the
most relevant are labelled. In red is distinguished the mutated residue. PDB
id: 2MW9.
Tyr11
Leu19
Leu26
Pro33
Trp30
Trp8
Nter
Cter
Figure 4.35: Same as Figure 4.34 but with the mutant Y19L (Y446L). PDB id:
2MWA.
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Tyr11 Tyr19Leu26
Pro33
Tyr30
Trp8
Nter
Cter
Figure 4.36: Same as Figure 4.34 but with the mutant W30F (W457F). PDB id:
2MWB.
Arg11
Tyr19
Leu26
Pro33
Trp30
Trp8
ΔNter
Cter
Figure 4.37: Same as Figure 4.34 but with the mutant NY11R (Y438R). PDB
id: 2MWF.
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Arg11
Tyr19
Leu26
Pro33
Trp30
Trp8
ΔNter
ΔCter
Figure 4.38: Same as Figure 4.34 but with the mutant  N CY11R (Y438R).
PDB id: 2MWD.
Arg11
Tyr19
Ala26
Pro33
Trp30
Trp8ΔNter
ΔCter
Figure 4.39: Same as Figure 4.34 but with the mutant  N CY11RL26A
(Y438R/L453A). PDB id: 2MWE.
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Table 4.9: Structural statistics of the six FBP28-WW2 mutants.
Y11R Y19L W30F
(Y438R) (Y446L) (W457F)
PDB: 2MW9 PDB: 2MWA PDB: 2MWB
Restraints used for the calculation
(120 structures ensemble)
Sequential (|i  j| = 1) 124 133 115
Medium range (1 < |i  j|  4) 48 41 53
Long range (|i  j| > 4) 165 193 147
Dihedrals 45 57 71
Hydrogen Bonds 10 10 10
RMSD (A˚) from experimental
NOE (x10-3) 3.2 ± 0.8 3.5 ± 0.8 2.2 ± 0.4
Bonds (x10-3) (A˚) 2.2 ± 0.5 4.2 ± 0.5 3.3 ± 0.5
Angles (º) 1.6 ± 0.02 0.6 ± 0.02 3.6 ± 0.05
Coordinate Precision (A˚)
Backbone 0.50 0.40 0.35
CNS potential energy (kcal mol-1)
Total energy -1321 ± 54 -1219 ± 27 -1409 ± 39
Electrostatic -1428 ± 56 -1434 ± 40 -1516 ± 43
Van der Waals -138.2 ± 8 -86.73 ± 13 -139.6 ± 10
Bonds 9.63 ± 0.6 10.4 ± 1 7.8 ± 0.6
Angles 38.5 ± 3 57.8 ± 5.5 33.8 ± 4
Structural quality (% residues) 20 best
structures
In most favoured region of Ramachandran
plot
89.1 88 93.6
In additionally allowed region 10.2 12 6.4
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 NY11R  N CY11R  N CY11RL26A
(Y438R) (Y438R) (Y438R/L453A)
PDB: 2MWF PDB: 2MWD PDB: 2MWE
Restraints used for the calculation
(120 structures ensemble)
Sequential (|i  j| = 1) 102 90 93
Medium range (1 < |i  j|  4) 38 43 54
Long range (|i  j| > 4) 170 178 146
Dihedrals 70 54 48
Hydrogen Bonds 10 10 10
RMSD (A˚) from experimental
NOE (x10-3) 4.3 ± 0.3 2.8 ± 0.3 3.1 ± 0.1
Bonds (x10-3) (A˚) 4.6 ± 0.1 3.2 ± 0.1 4.1 ± 0.1
Angles (º) 0.6 ± 0.02 0.6 ± 0.02 0.5 ± 0.02
Coordinate Precision (A˚)
Backbone 0.36 0.45 0.40
CNS potential energy (kcal mol-1)
Total energy -1168 ± 22 -1038 ± 22 -1047 ± 22
Electrostatic -1365 ± 22 -1075 ± 40 -1157 ± 25
Van der Waals -89.6 ± 6 -86.73 ± 13 -96.8 ± 8
Bonds 11.7 ± 0.8 10.6 ± 1 8.1 ± 0.6
Angles 55.5 ± 4 38.5 ± 6 32.3 ± 3
Structural quality (% residues) 20 best
structures
In most favoured region of Ramachandran
plot
90 89 86
In additionally allowed region 10 11 14
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5.1 Characterisation of the interaction
between TGIF1 and SMAD proteins
Description of the interaction between TGIF1 (256-347) and
SMAD2
￿e ￿rst objective of the present work was the characterisation at the
structural level of the interaction between TGIF1 and SMAD2, previ-
ously described biochemically [28]. For each protein, the region that
was described to interact was expressed and puri￿ed.￿e 1H-15NHSQC
of TGIF1 (256-347) fragment revealed the absence of tertiary structure,
in agreement with the predictions generated by MetaDisorderMD2 dis-
order predictor (Appendix Figure 7.1). Nevertheless, we could assign up
to 94% of the backbone peaks observed in the HSQC.
In order to observe the interaction between both fragments, HSQC
titration experiments were performed. First, SMAD2-EEE (186-467)
was titrated over 15N labelled TGIF1 (256-347), resulting in no chemical
shi￿ di￿erences. We also titrate the TGIF1 (256-347) previously doubly
phosphorylated by p38↵, as we wanted to investigate if the phosphory-
lations of Ser286 and Ser291 have in￿uence on the binding to SMAD2.
￿e addition of ￿ve equivalents of SMAD2-EEE (186-467) only causes
small changes in chemical shi￿s and intensities. However, the fact that
three of thosemodi￿ed peakswere related to the phosphorylation event
(both phosphorylated serines and Arg283) support our hypothesis that
the phosphorylation could modulate the interaction between the pair
of proteins in a more biological context.
In order to validate the interaction a MST experiment was carried out.
￿e results con￿rmed the absence of a strong interaction between both
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proteins in the experimental conditions used, suggesting that in vitro
the interaction of both protein fragments is weak.
A ￿nal titration was performed between TGIF1 (256-347) and SMAD2.
In this experiment we used a fragment of SMAD2 corresponding to the
MH1 (SMAD2-MH1 (10-174)) in order to discard an interaction through
theMH1 domain. With only three amino acids that weremodi￿ed upon
the titration (Cys273, Cys303, Leu313), the result suggested that the in-
teraction, if happens, is also weak.
Several explanations might account for these observations. (1)￿e in-
teraction perhaps requires a third (or more) partner/s to facilitate the
TGIF1 (256-347) and SMAD2-EEE (186-467) interaction. ￿is hypothe-
sis is supported by the western-blot experiments performed by Wot-
ton et al. where they demonstrated that the addition of SMAD4 or
FOXH1 enhances the binding between SMAD2 and TGIF1 [28]. (2) An-
other explanation lies on the results – somehow antagonistic with the
former – where TGIF1 does not bind to phosphorylated SMAD2 [48].
￿at is, TGIF1 and SMAD2 interaction is enhanced by the activation of
the TGF , but, by some unknown mechanism, it is the not activated
SMAD2 which binds to TGIF1 and not the phosphorylated one. In our
experiments we used a SMAD2 with three glutamic acid residues at the
C-terminus, which mimics the phosphorylated serines. If TGIF1 only
binds to unphosphorylated SMAD2, that could be a reasonable expla-
nation why we do not observe a thigh interaction between both frag-
ments. (3) It could be possible that TGIF1 only binds to the full-length
SMAD2. As we did not test this interaction, we cannot discard this pos-
sibility. (4) Finally, it may be possible that the TGIF1 fragment requires
another post-translational modi￿cation (PTM), such as phosphoryla-
tion on the serine 294 (also located in the SID domain), to interact with
SMAD2.
TGIF1(256-347) is phosphorylated in vitro by p38↵ and CK1
Post-translational modi￿cations (PTM) are one of themainways to reg-
ulate protein function and binding to other molecules [59]. Phosphory-
lation on serines, threonines and tyrosines are one of the most studied
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PTM. In this work, we report how three serines of TGIF1(256-347) are
phosphorylated in vitro by p38↵ and CK1 kinases.￿ese results mimic
the phosphorylations detected by mass spectrometry high-throughput
analysis in human embryonic stem cells [57].
We described that p38↵ phosphorylates in vitro Ser286 and Ser291 of
TGIF1 (256-347) fragment in a stepwise manner using Real-Time NMR
experiments. ￿e subsequent addition of CK1 phosphorylates Ser294.
￿is is the ￿rst time that TGIF1 is suggested to be a substrate for both
kinases. ￿e phosphorylations do not modify greatly the structure of
the TGIF1 (256-347) fragment. However, we have reported that the
chemical shi￿s a￿ributed to the side-chains of the arginines shi￿ upon
phosphorylation. ￿e localisation of these arginines – surrounding
the phosphorylated serines – make possible the assumption that these
shi￿s were due to the salt bridges formed between the guanidinium
group of the arginines and the phosphate group of the phosphorylated
serines [148].
We are aware that we only investigated the phosphorylation in this
speci￿c fragment of TGIF1 in vitro. ￿is evidence does not demon-
strate that these serines would be also phosphorylated by p38↵ and
CK1 when the full-length TGIF1 is the substrate or that others kinases
might participate in the process in vivo.
Description of the interaction between TGIF1 (150-248) and
SMAD2/4-MH1 proteins
Wewere also interested in the role of the homeodomain region in DNA
and SMADs interactions. In previous studies, it was found that the pre-
served region rich in arginines localised at N-terminal of the HOXC9
HD interacts with SMAD4-MH1 [150]. In contrast, this region has been
found to bind DNA in another homeodomain-TALE protein, PBX1 [41].
Based on this information, we generated a new TGIF1 homeodomain
construct (150-248) that contains not only the HD but also the arginine-
rich N-terminal region.
￿e TGIF1 (150-248) HSQC spectra evidences the presence of tertiary
structure, in agreement with the already determined TGIF1 HD struc-
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ture (PDB id: 2LK2). Unfortunately, we were incapable to assign the
TGIF1 (150-248) protein. Instead, we have used the information avail-
able in the BMRB to identify the ligand binding. Nevertheless, peaks
that were not isolated and the peaks corresponding to the N-terminal
region (absent in the 2LK2 construct) we could not extract any infor-
mation, even for those modi￿ed because of the titrations.
￿e ￿rst titration with the canonical DNA con￿rm the tight binding
between them, as most of the peaks were greatly modi￿ed upon the
binding.
In the next experiment, we wanted to con￿rm whether SMAD4-MH1
could bind to the TGIF1 (150-248) fragment. A￿er the addition of 1.6
equivalents of SMAD4-MH1 over the 15N labelled TGIF1 fragment, sev-
eral peaks changed, specially regarding their intensity.￿e localisation
of the modi￿ed peaks in the TGIF1 HD 2LK2 structure shows that all of
them are situated in the same region, towards the N-terminal region of
the construct, where the arginine-rich is located. However, these peaks
are di￿erent from the ones that are shi￿ed in the HOXC9 interaction
with SMAD4-MH1 [150], where only the peaks at the N-terminal of
the Arg-rich region are moved upon SMAD4-MH1 titration. Because
we have not assigned our TGIF1 (150-248) construct, we cannot assure
that the peaks related to the N-terminal Arg-rich region are also mod-
i￿ed by SMAD4-MH1 addition.
Moreover, the change in the intensity was positive, not negative. Usu-
ally, when some speci￿c residues bind to another molecule, their tum-
bling decreases. ￿erefore, their related peak gets broader, decreasing
its intensity [157]. In contrast, when there is no contact, the peak keeps
the same intensity. However, if the peak increases its intensity, as in
our case, that means that before the addition of SMAD4-MH1 those
residues were bound. And the presence of SMAD4 enhances the free-
dom of these residues, with more tumbling, narrower peak, and thus
higher intensity [157].
We hypothesise two possible reasons for those results. (1) TGIF1-HD
might be involved in contacts with other TGIF1-HD molecules in solu-
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tion, characteristic of a monomer-dimer equilibrium. Hence, the pres-
ence of SMAD4-MH1 (1-140) disturbs or impedes the dimer formation.
(2) Before the addition of SMAD4-MH1 domain, the TGIF1-HD might
be in a closed conformation, with the N-terminal tail ￿rmly bound to
the domain. However, in the presence of the SMAD4-MH1, the open
conformation is favoured, allowing a free tumbling of those residues.
Furthermore, some of these residues are located in the third ↵-helix and
may be important for the interaction with DNA. Unfortunately, we can-
not con￿rm the interaction of SMAD4 with the N-terminal tail because
the lack of the full assingment. We also tried some docking simulations
between TGIF1 and SMAD4-MH1 without any result.
￿e titration of the SMAD2-MH1 over the same labelled protein re-
vealed analogous behaviour aswith SMAD4-MH1, with almost the same
modi￿ed peaks. However, less peaks were a￿ected and the intensity
variation was not so high. We conclude that we were observing the
same phenomena but in a lesser intensity.
Further EMSA experiments provide more evidences of the binding. In
particular, the addition of SMAD4-MH1 or SMAD2-MH1 interfereswith
the binding between TGIF1 (150-248) and its canonical DNA.￿is re-
sult highlights the importance of the binding as it interferes with one
of the main TGIF1 functions. Curiously, in the EMSA experiments, the
SMAD2-MH1 domain seems to interfere more than SMAD4-MH1, in
contrast with the NMR results.
Globally, these results complement the previous and controversial ￿nd-
ings [28, 48]. On one hand, Wo￿on et al. demonstrated that the pres-
ence of SMAD4 enhances the binding between SMAD2 and TGIF1, dis-
carding the interaction between SMAD4 and TGIF1 [28]. On the other
hand, Seo et al. proved that the addition of TGIF1 prevents the for-
mation of the SMAD2/SMAD4 complex [48]. To that previous knowl-
edge, we con￿rmed that SMAD4-MH1 and SMAD2-MH1 interact with
the TGIF1 HD region interfering with its DNA binding. In addition,
we cannot discard an interaction between the SID region of TGIF1 and
SMAD2, maybe e￿ective only when TGIF1 is triple phosphorylated at
serine 286, 291 and 294.
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TGIF1 (256-347) and TGIF1 (150-248) interact with each other.
￿e NMR titration experiment con￿rmed the interaction between the
two TGIF1 fragments (150-248) and (256-347). ￿is binding event ar-
gues for the closed conformation of the full length protein. It could
be that, in physiological conditions, the two regions interact with each
other and the phosphorylation upon TGIF1 (256-347) would disrupt the
interaction. Moreover, the EMSA results indicate that the addition of
TGIF1 (256-347) interferes with the normal binding between TGIF1 HD
and its canonical DNA, in a similar way as SMAD4-MH1 and SMAD2-
MH1.
General perspectives
￿is PhD project was aimed to structurally characterise the binding of
TGIF1 protein with its partners, SMAD2, SMAD4 and also DNA. ￿e
results obtained within this thesis might be used as preliminary infor-
mation for further structure-based rational drug design against several
diseases such as cancer or HPE. By knowing the exact interaction sur-
face of TGIF1 with the binding partners we could ￿nd interesting and
promising hot spots that can serve as targets of chemical compounds
that would speci￿cally inhibit these interactions.￿e ￿rst stepwas then
to describe those interactions biophysically and structurally.
To conclude, this project is an ongoing project in our lab. We have
planned more experiments in order to con￿rm our results. Such exper-
iments include TGIF1-HD bound to DNA X-Ray structure, KD deter-
mination by isothermal titration calorimetry (ITC) and NMR titrations
with the protein combinations that we could not perform.
5.2 Study about the cysteine-free direct
aminolysis ligation reaction
Nowadays there are many published strategies to ligate peptides in
order to synthesise longer polypeptides, even proteins in some cases.
However, there is no yet standard protocol as each strategy has its own
advantages and limitations, depending of the protein of interest. Native
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chemical ligation (NCL) is currently the most popular and established
technique. Moreover, recent advances in desulfuration techniques have
opened the door to replace the required cysteine in the ligation junc-
tion for up to 12 di￿erent amino acids [158]. ￿ese discoveries solved,
at least partially, the main limitation of the NCL. ￿erefore, the NCL
is currently feasible, at least theoretically, with almost any peptide se-
quence.
However, othermethods are under developmentwith the goal to achieve
a peptide ligation that would be chemoselective, free of epimerisation,
independent of the amino acid at the ligation junction and with high
reaction rate. One of thesemethods is focus on the direct aminolysis be-
tween the two peptides, without the requirement of any external thiol
at the ligation junction. Based on the ligation method developed by
Wong and coworkers [83], in our work we have demonstrated that the
addition of HOBt to the ligation bu￿er increases the conversion, but not
the rate, of every peptide ligation tried, regardless which amino acids
are at the ligation junction (with the exception of cysteine). Especially
interesting was the increasing of the conversion when valine, leucine
or tyrosine where at the ligation junction. In those reactions, the addi-
tion of HOBt was crucial to obtain a satisfactory yield (between 34 and
57%).
￿e use of HOBt has also been reported in others peptide ligation stud-
ies. ￿us, Danishefsky and coworkers used HOBt as a catalyst for a
direct aminolysis peptide ligation between a thioacid and a free N-
terminus peptide [159]. Based on their experiments, the authors pro-
posed an oxidation mechanism, where the presence of an oxidant in
the reaction (such air versus argon) makes a di￿erence in the yields re-
ported. In our work, we hypothesise that HOBt catalyses the reaction
between the thiophenolic intermediate and the ￿nal product. ￿e bet-
ter HOBt leaving group versus the thiophenolic leaving group (based
on their di￿erent pKa) would explain this mechanism of reaction.
Regarding the special case of cysteine, we hypothesise that another re-
action pathway, presumably NCL, was also taken place. As the NCL is
faster than the direct aminolysis reaction, the presence of HOBt induce
the direct aminolysis pathway, sequestering reagents for the NCL and
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thus, slowing the reaction.
In addition of HOBt, we also tried the e￿ect of the presence of HOAt
(an HOBt analogue) and DIPEA or DBU (two bases) in the ligation reac-
tion. Only the addition of 4 equivalents of DIPEA demonstrated be￿er
results in comparison with HOBt alone, while the other reagents were
either worse or equal to theHOBt option. In another set of experiments,
we investigated the same reaction but using free N-terminus thioesters
instead of protected with acetyl group. However, in all these trials the
competitive intramolecular cyclisation reaction was dominating over
the aminolysis and thus we discarded this option.
Moreover, we demonstrated that the method is also applicable to phos-
phorylated peptides. However, for the phosphorylated TGIF1 peptide,
the use of the peptide synthesis followed by peptide ligation method
ends in a ￿nal low yield. ￿erefore, the heterologous expression with
in vitro phosphorylation was the preferred option in our case.
S
O
+
Peptide 1 Peptide 2
O
Peptide 1
H
N
O
N
H
R
in 4:1 (v/v) NMP:6 M GuHCl
 +1 M HEPES, pH 8,5  
2% vol. PhSH + 2 eq HOBt
O
N
H
NH2
R Peptide 2
Figure 5.1: Scheme of the Wong direct aminolysis peptide ligation with the
improvement we presented in this thesis (in red).
To sum up, the improvement presented in this thesis is a small step to-
wards having a perfectly valid direct aminolysis peptide ligation reac-
tion (Figure 5.1). Moreover, the easy separation of the ligation product
by HPLC is another good argument for the applicability of the tech-
nique. However, much more e￿ort has to be done in order to establish
this method as an appropriate alternative to the NCL. Some of the is-
sues that need to be solved in the future include the improvement of
the ligation rate and conversion and the expansion of the chemoselec-
tivity also for non protected lysines. Here, we want to point out that
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the addition of DIPEA to the ligation bu￿er is a promising start point
for further developments.
Finally, all the results of this section are published in Biopolymers (Pep-
tide Science) under the title ”Addition of HOBt improves the conversion
of thioester-amine chemical ligation” [119] (Appendix).
5.3 Determination of six mutant structures
of FBP28-WW2
￿e determination of the six mutants structures of the FBP28-WW2
domain was key to validate the simulations performed by the UNRES
force ￿eld. In particular, the solved structures indicate that the point
mutations on the WW2 domain, including deletions at the N and C-
terminus, do not alter the overall structure. Interestingly, the shortest
structures,  N CY11R and  N CY11RL26A, with only 28 residues,
are the smallest WW domain structures determined so far.
￿e UNRES simulations analysis revealed that the WT and four mu-
tants exhibit double-exponential kinetics (three-state folding) while the
Y19L and W30F mutants show single-exponential kinetics (two-state
folding). Most of the results are in agreement with the experimental
kinetics studies done by Nguyen et al. [156] while the discrepancies
observed can be explained in terms of the free-energy barrier heights.
Overall, this study concluded that UNRES force ￿eld is a valid compu-
tational tool as it can simulate accurately the kinetic constants obtained
experimentally.
￿is work was published in PNAS under the title “Folding kinetics of
WW domains with the united residue force ￿eld for bridging micro-
scopic motions and experimental measurements” [122] (Appendix).
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1.- Interaction between SMAD2 and TGIF1 by NMR.
We have prepared several fragments of TGIF1 and analysed their in-
teractions with SMAD2 in vitro. No direct interaction between TGIF1
(256-347) and with SMAD2-EEE (186-467) was detected in our experi-
mental conditions. ￿e phosphorylation on Ser286 and Ser291 favours
a weak interaction between both proteins. On the other hand, we also
observed weak interaction between TGIF1 (256-347) and the MH1 of
SMAD2.
2.- p38↵ and CK1 phosphorylate TGIF1 (256-347) in vitro.
For the ￿rst time it is reported a stepwise phosphorylation of Ser286
and Ser291 by p38↵ and the subsequent phosphorylation of Ser291 by
CK1.￿e phosphorylations do not disturb the previous TGIF1(256-347)
global structure but modify the side-chains of nearby arginines.
3.- SMAD2/4-MH1 interactions with TGIF1 (150-248).
￿e addition of SMAD4-MH1 or SMAD2-MH1 domains disrupts the
binding of TGIF1 homeodomain with the DNA. Moreover, the NMR
titrations suggest that the presence of either SMAD4-MH1 or SMAD2-
MH1 domains a￿ects the conformational freedom of certain residues
located in the N-terminal region of the homeodomain.
4.- TGIF1 (150-248)-TGIF1 (256-347) interaction might suggest
the presence of open and closed conformations of full-length
TGIF1.
NMR titrations con￿rmed the interaction and EMSA experiments showed
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that TGIF1 (256-347) disrupts the binding of the homeodomain with
DNA.
5.-￿e addition ofHOBt improves the cysteine-free direct aminol-
ysis ligation strategy.
￿e addition of HOBt improves the reaction conversion, but not the
rate, of the ligation reaction, especially when sterically hindered amino
acid (such as valine or leucine) are present at the ligation junction.
￿e reaction is also compatible with phosphorylated peptides but in-
tramolecular cyclisation side-reactions appearwhen the peptide thioester
is not protected at the N-terminus.
6.- Six selected mutants structures of FBP28-WW2 were deter-
mined de novo by NMR.
￿e sixmutantsmaintain themain characteristics ofWWdomain struc-
ture, even for the mutations introducing deletions at the N and C ter-
minus.￿e structures were the experimental con￿rmation of the e￿ect
of this set of mutations in the structure.￿e existence of the WW fold
in all these mutants was key to provide the grounds for the simulated
folding curves generated using the UNRES force ￿eld.
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proteins
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Figure 7.1:MetaDisorderMD2 prediction plot [43]. All residues whose disor-
der probability is over 0.5 are considered as disordered.￿e sequence starts at
the TGIF1 amino acid number 130.
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Figure 7.2:  15N 117.96 ppm strips from the CBCANH experiments on TGIF1
(256-347) before and a￿er phosphorylation by p38↵. ￿e strips correspond
to the superimposed￿r268 and Ser286 peaks. ￿e horizontal lines connect
equal peaks while the circle indicates the place where the peaks related to
Ser286 should have been. C↵ peaks are red; C  are green.
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15N-TGIF1 256-347 vs SMAD2-EEE (186-467)
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Figure 7.3: Intensity and CSP graph for the titration between 15N-TGIF1 (256-
347) and SMAD2-EEE (186-467).￿e amino acids are displaced randomly, but
in the same order between both graphs. In green are labelled those peaks
above the cut-o￿.
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Figure 7.4: Intensity and CSP graph for the titration between 15N-pTGIF1
(256-347) by p38↵ and SMAD2-EEE (186-467). ￿e amino acids are displaced
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15N-TGIF1 256-347 vs SMAD2-MH1 (10-174)
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Figure 7.5: Intensity and CSP graph for the titration between 15N-TGIF1 (256-
347) and SMAD2-MH1 (10-174).￿e amino acids are displaced randomly, but
in the same order between both graphs. In green are labelled those peaks
above the cut-o￿.
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Figure 7.6: Intensity and CSP graph for the titration between 15N-TGIF1
homeodomain (150-248) and SMAD4-MH1 (10-140). ￿e amino acids are dis-
placed randomly, but in the same order between both graphs.￿e interrogant
mark indicates that those peaks could not be assigned. In green are labelled
those peaks above the cut-o￿.
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Study about the cysteine-free direct aminolysis ligation
reaction
Table 7.1: List of the cations followed for each amino acid combination.
Ligation Combinations Experimental m/z of
the product
Experimental
m/z of exchanged
thiophenol
thioster
I Ac-GASATVSPLG-SC7H7 + [M + H]+ = 1783.4 [M+H]+= 993.5
NH2-GGPSPLGFLG-CONH2 [M + 2H]2+ = 892.2
II Ac-GASATVSPLS-SC7H7 + [M + H]+ = 1813.2 [M+H]+= 1023.5
NH2-GGPSPLGFLG-CONH2 [M + 2H]2+ = 907.1
III Ac-LYRAG-SC7H7 + [M + H]+ = 1168.5 [M + H]+ = 713.5
NH2-GSPGYS-CONH2
IV Ac-LYRAG-SC7H7 + [M + H]+ = 1182.5 [M+H]+= 713.5
NH2-ASPGYS-CONH2
V Ac-GASATVSPLS-SC7H7 + [M + H]+ = 1859.0 *
NH2-CGPSPLGFLG-CONH2 [M + 2H]2+ = 930.0
VI Ac-GASATVSPLS-SC7H7 + [M + H]+ = 1855.4 [M + H]+= 1023.5
NH2-VGPSPLGFLG-CONH2 [M + 2H]2+ = 928.2
VII Ac-GASATVSPLV-SC7H7 + [M + H]+ = 1867.2 [M + H]+= 1035.5
NH2-VGPSPLGFLG-CONH2 [M + 2H]2+ = 934.1
VIII Ac-GASATVSPLV-SC7H7 + [M + H]+ = 1881.4 [M + H]+= 1035.5
NH2-LGPSPLGFLG-CONH2 [M + 2H]2+ = 941.2
IX Ac-LYRAG-SC7H7 + [M + H]+ = 1274.6 [M + H]+= 713.5
NH2-YSPGYS-CONH2
X Ac-PSpSPGSV-SC7H7 + [M + H]+ = 1488.6 [M + H]+= 844.8
NH2-LARPSVI-CONH2 [M + 2H]2+ = 744.8
*As the N-terminal peptide starts with cysteine, the intermediate through thiophenol
thioester was not observed.
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Figure 7.9: Kinetics of the thiophenolic peptide ester in the reaction II. Com-
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MPAA (dashed line).
154
Addition of HOBt Improves the Conversion of Thioester-Amine
Chemical Ligation
Toni Todorovski,1 David Su~nol,1 Antoni Riera,1,2 Maria J. Macias1,3
1Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology,
Baldiri Reixac, 10 08028 Barcelona, Spain
2Departament de Qu!ımica Org"anica, University of Barcelona, Mart!ı i Franque`s, 1, Barcelona 08028, Spain
3Catalan Institution for Research and Advanced Studies (ICREA), Passeig Lluis Companys, Barcelona 23 08010, Spain
Received 6 May 2015; revised 10 September 2015; accepted 18 September 2015
Published online 22 September 2015 in Wiley Online Library (wileyonlinelibrary.com). DOI 10.1002/bip.22745
ABSTRACT:
The syntheses of large peptides and of those containing
non-natural amino acids can be facilitated by the appli-
cation of convergent approaches, dissecting the native
sequence into segments connected through a ligation reac-
tion. We describe an improvement of the ligation protocol
used to prepare peptides and proteins without cysteine
residues at the ligation junction. We have found that the
addition of HOBt to the ligation, improves the conversion
of the ligation reaction without affecting the epimeriza-
tion rate or chemoselectivity, and it can be efficiently used
with peptides containing phosphorylated amino acids.
VC 2015 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 104: 693–702, 2015.
Keywords: ligation of peptide fragments through direct
aminolysis; cysteine-free native chemical ligation; native
chemical ligation with b-branched residues at ligation
junction; formation of highly reactive HOBt esters
This article was originally published online as an accepted
preprint. The “Published Online” date corresponds to the pre-
print version. You can request a copy of any preprints from
the past two calendar years by emailing the Biopolymers edi-
torial office at biopolymers@wiley.com.
INTRODUCTION
S
olid-phase peptide synthesis (SPPS), developed in
the 60s by B. Merrifield,1 is nowadays the standard
methodology for chemical preparation of peptides.
Although peptides up to 50 residues can be obtained
using this methodology 2,3 the linear synthesis of
large or complex sequences frequently yield mixtures con-
taining undesired products and is usually not practical.
Improvement of these syntheses often require the application
of a convergent approach, dissecting the native sequence in
segments that are connected using a ligation reaction (Figure
1, Panel A).4–6 These protocols also facilitate the introduc-
tion of modified amino acids in proteins (including phos-
phorylated or acetylated residues or non-natural amino
acids) as well as to the addition of specific labels for antibody
recognition, protein detection and cell imaging.7
The direct coupling of two peptides was reported for the
first time by Kemp et al. in 1974.8,9 This method allows a liga-
tion reaction to occur independently of the amino acids pairs
at the ligation junction. The reaction couples a peptide con-
taining an activated carboxylic derivative at its C-terminus to a
second peptide carrying an unprotected NH2-group at its N-
terminus. The success of the method depends on the aqueous
solubility of the designed segments and suffers from the epi-
merization of the product at the ligation site. Improvements to
the direct aminolysis method were described later by Blake
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et al. and Aimoto et al.10–12 However, in these protocols the
reaction conditions cause epimerization of the C-terminal
thioester residue, and therefore only non-epimerizable amino
acids (glycine or proline) can be introduced at this position.
A breakthrough in the ligation strategy was the develop-
ment of the native chemical ligation (NCL) approach.4 In this
reaction, carried out in aqueous buffers, the peptide containing
a C-terminal thioester is attacked by the thiol group of a cyste-
ine residue located at the N-terminus of the second peptide.
The thioester intermediate forms a native amide bond after an
intramolecular rearrangement. This ligation reaction can also
be used with recombinant proteins to generate the segment
carrying the thioester group at the C-terminus via intein-
mediated cleavage.13 A drawback in this process is that proteins
synthesized by NCL are generated mainly from two segments
and are often limited by the presence of cysteines in the
sequence. If cysteines are not present in the native sequence,
the ligated peptide would require a desulfurization step which
is not always straightforward.14,15
Novel approaches have recently been described by Wong
and coworkers, that partially overcome the above mentioned
drawback.16,17 Their works report the chemical ligation of pep-
tides and proteins without cysteine residues at the ligation
junction with high chemoselectivity and low levels of
FIGURE 1 Schematic representation of the ligation reaction through direct aminolysis (Panel A)
Peptides designed for the ligation reactions used in this study. The m/z experimental values (which
are same as theoretically calculated ones) obtained for each peptide is shown next to the corre-
sponding sequences prior the ligation (Panel B). Ligated peptides sequences (the ligation site is rep-
resented with a circle) are listed, with yields and conversion percentages obtained for ligation
reactions carried in the presence or in the absence of HOBt (Panel C).
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epimerization. The main limitation of these strategies is the
ligation rate, normally requiring long reaction times, ranging
from a few hours to several days.
We considered that adding 1-hydroxybenzotriazole (HOBt),
a common reagent used in SPPS, to the protocol described by
Wong and coworkers,16 could improve the ligation yield and
the conversion of the ligation reaction without affecting the
epimerization rate or chemoselectivity. To test this hypothesis,
we prepared various peptides with different amino acids at the
ligation junction including a WWdomain sequence (of 35 aa)
containing at non-natural residue. Some of the peptides
included phosphorylated amino acids, which are often a chal-
lenge due to the steric hindrances that they introduce during
couplings, as well as their tendency to undergo alpha, beta-
elimination under strong reaction conditions. Our results indi-
cate that, the presence of HOBt increases the yield and conver-
sion of the ligation, thus reducing the possibility of side-
products and degradation. These experimental conditions are
especially suited for the preparation of intrinsically unfolded
protein segments that are particularly prone to degradation.
MATERIALS AND METHODS
General Procedure for the Synthesis of Peptide Thioest-
ers. Six peptide thioesters (Figure 1, Panel B) were synthesized using
the SPPS approach and 4-sulfamylbutyryl resin (Supporting Informa-
tion). The coupling of the first residue was performed as recom-
mended by the manufacturer.18 In brief: Fmoc-AA-OH (4 equiv.),
DIC (4 equiv.) and 1-methylimidazole (4 equiv.) were dissolved in
DCM (12 lL/lmol). The solution was added to 1 equiv. of the resin
and the mixture was gently agitated for the next 18 h at 258C. The
resin was then washed 5 times with DMF and 5 times with DCM
before being dried. Coupling efficiency was estimated through resin
load determination by UV analysis of Fmoc-release. The remaining
amino acids were incorporated manually using 5 equiv. of the corre-
sponding amino acid derivatives activated with 4.9 equiv. of DIC in
the presence of 4.9 equiv. of HOBt in DMF at 100 lmol scale using
Fmoc/tBu chemistry. The efficiency of the couplings was verified with
the Kaiser test.19
After completion of the sequences, all peptides were either acety-
lated or Boc-protected at the N-terminus prior to final peptide cleav-
age from the resin. The procedure for the peptide activation was the
following: iodoacetonitrile (67 equiv.) and DIPEA (13 equiv.) in DMF
(72 lL/lmol) were added to the resin and gently agitated for the next
18 h. The resin was then washed six times with DMF, six times with
DCM and then dried. In the next step, the peptide was cleaved from
the activated resin using benzyl mercaptan (50 equiv.) and DIPEA (13
equiv.) in DMF (72 lL/lmol) in an 18 h reaction with gentle agita-
tion. The peptide solutions were filtered and collected in a round-
bottom flask. The resin was washed twice with DMF (4 mL each
time) and the combined filtrates were concentrated under vacuum in
order to completely remove DMF. The crude product was dissolved in
6 mL of a TFA/triisopropylsilane/water mixture (95:2.5:2.5 by vol.)
and stirred at room temperature for 3 h, yielding the peptide thioester
without the side-chain protecting groups. The peptide thioesters were
then precipitated in cold diethyl ether and centrifuged (3000g). The
pellet was washed twice with cold ether, dried, and stored at2208C.
The crude thioesters were analyzed by LC-MS and, depending on
their purity, some of them were additionally purified by preparative
RP-HPLC prior to their use in the ligation reactions.
General Procedure for Free N-Terminus Peptide Synthesis.
Peptides containing a free N-terminus (Figure 1, Panel B) were syn-
thesized manually using a Rink amide AM resin and Fmoc/tBu chem-
istry with 5 equiv. of the amino acids derivatives activated by 4.9
equiv. of DIC in the presence of 4.9 equiv. of HOBt in DMF at the
100-lmol scale. The efficiency of the manual coupling was verified by
the Kaiser test.19
The resin-bound peptides were cleaved and deprotected with TFA
containing a scavenger mixture of water, thioanisol, and ethanedithiol
(90:5:2.5:2.5 by vol) at RT for 2 h. They were then precipitated in cold
diethyl ether and centrifuged (3000 g). The pellet was washed twice
with cold ether, dried and stored at2208C.
Finally, the crude peptides were purified by preparative RP-HPLC.
Pure fractions were collected, lyophilized, and stored at 2208C. They
were then analyzed by MALDI-MS and LC-MS prior to their use in
ligation reactions.
General Procedure for Peptide Ligation Reactions. The free
N-terminus peptides (1.5 equiv. or 0.5 equiv.) were dissolved in
120 lL of ligation buffer (Ligation buffer5NMP:6M GnHCL1 1M
HEPES5 4:1 (v/v). A buffer containing 6 M GuHCl and 1M HEPES
was prepared (50 mL) and adjusted to pH 8.5 using 25% NaOH solu-
tion and degassed. For each ligation trial 100 lL of the buffer was mixed
with 400 lL of NMP). The resulting solution was used to dissolve the
thioester peptide (between 0.3 and 1.5 lmol) (Depending of the pep-
tide thioester amount the final volume of the ligation buffer was different
(the volume of 80 lL and the described procedure is for peptide thioester
amount of 1 lmol). However, the free NH2 peptide was always 1.5 equiv.
higher (Table I, entry 1, 2, 5, 6 and 7) or 0.5 equiv. lower (Table I, entry
3, 4 and 8) from the peptide thioester equivalents). For each reaction,
the solution was separated into two equal parts, and 15 lL of HOBt
dissolved in the same ligation buffer (2 equiv. based on the amount of
peptide thioester) were added to the ligation series with HOBt, while
15 lL of the ligation buffer was added to the other part, for compari-
son, as a control. For the ligations with HOAt and DIPEA, 2 equiv of
HOAt, or, 4 equiv of DBU and DIPEAwere added to the ligation mix-
ture, respectively.
Finally, thiophenol (2% by volume, 1.5 lL) was added to the reac-
tions in the presence or absence of activators, and the resulting mix-
ture was incubated at 378C with gentle agitation until the reaction
was completed. At various time points the reaction was followed by
LC-MS, and in some cases by MALDI-MS and RP-HPLC, depending
on the peptide sequences and amino acids at the ligation junction
(Table I, Supporting Information Table I). At each time point, 8 lL
aliquots of the ligation mixture were taken and quenched by the addi-
tion of 0.1% TFA in water (32 lL) or tris(2-carboxyethyl)phosphine
(TCEP) solution (32 lL, of a 10 mg/mL solution) when the products
contained cysteine residues. The quenched mixtures were diluted up
to 1.5 mL with % MeCN/0.1% FA in water (Supporting Information
Table I) and stored at2208C.
Improvement of peptide ligation using HOBt 695
Biopolymers (Peptide Science)
7 Publications
157
Synthesis of Modified Human Pin 1 Protein Using the
Cysteine-Free Ligation Protocol With HOBt. Human Pin 1
protein was synthesized using the ligation protocol with HOBt,
through ligation of segment 1 with segment 2 (Scheme 1, Sup-
porting Information figures). Segment 1 was synthesized as thio-
ester following the above described procedure and acetylated at
the N-terminus. Segment 2, up to the Asn, was synthesized in a
microwave-assisted peptide synthesizer (Liberty Blue, CEM Corpo-
ration). Starting from Phe, the rest of the sequence of segment 2
was coupled manually following the general procedure for peptide
synthesis. The ligation was performed following the protocol
described previously, using 3.2 lmol of segment 1 and 4.8 lmol
of segment 2. The final volume of the ligation buffer was 700
lL due to the tendency of segment 2 to form a viscous gel (the-
oretically the final volume of the ligation buffer should be 240
lL). The reaction was followed by MALDI-MS and stopped after
78 h. The crude product was purified by RP-HPLC, and the frac-
tions corresponding to the ligation product were collected, lyophi-
lized, and stored at 2208C. In order to remove the Lys side-
chain protecting group (ivdDe), the product was dissolved in
DMF containing 3% of hydrazine. The solution was left at room
temperature for 1h with a gentle mixing. Afterwards, DMF was
removed under reduced pressure and the solid residue was dis-
solved in water solution containing 20% MeCN/0.1% FA. The
solution was lyophilized and afterwards stored in the freezer at
2208C.
MALDI-MS. Mass spectra were acquired on a 4700 Proteomic ana-
lyzer or on a 4800 Plus MALDI TOF/TOF Analyzer (AB Sciex) cali-
brated with Calmix (Calmix 4700 Proteomics Analyzer Calibrating
Mixture). The mass spectra were recorded in positive reflector TOF
mode in the m/z range 500–2000 or 1500–4500 at a fixed laser inten-
sity of 4800 using alpha-cyano-4-hydroxycinnamic acid as a matrix.
Spectra were analyzed by Data Explorer software (Version 4.6, Applied
Bisystems GmbH).
RP-HPLC. Crude peptides, peptide thioesters, and ligation mixtures
were purified using an Aqua C18-column (internal diameter 4.6 mm,
length 150 mm, particle size 5 lm, pore size 12.5 nm, Phenomenx)
with a linear gradient from 10% to 24% aqueous acetonitrile (0.1%
TFA) over 1.2 min, followed by a gradient of 24% to 57% for the next
42 min with a flow rate of 1 mL/min using an €AKTA purifier 10
HPLC System (GE Healthcare Life Sciences). Fractions were analyzed
by MALDI-MS and those containing the products were collected,
lyophilized, and stored at2208C.
Ligation mixtures were analyzed on the microbore Aqua C18-col-
umn using a linear gradient from 4.75% to 57% or from 9.5% to 57%
aqueous acetonitrile (0.1% TFA) for 25 min at a flow rate of 1 mL/
min.
LC-MS. The ligation mixtures (30 lL, at final concentration of
approx. 60 lmol/L for each time point) were injected into the HPLC-
MS system (Waters, model Alliance 2796 with a quaternary pump
Table I Ligation Combinations Used in the Study With the Experimental Masses for the Product and Exchanged Thiophenol
Thioester Used for Monitoring the Reaction Kinetics
Ligation Combinations
Experimental m/z
of the Product
Experimental m/z of
Exchanged Thiophenol
Thioester SC7H7»
SC6H5
Yield (Y)/conv.(C)
With HOBt
addition (%)
Yield (Y)/conv.(C)
Without HOBt
Addition (%)
1 Ac-GASATVSPLG-SC7H71
NH2-GGPSPLGFLG-CONH2
[M1H]151783.4
[M12H]215892.2
[M1H]15993.5 n.d n.d
2 Ac-GASATVSPLS-SC7H71
NH2-GGPSPLGFLG-CONH2
[M1H]151813.2
[M12H]215907.1
[M1H]151023.5 n.d n.d
3 Ac-LYRAG-SC7H71
NH2-GSPGYS-CONH2
[M1H]151168.5 [M1H]15713.5 89 (Y) 83 (Y)
4 Ac-LYRAG-SC7H71
NH2-ASPGYS-CONH2
[M1H]151182.5 [M1H]15713.5 n.d n.d
5 Ac-GASATVSPLS-SC7H71
NH2-VGPSPLGFLG-CONH2
[M1H]151855.4
[M12H]215928.2
[M1H]151023.5 36 (Y) 10 (Y)
6 Ac-GASATVSPLV-SC7H71
NH2-VGPSPLGFLG-CONH2
[M1H]151867.2
[M12H]215934.1
[M1H]151035.5 34 (Y) 5.2 (Y)
7 Ac-GASATVSPLV-SC7H71
NH2-LGPSPLGFLG-CONH2
[M1H]151881.4
[M12H]215941.2
[M1H]151035.5 36.7 (C) 16.7 (C)
8 Ac-LYRAG-SC7H71
NH2-YSPGYS-CONH2
[M1H]151274.6 [M1H]15713.5 57 (Y) 33 (Y)
9 Ac-PSpSPGSV-SC7H71
NH2-LARPSVI-CONH2
[M1H]151488.6
[M12H]215744.8
[M1H]15844.8 31.5 (C) 18.8 (C)
10 Ac-GASATVSPLS-SC7H71
NH2-CGPSPLGFLG-CONH2
[M1H]151859
[M12H]215930
n.d. n.d
The ligation junctions are in bold and italic.
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and UV/Vis dual absorbance detector Waters 2487 connected with
ESI-MS model Micromass ZQ). The separation was achieved on a
Sunfire C18-column (internal diameter 2.1 mm, particle size 3.5 lm,
length 100 mm) using a linear gradient from 10% or 20% to 100%
aqueous acetonitrile (0.1% FA) in 8 min at a flow rate of 0.3 mL/min.
The mass spectra were acquired for a mass range from m/z 500 to
2000 in positive ion mode using five different cone voltages ranging
from 5 to 70 V. The TIC spectra used for peak integration correspond
to the cone voltage of 30Vand were analyzed by Masslynx 4.0 software
(Waters).
Kinetics of Cysteine-Free Ligation With and Without HOBt.
As mentioned above, depending on the peptide sequence and amino
acids at the ligation junction, the kinetics of the ligation reaction was
followed using different time intervals (Supporting Information
Table I). At each time point, aliquots of 8 lL of the ligation mixture
were taken and quenched by the addition of 0.1% TFA in water (32
lL) or of a TCEP solution (32 lL, of a 10 mg/mL solution) if the
products contained cysteine residues. The samples were diluted up to
1.5 mL with solution containing H2O/MeCN/FA at different ratios by
volume (Supporting Information, Table I, column 4) and analyzed by
LC-MS, in some cases additionally by MALDI-MS or analytical RP-
HPLC. The kinetics was followed through integrating the peak areas
of the single or double charged ions of ligated product and exchanged
thiophenol thioester (Table I). Yields were calculated after the RP-
HPLC purification of the crude ligation mixture, while the given con-
versions where calculated from the integrated ions ratio of ligated
product vs peptide thioester in the TIC spectra. In those cases, were
the experiments were performed in triplicate the standard error was
calculated (Reagents provided as supplementary material).
RESULTS AND DISCUSSION
To test if the addition of HOBt to the reaction protocol
described by Wong and coworkers16 can improve the rate and
conversion of ligation we first selected a set of different native
sequences, present in TGIF1 and FoxH1 proteins (Supporting
Information Figure 1) and collected in Figure 1. The selected
peptides contain b-branched (Table I, entries 5, 6 and 7) or
aromatic residues (Table I, entry 8) at the ligation site, since
these residues -and also phosphorylated amino acids- are often
present in protein binding interfaces and are known to add
complexity to the ligation reaction.20,21 All sequences of the
acetylated C-terminal peptide thioesters and free N-terminal
amidated peptides used here are given in Figure 1. These pep-
tides were subjected to the chemical ligation with and without
HOBt as additive. We performed the ligation studies following
the protocol described by Wong et al.,16 in conjunction with a
set of experiments where 2 equivalents of HOBt (1:2 molar
ratio of peptide thioester:HOBt) were added to the ligation
FIGURE 2 Kinetics of ligated product formation in ligation reactions with HOBt and without
(solid or dashed lines respectively). The combinations shown are GASATVSPLS-VGPSPLGFLG
(panel A), GASATVSPLVVGPSPLGFLG (panel B), GASATVSPLV-LGPSPLGFLG (panel C) and
LYRAG-YSPGYS (panel D). The reaction was followed by LC-MS and through peak integration of
the product ions at m/z 928.2 (doubly charged, panel A), m/z 934.1 (doubly charged, panel B), m/z
941.2 (doubly charged, panel C), m/z 1274.6 (singly charged, panel D).
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mixture. The combinations are shown in Figure1, panel C and
Table I.
In all cases, the final conversion, based on the peak integra-
tion of the product ions in the LC-MS experiments, and yield
was higher when HOBt was present in the ligation mixture
(Figures 1 panel C, Figure 2, Supporting Information Figure 2,
Table I) independently of the peptide thioester/peptide molar
ratio. Moreover, in the cases when aromatic or b-branched
amino acids were present at the ligation junction, the influence
of the added HOBt on the final conversion/yield was greater
(Figure 1 panel C, Figure 2 bold lines) than when the peptide
had less sterically hindered amino acids (Figure 1 panel C,
Supporting Information Figure 2 bold lines). Interestingly, the
HOBt addition specifically increased the final conversion/yield,
while having very little or no influence on the rate of ligation
(except in the case of GY ligation junction, Figure 2 panel D).
The addition of 10 equiv. of HOBt did not improve the final
conversion or the reaction rate further (Supporting Informa-
tion Figure 3), but led to a reduction in the conversion rate
(Supporting Information Figure 3 dashed lines). We attribute
this observation to a decrease of the pH of the ligation mixture
caused by the acidic nature of HOBt.22 Furthermore, using the
above-described conditions the product can be obtained with
high purity since it elutes at a different retention time than the
starting peptide reagents (thioester and the free N-terminus
peptide), as displayed in Figure 3.
In another set of experiments performed as controls, we
ligated the same set of NH2-peptide sequences as before, in the
FIGURE 3 Reversed-phase HPLC chromatograms of the ligation reaction with HOBt (Panel A
and C) and without HOBt (Panel B and D) using two peptides, LYRAG-YSPGYS (Panel A and B)
and GASATVSPLVVGPSPLGFLG (Panel C and D).
Table II NH2-Free C-Terminal Peptide Thioesters and N-Terminal Peptide-Free Amines Used in the Ligation Studies
Peptide Thioesters m/z theor m/z exper Peptides m/z theor m/z Exper Lig. Com.
1. NH2-GASATVSPLG-SC7H7 965.54 965.58 A. NH2-GGPSPLGFLG-CONH2 900.49 900.47 1-A
2-A
2-B
3-B
4-C
2. NH2-GASATVSPLS-SC7H7 995.49 995.46 B. NH2-VGPSPLGFLG-CONH2 942.54 942.55
3. NH2-GASATVSPLV-SC7H7 1007.53 1007.55 C. NH2-CGPSPLGFLG-CONH2 946.48 946.46
4. NH2-GASATVSPLL-SC7H7 1021.54 1021.57
Lig. Com.: ligation combinations.
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presence of HOBt but using unprotected thioesters (at the
N-terminus) (Table II). In all cases the formation of the
expected ligation product was observed (Supporting Informa-
tion Figure 4 solid lines); however, in the presence of cyclic
side-products (Supporting Information Figure 4 dashed lines).
According to the observed m/z values, the cyclization products
are formed due to the intramolecular cyclization of the peptide
thioesters, a competitive side reaction favored by the unpro-
tected N-termini of the peptide thioester.
Finally, ligation reactions with or without N-terminal pro-
tected thioesters and peptides containing a N-term Cysteine
were much faster than in all the other ligation reactions tested,
(Supporting Information Figure 5).
The addition of HOBt suppresses the 5(4H)-oxazolone for-
mation, preventing plausible racemization, and thus, improv-
ing the aminolysis rate through the formation of more
effective acyl donors esters.23 For this reason, we hypothesized
that the presence of HOBt in the ligation mixture improves the
ligation reaction yield and also contribute to increasing the
conversion.
Effects of the Presence of DBU and DIPEA Activators
The addition of a base activator can improve the final conver-
sion and speed up the reaction. To test this hypothesis, we per-
formed ligation reactions with HOBt and DBU and DIPEA as
activating bases, since they are strong bases but weak nucleo-
philes (Figure 4, panel A dotted line and solid line, correspond-
ingly). To test the effect of the activators we chose Val-Val
residues at the ligation site because HOBt-enhances the liga-
tion reaction in cases where b-branched or aromatic amino
acids were present at the junction (Figure 1 panel C, Figure 2
and Table I). In the case of DIPEA, we observed limited
improvement in the final conversion (Figure 4, panel A solid
line), while for DBU the final conversion was lower, despite the
fact that up to 50 h the kinetics of the reaction was almost
identical to that achieved using DIPEA (Figure 4, panel A dot-
ted line). The observation is directly related to a transthioester-
ification step (which can be followed by a singly charged ion at
m/z 1035.5), as after 50 h the number of ions corresponding to
the thiophenol thioester exchange was close to zero in the case
of DBU (Figure 4, panel B dotted line). Our results indicate
that the presence of DBU do not contribute to increasing the
ligation rate under the experimental conditions we have
investigated, while in the case of DIPEA we could detect small
improvements regarding the final conversion.
Potential Alternatives to HOBt
Regarding the choice of an alternative to HOBt, we used
HOAt, a molecule similar to HOBt but with a lower pKa (pKa
3.28 and 4.60 respectively)24,25 and therefore potentially a bet-
ter leaving group. However, we observed that the final conver-
sion and also the reaction rate were similar to those obtained
with HOBt in the experimental conditions tested (Figure 4,
panel A). This observation could be attributed to the fact that
HOAt requires double the induction time relative to all other
cases (Figure 4, panel A long-dashed line). This extended time
can be explained by the fact that the transthioesterification is
also slower for HOAt (Figure 4, panel B long-dashed line).
These observations imply that if reactions were allowed to pro-
ceed for longer (more than 96 h), we would achieve a higher
final conversion; however, this would also cause an increase in
side products, thereby reducing the yield of the product of
interest and adding complexity to the purification step. How-
ever, when the ligation reactions are more favorable, the use of
HOAt could be beneficial with regards to the final conversion,
as increases in the reaction time will not have a strong influ-
ence on the amount of side products.
Synthesis of a WW Domain Containing a
Non-Natural Amino Acid
Finally, as an application of the ligation protocol here described
we synthesized a modified WW domain using the peptidyl-
prolyl isomerase I (Pin I, 34 AA, Supporting Information
Scheme 1) sequence as the template. Pin1 is a modular protein
that contains a WWdomain, responsible for target recognition,
FIGURE 4 Kinetics of ligated product formation (panel A) and
transthioesterification step (panel B) in the ligation reaction with
HOBt1DIPEA (solid line), HOBt (dashed lines), HOBt1DBU
(dotted lines) and HOAt (long-dashed lines). The ligation was per-
formed using ligation combinations GASATVSPLV-VGPSPLGFLG.
The reaction was followed by LC-MS and through peak integration
of the product ion at m/z 934.1 (doubly charged, panel A), and
through peak integration of the ion at m/z 1035.5 (singly charged,
panel B).
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and the catalytic domain involved in the cis-trans isomeriza-
tion of phosphor-Ser/Thr-Pro bonds.26,27 The folding pathway
of the Pin1 WW domain has been the subject of many stud-
ies,28 which have shown that the domain can be unfolded and
refolded with high efficiency. In addition, many structures of
this WWdomain in complex with target peptides are described
in the literature.29 Since folding and binding studies often
require the production of many WW proteins carrying muta-
tions, we explored the possibility of using peptide synthesis
and refolding as an efficient strategy to prepare these samples.
If some of these mutations are designed to include non-natural
amino acids, a ligation strategy might be the best choice to
optimize the segment’s design and purification. As an example,
we prepared a WW sequence with a non-natural residue 2,4,6-
trimethylphenyl Ala (Msa)30–32 at position 19 and several point
mutations: Lys 1 was replaced with Gly, whereas Arg 9 and Arg
12 were replaced by Ala. The replacement of both arginines
prevented possible intramolecular cyclization with the guanidi-
nium group of the Arg side-chain, while the Lys at position 8
was protected with ivdDe. The ligation junction was chosen at
a Ser-Gly (position 14-15) due to the expected faster ligation
rate when compared with the other options (Supporting Infor-
mation Figure 2, panel B). The crude product was purified by
RP-HPLC (Figure 5, panel A) and the modified Pin I was
obtained with high purity (Figure 5, panel B and C). After suc-
cessful removal of the ivdDe side chain group (Figure 5, panel
D) the pure product was obtained at final yield of 15%.
Despite the low yield obtained in this example, the synthesis of
the modified Pin1 is a proof of principle of the applicability of
the method, and we consider that the yield could be signifi-
cantly improved with further optimizations.
Addition of HOBt to Peptides Containing
Phosphorylated Residues
We also tested the HOBt-ligation protocol using peptide
sequences that correspond to TGIF1 protein containing phos-
phorylated Ser (Table I entry 9) in the sequence of the acety-
lated C-terminal peptide thioester. The expression of proteins
containing phosphorylated residues is complicated and expen-
sive. In addition, the synthesis of phosphorylated polypeptides
using microwave (MW)-assisted SPPS is inefficient due to the
alpha,beta-elimination of the phosphate group under MW
conditions catalyzed by piperidine.33 Therefore, the cysteine-
free ligation with HOBt could also be useful in the synthesis of
phosphorylated polypeptides. The addition of HOBt signifi-
cantly improved the final conversion (Figure 1 panel C, Figure
6, Table I entry 9 and Supporting Information). Furthermore,
FIGURE 5 Reversed-phase chromatograms (Panel A and B) and MALDI-MS (Panel C and D) of
modified human Pin I protein. After purification of the crude Pin I (Panel A) the pure sample
(Panel B) was analyzed by MALDI-MS with ivdDe group present at the Lys residue (Panel C) and
after removal of the ivdDe group (Panel D). The masses corresponding to the Pin 1 protein are
labeled in bold, while the doubly charge ion of the Pin 1 protein is with asterisk. The peak in Panel
A, labeled with double asterisk corresponds to the Pin I protein with a 16 Da higher mass.
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the phosphorylated residue did not participate in any side
reaction with the added HOBt, and the products that corre-
spond to truncated peptide sequences or sequences with
dephosphorylated Ser residue were not detected.
Mechanism of Reaction
Our experimental results suggest a possible general mechanism
for the ligation reactions (Supporting Information Scheme 2).
The initial conversion of the benzyl to the phenyl thioester is
followed by the subsequent substitution by the more reactive
HOBt ester. The lower pKa of HOBt (pKa 4.6) compared to
that of thiophenol (pKa 6.6) would make the former a better
leaving group.
Our results indicate that the limiting reaction step is the
transthioesterification, as the ligation reaction does not occur
in the absence of thiophenol. It is known that the thiophenol is
able to undergo rapid and almost complete thiol-thioester
exchange34 and is an excellent leaving group. Therefore, in the
absence of thiophenol, the initial benzyl thioesters won’t be
able to undergo aminolysis or to form active HOBt esters,
since alkanethiols are poor leaving groups.34 When thiophenol
is replaced by 4-(carboxymethyl)thiophenol (MPAA), which
has a pKa of 6.6, similar to that of thiophenol, the rate of
transthioesterification is lower (Supporting Information Figure
7, panel A dashed line). We believe that the ligation buffer can
affect this step since the presence of MPAA, which shows better
solubility in aqueous buffers, induces a higher and faster trans-
thioesterification than thiophenol.34 Moreover, in our experi-
ments, the concentration of the MPAA thioester formed after
the transthioesterification remained constant during the
experiment. Consequently, the ligation conversion is six times
lower, as shown by peak integration in the LC-MS experiments
(Supporting Information Figure 7, panel B solid and dashed
line, respectively). In addition, when HOBt, was added to the
ligation mixture in the absence of thiophenol, no ligation
product was detected (data not shown). Again, as we men-
tioned before, we believe that this is due to the fact that alkane-
thiols are poor leaving groups and therefore the preformed
benzyl thioesters are not able to react giving the active HOBt
esters. In summary, the addition of HOBt facilitates the reac-
tion of the exchanged phenyl thioester with the free N-termi-
nus peptide, probably through formation of highly reactive
HOBt-ester, However, it does not have a significant effect on
the extent of transthioesterification. These observations are
shown in Supporting Information Figure 8 (panel A-D), where
the final conversion of the transthioesterification step (Sup-
porting Information Figure 8, dotted and long-dashed lines)
differs from the final conversion of the product (Supporting
Information Figure 8, dashed and solid lines). In addition, the
induction time of the reaction is related to the transthioesterifi-
cation step, i.e., when the transthioesterification reaches the
maximum and begins to drop, the formation of the product
starts immediately.
CONCLUSIONS
We have found that the addition of HOBt to the ligation of
C-terminal peptide thioesters with various free N-terminus
peptides increases the ligation conversion, especially when
b-branched or aromatic amino acids are present at the ligation
junction. This increase is probably due to the in-situ formation
of a highly reactive HOBt-ester. Furthermore, all reactions pro-
ceeded without epimerization and the method is chemoselec-
tive. Only when Lys residues are present in the sequence it is
expected that the residue’s side chain react with the in-situ
formed HOBt-ester in a similar way as with a thioester previ-
ously reported by Wong et al.16 Despite the long reaction
times, the method shows potential for application in the
synthesis of peptide sequences that cannot be generated by
other ligation techniques, especially in the presence of b-
branched or aromatic amino acids at the junction site. The
improvement of the method is also applicable to the synthesis
of phosphorylated peptides that, despite recent developments
in protein chemistry, are not readily obtainable due to their
tendency to suffer alpha,beta-elimination of the phosphate
group.
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To demonstrate the utility of the coarse-grained united-residue
(UNRES) force field to compare experimental and computed kinetic
data for folding proteins, we have performed long-time millisecond-
timescale canonical Langevin molecular dynamics simulations of
the triple β-strand from the Formin binding protein 28 WW domain
and six nonnatural variants, using UNRES. The results have been
compared with available experimental data in both a qualitative
and a quantitative manner. Complexities of the folding pathways,
which cannot be determined experimentally, were revealed. The
folding mechanisms obtained from the simulated folding kinetics
are in agreement with experimental results, with a few discrep-
ancies for which we have accounted. The origins of single- and
double-exponential kinetics and their correlations with two- and
three-state folding scenarios are shown to be related to the rela-
tive barrier heights between the various states. The rate constants
obtained from time profiles of the fractions of the native, inter-
mediate, and unfolded structures, and the kinetic equations fitted
to them, correlate with the experimental values; however, they
are about three orders of magnitude larger than the experimental
ones for most of the systems. These differences are in agreement
with the timescale extension derived by scaling down the friction
of water and averaging out the fast degrees of freedom when
passing from all-atom to a coarse-grained representation. Our
results indicate that the UNRES force field can provide accurate
predictions of folding kinetics of these WW domains, often used
as models for the study of the mechanisms of proein folding.
FBP28 WW domain | nonnatural variants | folding rates | free-energy
landscapes | millisecond-timescale canonical MD simulations
Recent advances in computer simulation techniques have fa-cilitated the direct study of the folding process of small fast-
folding proteins, using all-atom force fields (1). However, it is
important to validate the simulation methodologies, and the only
way to accomplish this is a quantitative comparison with exper-
imental data with proper statistics. The validation of all-atom
simulation methodologies is still a major problem because of the
differences between the experimental timescale (from multiple
microseconds to seconds) and the theoretical one (from hun-
dreds of nanoseconds to microseconds). To overcome this
problem, many approximate coarse-grained methods have been
developed during the past decade (2–5). One of them makes use of
a physics-based united-residue (UNRES) force field developed in
our group over the past years (6–14) (SI Appendix, Fig. S1 and SI
Materials and Methods).
The folding and unfolding rates are among the most accessible
quantitative observables for two- and multistate folding proteins;
therefore, a study of protein folding kinetics can bridge micro-
scopic motions and the world of experimental measurements. In
analyzing protein folding kinetics, the differential rate equations
and their integrated forms become more complex as the number
of intermediate forms between the completely unfolded form
and the native form increases. Therefore, to determine the
mechanisms and the microscopic rate constants, it is necessary to
vary them to obtain a computed folding trajectory that matches
the one that is simulated by molecular dynamics.
To cover a sufficiently large timescale and obtain a stable
folding trajectory theoretically, it is necessary to use a coarse-
grained, rather than an all-atom, force field. For this purpose,
use is made of the UNRES force field to compute folding tra-
jectories by canonical Langevin dynamics simulations. Then, any
intermediate states are identified, and the dependence of the
fractions of unfolded, intermediate, and native states of the
protein (averaged over all trajectories) are determined as a
function of time, and the kinetic equations are fitted to these
data to compare the calculated rate constants with those de-
termined experimentally (15).
This general approach is illustrated here, as an example, with
the triple-β–stranded WW domain from the Formin binding
protein 28 (FBP28) (PDB ID 1E0L) (16) and its full-size and
truncated mutants (15) (SI Appendix, Fig. S2). The FBP28 WW
domain is a member of the WW-domain family (17), with its
kinetics examined by possible two-state and three-state models.
The FBP28 WW domain is a good model with which to study
Significance
In spite of recent advances made in computer simulation
techniques, one of the main challenges in the protein-folding
field is to bridge microscopic motions and experimental mea-
surements. This paper demonstrates that the physics-based,
coarse-grained united-residue (UNRES) force field, which has the
ability to simulate folding of small- and midsize proteins in the
millisecond timescale, can predict the folding kinetics correctly
and bridge theoretical and experimental worlds. The results
suggest that the use of the UNRES force field will open a new
door to the understanding of protein motions at much longer
timescales and help explain the differences between theoretical
results and experimental observations.
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β-sheet formation. It should be noted that the WW domains have
been the subject of extensive theoretical (1, 14, 18–28) and ex-
perimental (15–17, 29–34) studies because of their small size,
biological importance (35), and interesting fast-folding kinetics.
As indicated here, a controversy still exists about whether the
FBP28 WW domain folding proceeds by a two- or three-state
mechanism. Using temperature denaturation and laser temperature-
jump relaxation experiments, Nguyen et al. (15) concluded that
the FBP28 WW domain can be tuned between two-state and
three-state kinetics by temperature changes, selected point mu-
tation, and truncation. These experiments (15) indicated that,
below the transition midpoint, the wild-type (WT) FBP28 WW
domain deviates from single-exponential kinetics, implying at
least a three-state folding scenario, with two folding rate con-
stants of 0.030 μs−1 and <  0:0011 μs−1, respectively. Above the
folding-transition temperature, single-exponential kinetics were
observed with a folding-rate constant of 0.071 μs−1 (15). On the
other hand, Ferguson et al. (31) argued that the kinetics proceed
by a two-state mechanism and that the biphasic kinetics observed
by Nguyen et al. (15) might be related to misfolding and aggre-
gation, rapidly forming ribbon-like fibrils at physiological tem-
perature and pH, with morphology typical of amyloid fibrils.
Recently, by using infrared and fluorescence spectroscopy in
studying the FBP28 WW domain and its tryptophan mutants
(W8Y and W30Y), Davis and Dyer (36) found that the folding
mechanism for the FBP28 WW domain is similar to that proposed
by others (15, 29, 32), but their W8Y and W30Y mutants (36)
provide evidence of an intermediate dry molten globule state.
Many computational studies were also performed on the
FBP28 WW domain to gain atomic details and femtosecond
temporal resolution. By carrying out all-atom molecular dy-
namics simulations with a G"o-like model on the FBP28 WW
domain, Karanicolas and Brooks (18) demonstrated that bi-
phasic kinetics originated from slow formation of the C-terminal
β-hairpin in the FBP28 WW domain. Xu et al. (25) applied an
all-atom Monte Carlo simulation to study the folding kinetics
and revealed that two major folding pathways exist that differ in
the order and mechanism of hairpin formation. Mu et al. (20)
carried out replica exchange molecular dynamics (REMD) with
explicit water at the all-atom level to explore the details of the
kinetics. The results of Mu et al. showed that the formation of
the second turn in the transition-state structure was responsible
for the stable intermediate state that would lead to aggregation
and misfolded structures as proposed by Ferguson et al. (31). By
studying the effects of macromolecular crowding and confine-
ment on the transition state structures in comparison with bulk
for the 1PIN WW domain, Cheung and Thirumalai (37) found
that (i) the folding rates of this protein in the presence of
crowding or in confined spaces typically, but not always, increase
because of entropic destabilization of the denatured states and,
(ii) depending on which phenomenon is dominant, the entropic
stabilization or enthalpic interactions, the transition state struc-
tures can be similar to or different from those in bulk.
One way to settle the discrepancies between the theoretical
and experimental studies is to compare the same parameters
obtained from theoretical simulations and experimental data.
Therefore, we have generated a large number of trajectories
by canonical Langevin dynamics simulations with the UNRES
force field to analyze the folding kinetics of the FBP28 WW
domain and its six mutants (Y11R, Y19L, W30F, ΔNY11R,
ΔNΔCY11R, and ΔNΔCY11R/L26A, where ΔN and ΔC denote
the deletion of the five N-terminal and the four C-terminal
residues, respectively). These mutants, as well as the WT FBP28
WW domain, are associated with a strand-crossing hydrophobic
cluster Tyr11/Tyr19/Trp30, involved in either hairpin of each
protein (15). We ran 512 trajectories for each system (about
5–8 μs formal time and effectively 5–8 ms of each trajectory, per the
UNRES timescale) of canonical Langevin dynamics simulations,
starting from the fully extended structure. Then, we identified
the native, intermediate, and unfolded states and determined the
dependence of the fractions of these three states of each protein
(averaged over all trajectories) as a function of time and fitted
kinetic equations to these time-dependent fractions. The calcu-
lated rate constants were compared with those determined ex-
perimentally (15). Moreover, the MD trajectories were analyzed
in terms of free-energy landscapes (FELs) along the Cα-rmsd
from the native structure and radius of gyration (Rg). We have
also characterized the structures of all variants, using the data
obtained from high-resolution NMR (SI Appendix, Fig. S2). The
variants investigated adopt a similar fold to that of the wild-type
protein, with small differences in and around the sites where
mutations and deletions have been introduced.
Results
Kinetic Studies for Wild-Type FBP28 Domain and Its Mutants. The
simulated results for the three full-size and three truncated
mutants, as well as the WT FBP28 WW domain (SI Appendix,
Fig. S2), are presented here. All parameters obtained from the
fitting of the simulation data by Eq. 1 (single-exponential ki-
netics) and Eqs. 2 and 3 (double-exponential kinetics) are sum-
marized in Table 1. Plots of the fractions of native structures vs.
time, [N](t) (light blue ragged lines), and the fractions of in-
termediate structures vs. time, [I](t) (light blue ragged lines),
along with fitting curves [single-exponential kinetics (dotted
black line) and double-exponential kinetics (solid black line)] for
Table 1. Fitting results of native states by single- (Eq. 1) and double-exponential (Eqs. 2 and 3) kinetics
Fitting results
Two-state model Three-state model Experimental data§
Name C0
λ0*, × 10−3
ns−1 χ2†, × 10−2 C1 m1 C2 m2
λ1 (sim)
‡,
ns−1
λ2 (sim)
‡,
ns−1 χ2†, × 10−2
λ1 (exp)
{,
μs−1
λ2 (exp)
{,
μs−1
Wild type 0.67 0.43 2.4 0.72 0.11 0.15 0.57 0.085 0.00032 1.4 0.030(1)# <0.0011
Y11R 0.80 3.0 1.8 0.80 0.12 0.10 1.97 0.040 0.0026 1.3 0.025(4) <0.0014
Y19L 0.018 6.2 0.23 0.019 0.79 0.57 0.35 0.24 0.00041 0.65 0.035(2) <0.0021
W30F 0.16 1.3 0.84 0.31 0.26 0.68 0.33 0.36 0.00012 1.8 0.054(2) —
ΔNY11R 0.37 2.8 2.2 0.37 0.05 0.24 0.81 0.76 0.0025 2.0 0.026(3) <0.0016
ΔNΔCY11R 0.33 3.2 1.8 0.33 0.17 0.37 0.51 0.061 0.0025 1.7 0.050(2) —
ΔNΔCY11R/L26A 0.46 2.2 2.0 0.47 0.14 0.29 0.55 0.039 0.0019 1.7 0.044(1) <0.0020
*λ0 of Eq. 1.
†Sum of squares of SI Appendix, Eq. S24, divided by the number of degrees of freedom.
‡λ1 (sim) and λ2 (sim) of Eqs. 2 and 3.
§Ref. 15.
{λ1 (exp) and λ2 (exp) are the same as k1 and k2 in ref. 15.
#SDs are in parentheses.
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the WT FBP28 WW domain (Fig. 1 A and B) and its two mutants,
Y11R (Fig. 1 C and D) and ΔNΔCY11R/L26A (Fig. 1 E and F),
are shown (similar plots for the rest of the mutants are illustrated
in SI Appendix, Fig. S3). The fitting results, illustrated in Fig. 1 and
SI Appendix, Fig. S3, and χ2 values in Table 1 indicate that all
systems, except for the Y19L and W30F mutants (SI Appendix,
Fig. S3 A–D), exhibit double-exponential kinetics, i.e., are three-
state folders. The single-exponential kinetics of W30F are in
agreement with experimental results (15), whereas the single-
and double-exponential kinetics of Y19L (SI Appendix, Fig. S3
A and B) and ΔNΔCY11R (SI Appendix, Fig. S3 G and H)
mutants, respectively, differ from experimental results, in which
Y19L and ΔNΔCY11R mutants exhibit double- and single-
exponential kinetics, respectively (15).
For the three-state folding systems, both macroscopic rate
constants λ1 and λ2, in Table 1, have meaningful (positive) values,
and the intermediate state is present in remarkable quantity even
at the end of the simulations for all molecules, sometimes in an
amount comparable to or greater than that of the native state, as
illustrated for ΔNΔCY11R/L26A, ΔNY11R, and ΔNΔCY11R in
Fig. 1F and SI Appendix, Fig. S3 F and H, respectively. Table 1
also includes the experimental rate constants, determined by
Nguyen et al. (15). The rate constants determined by fitting to
simulation results are about three orders of magnitude greater
compared with experimental values (except for ΔNY11R), which
is consistent with the fact that the timescale of UNRES is ex-
tended by about three orders of magnitude because of averaging
out the fast motions of the secondary degrees of freedom (19)
and scaling down water friction in our Langevin dynamics sim-
ulations by a factor of 1,000.
The values of the fast-phase rate constants (λ1) determined by
simulations correlate well with their experimental counter-
parts except for the truncated ΔNY11R, ΔNΔCY11R, and
ΔNΔCY11R/L26A mutants, which are clear outliers (Fig. 2).
Unfortunately, the experimental values of the slow-phase rate
constants (λ2) are not accurate enough to make the similar
meaningful comparison with their simulated counterparts.
The preexponential parameter m1 in Eq. 2 determines the per-
centage of pathways following the fast-phase (single-exponential)
folding kinetics; consequently, the parameter (1 − m1) indicates
the percentage of pathways following the slow-phase (double-
exponential) folding kinetics. Indeed, the results for the m1 pa-
rameter, shown in Table 1, are in agreement with the fitting
results. For example, the m1 parameter for WT and Y19L is 0.11
and 0.79, respectively; this indicates that 11% and 79% of the
pathways of WT and Y19L, respectively, follow the fast-phase
route and 89% and 21% of the pathways of WT and Y19L, re-
spectively, follow the slow-phase route. A disagreement between
the fitting results and the m1 parameter occurs only for the
W30F mutant. A plausible explanation of this discrepancy is
given below in Discussion.
Free-Energy Landscapes of Wild-Type FBP28 WW Domain and Its
Mutants. To obtain more insights into the folding kinetics of
these proteins and explain the causes of the discrepancies be-
tween the experimental and computational results shown above
(Figs. 1 and 2 and SI Appendix, Fig. S3), we analyzed the dis-
tribution of the conformational states in terms of free-energy
landscapes along the Cα-rmsd from the native structure and the
radius of gyration (Rg) as order parameters in three time inter-
vals: initial, for which the fraction of the native structures is
below 20% of the maximum (equilibrium) fraction; intermediate,
for which the fraction of the native structures is from 20%
to 50% of the maximum fraction of the native structures; and
final, for which the fraction of the native structures exceeds
50% of the maximum value. The FELs along Cα-rmsd and Rg
[μðrmsd;RgÞ=−kBTln  Pðrmsd;RgÞ, where P, T, and kB are the
probability distribution function (pdf), the absolute temperature,
and the Boltzmann constant, respectively] for the WT FBP28
WW domain and its Y11R and ΔNΔCY11R/L26A mutants are
shown in Figs. 3–5, respectively. The FELs for the rest of the
mutants are illustrated in SI Appendix, Figs. S4–S7.
As was expected, and can be deduced easily from the fraction
curves of Fig. 1 and SI Appendix, Fig. S3, the FELs of WT and all
full-size and truncated mutants exhibit three-state folding ki-
netics; however, there are some discrepancies in the folding
pathways and in the depths of the states. For example, mutants
Y11R and Y19L fold along two different folding pathways (Fig. 4
and SI Appendix, Fig. S4), whereas WT and the rest of the
mutants (W30F, ΔNY11R, ΔNΔCY11R, and ΔNΔCY11R/
L26A) follow a single folding pathway (Figs. 3 and 5 and SI
Appendix, Figs. S5–S7). Both Y11R and Y19L fold either along
the pathway, in which hairpin 1 forms first in the intermediate
state and then the protein jumps to the native state, or with
a different order of formation of hairpins; i.e., hairpin 2 forms
first in the intermediate state before the protein reaches the
native state. These findings are in agreement with our previous
study (27). The replacement of a nonpolar aromatic amino acid
(Tyr) by a charged extremely hydrophilic amino acid (Arg) for
the Y11R mutant and by a very nonpolar branched aliphatic
amino acid (Leu) for the Y19L mutant, both in hairpin 1, may
destabilize this hairpin and induce the second folding pathway, as
was pointed out in our earlier work (27) (see the spherical rep-
resentation of the mutated residue in the representative struc-
tures of the intermediate state in Fig. 4 and SI Appendix, Fig. S4).
The WT and the rest of the mutants fold along a pathway, in
which hairpin 1 forms first in the intermediate state before the
protein reaches the native state (Figs. 3 and 5 and SI Appendix,
Figs. S5–S7). These findings are in agreement with previous
experimental (15, 30, 32, 33, 36) and theoretical (18, 24, 27, 28)
studies. However, by performing unfolding MD simulations of
the FBP28 WW domain, Petrovich et al. (32) found that, in 30%
of the trajectories, the nonnative helical structure is formed,
instead of the first β-strand, allowing the second hairpin to form
first. We also observed the nonnative helical structure formed in
Fig. 1. Fractions of native (A, C, and E) and in-
termediate (B, D, and F) structures as functions of
time for the wild-type FBP 28 WW domain (A and B)
and its Y11R (C and D) and ΔNΔCY11R/L26A (E and
F) mutants. Light blue ragged lines present the
simulation data; dotted lines correspond to the fits
by single-exponential kinetics (Eq. 1, fractions of
only native structures); solid lines correspond to the
fits by double-exponential kinetics (Eqs. 2 and 3,
fractions of the native and intermediate structures,
respectively). Insets represent the enlarged values of
fractions of native structures for the first several
hundred nanoseconds of time.
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the N-terminal region in the unfolded state for WT; however,
it did not help the second hairpin to form first. Moreover,
Petrovich et al. (32) explained the formation of the first hairpin
in the remaining 70% of the trajectories; in particular, they
found that the first loop is present in the early stage as a kink in
the backbone of the protein to allow long-range interactions to
occur, followed by side-chain interactions and hydrophobic col-
lapse of residues to enable the first and second β-strands to form
the first hairpin. This finding is in agreement with our recent
study (28).
The folding scenarios illustrated in the FELs for Y19L and
W30F mutants (SI Appendix, Figs. S4 and S5) contradict our
findings obtained by fitting the fractions of native and in-
termediate structures (SI Appendix, Fig. S3 A–D). In particular,
the FELs of Y19L and W30F mutants clearly show a three-
state folding scenario, whereas the fitting results in SI Ap-
pendix, Fig. S3 indicate single-exponential kinetics, which
normally implies a two-state folding scenario.
In the end, it should be noted that, based on the results shown
in SI Appendix, Figs. S3 A and B and S4, the replacement of Tyr-
19 by Leu had the most destabilizing influence among all
mutations, which indicates the importance of the Tyr-19 residue
for the stability of the protein. These results are in agreement
with the findings of an earlier experimental study (16), in which
the structural roles of the conserved residues were studied by
using site-directed mutagenesis of the FBP28 WW domain.
Discussion
To account for the discrepancies between the results obtained
from the kinetic studies and FELs, we drew the free-energy
diagrams (SI Appendix, Fig. S8) based on the distributions of the
populations of the native, intermediate, and unfolded structures
(PN, PI, PU) for all of the systems studied.
The main differences, illustrated in these free-energy diagrams,
between the mutants exhibiting single- and double-exponential
kinetics are (i) in the depth of the intermediate state and (ii) in the
barrier heights of the unfolded/intermediate and intermediate/
native states (SI Appendix, Fig. S8). In particular, the intermediate
state is the deepest and the barrier height between the unfolded
and intermediate states is much lower than the one between the
intermediate and native states [ratios (R) between the barrier
heights for all systems are in SI Appendix, Fig. S9] for the
mutants exhibiting single-exponential kinetics (SI Appendix, Fig.
S8 D and E); whereas the systems exhibiting double-exponential
kinetics have the deepest native state, and the barrier height
between the unfolded and intermediate states is higher than (or
comparable to) that between the intermediate and native states
(SI Appendix, Figs. S8 A–C and F and S9). This explains why
single-exponential kinetics emerge during three-state folding.
The point is that the barrier height between the intermediate and
native states is so high compared with that between the unfolded
and intermediate states [three (for Y19L) or four (for W30F)
times higher than that between the unfolded and intermediate
states] that the timescale separation occurs and only the slowest
step is observed by experiment due to experimental limitations;
hence, single-exponential kinetics arise. Among the studied
mutants, ΔNΔCY11R is the only exception, which exhibits
double-exponential kinetics from the fitting, but the features
(depth of the intermediate state, barrier heights) illustrated in
the free-energy diagram (SI Appendix, Fig. S8G) are character-
istic of single-exponential kinetics, which actually were observed
in the experiment (15) for this mutant. The reason for the
double-exponential kinetics for the ΔNΔCY11R mutant is that
the difference between the barrier heights of the unfolded/
intermediate (0.53 kBT) and intermediate/native (0.60 kBT)
states is not large enough to lead to single-exponential kinet-
ics. However, the difference between the values of χ2 (0.018
and 0.017, respectively) (Table 1) of the single- and double-
exponential fits for the ΔNΔCY11R mutant is the smallest among
all mutants, which indicates that there is a tiny threshold between
single- and double-exponential kinetics for this mutant.
In a perceptive analysis of the timescales for protein folding
kinetics, Thirumalai (38) showed that, at the atomic level, the
free-energy barrier height scales as N1/2, where N is the number
of residues; i.e., the free-energy barrier heights for the FBP28
WW domain and its full-size (n = 37) and truncated (n = 32 and
n = 28) mutants should vary between 5.3 kBT and 6 kBT. How-
ever, because of averaging out the fast motions of the secondary
degrees of freedom, at the coarse-grained level, the free-energy
barriers, illustrated in SI Appendix, Fig. S8, are lower than those
at the atomic level.
Thus, we have illustrated that single-exponential kinetics do
not arise only in two-state folding. They may emerge during
Fig. 2. A correlation plot of the experimental (15) and simulated fast cu-
mulative constants (λ1 of Table 1) with a least-squares fitting line.
Fig. 3. Variation of the distribution of confor-
mational states in terms of FELs (in kcal/mol) along
the Cα-rmsd and Rgyr order parameters for the
wild-type FBP28 WW domain. The data have been
collected from different sections of all 512 trajec-
tory sets for the molecule (shown in A–C, re-
spectively). The FEL corresponding to the initial
parts of the trajectories (with the average fraction
of the native structures up to 20% of the maxi-
mum fraction) is shown in A; the FEL from the
middle parts of the trajectories (the fraction of
the native structures between 20% and 50% of
the maximum fraction) is shown in B; and the FEL
from the final parts of the trajectories (the fraction
of the native structures exceeds 50% of the max-
imum fraction) is shown in C, respectively. The
letters “U,” “I,” and “N” correspond to unfolded,
intermediate, and native states, respectively. The representative structures of unfolded, intermediate, and native states are plotted on top of each state.
Hairpin 1 and hairpin 2 are circled by black and red lines, correspondingly, in A.
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three-state (or multistate) folding when one of the free-energy
barriers is much higher than the other; consequently, a separa-
tion of timescales occurs and single-exponential kinetics arise.
To explain the discrepancy between the fitting results (SI
Appendix, Fig. S3 C and D) and the m1 parameter for the W30F
mutant, we have calculated the changes in the populations of the
intermediate state over the above-defined time intervals (shown
in Fig. 3 legend). It turns out that, unlike in the other mutants (in
which PI increases gradually over time), PI increases rapidly
(∼28%) in the initial part of the trajectories, in W30F, then
decreases slightly (∼25%) in the middle part of the trajectories,
and then increases again (∼38%). This has been reflected in a bit
of unusual behavior of the fitted curve of the fractions of the
intermediate structures (light blue ragged line in SI Appendix,
Fig. S3D); consequently, the m1 parameter obtained from this
fitting differs from the expected one (>0.5).
It should be noted that, for a similar reason, i.e., a rapid in-
crease of PI in the initial part of the trajectories, the fast-phase
rate constant of the ΔNY11R mutant increased by one order
of magnitude.
In the end, the truncated mutants that are outliers in Fig. 2
might be caused by the unusual states with structures similar to
the native states, but with the second hairpin shifted (Fig. 5 and
SI Appendix, Figs. S6 and S7), which suggests that these states
might derail folding to misfolded states (20, 39). One of the rea-
sons for the “distortion” of structures of the ΔNΔCY11R and
ΔNΔCY11R/L26Amutants could be the deletion of the C-terminal
Leu36 residue, part of a delocalized hydrophobic core, Trp8/
Tyr20/Pro33. As for the ΔNY11R mutant, based on earlier ex-
perimental studies (15, 16), the truncation of the N-terminal
residues has no observable effect on the stability of the domain;
hence, the reasons for the distortion of the structure must be
different. An investigation of the reasons for this distortion is
beyond the scope of the present study but it is worth pursuing in
the future.
Conclusions
In this study, we carried out a quantitative analysis of the sim-
ulated kinetics of the folding of the FBP28 WW domain and its
six mutants at the coarse-grained level. By analysis of the frac-
tions of the native structures, we found double-exponential ki-
netics (three-state folding) for the WT and its mutants except for
the Y19L and W30F mutants, which exhibited single-exponential
kinetics implying two-state folding. The results from the FELs
along the Cα-rmsd and Rg indicate that the WT and all its
mutants are three-state folders. For most of the mutants, the
obtained results are in agreement with experiment (15). The
discrepancies between the results of our simulation and the ex-
perimental (15) kinetics studies and the FELs for some mutants,
as well as the origins of single- and double-exponential kinetics
and their correlations with two- and three-state folding, are
explained in terms of the free-energy barrier heights. In partic-
ular, we have shown that single-exponential kinetics can emerge
even in three-state (or multistate) folding when one of the free-
energy barriers is much higher than the other. The calculated
fast-phase rate constants correlate with the experimental values
determined by Nguyen et al. (15) except for the truncated
mutants. For most of the systems, the rate constants obtained by
simulations are greater by about three orders of magnitude,
which is caused by averaging out the fast degrees of freedom in
our coarse-grained treatment (19) and by scaling down water
friction by a factor of 1,000. It should be noted that scaling down
the friction is a common practice in coarse-grained Langevin-
dynamics simulations to accelerate the simulations (40, 41).
Fig. 4. (A–C) Same as in Fig. 3 but for the Y11R full-size mutant.
Fig. 5. (A–C) Same as in Fig. 3 but for the ΔNΔCY11R/L26A truncated mutant.
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An important finding of this work is that, for such small proteins
as the FBP28 WW domain and its variants, the intermediate and
unfolded states are at equilibrium with the native state in water
solutions (Fig. 1 and SI Appendix, Fig. S3). Therefore, estimating
the content of the native state based on, e.g., the CD or fluores-
cence spectra of a protein solution must be considered with caution
because the unfolded protein/intermediate state can be present
even at temperatures well below the folding-transition temperature.
As in our previous studies (27, 28), consistent with previous
findings (15, 18, 24, 30, 32, 33, 36), we found that the intermediate
state consists predominantly of conformations with hairpin 1 well
established and hairpin 2 only outlined. The Y11R and Y19L
mutants are exceptions (Fig. 4 and SI Appendix, Fig. S4) because of
the destabilization of hairpin 1 caused by the replacement of a hy-
drophobic tyrosine residue with a charged extremely hydrophilic
(arginine) and a very nonpolar branched aliphatic (leucine) residue.
Materials and Methods
To determine the rate constants for protein folding kinetics, we first derived
the rate equations for two- and three-state folding models. All steps of
derivations are given in SI Appendix, SI Materials and Methods. Here, we
present only the equations, in final form, for the mole fractions of the native
state as a function of time, ½N$ðtÞ, for a two-state folding model,
½N$ðtÞ=C0½1− expð−λ0tÞ$, [1]
and for the mole fractions of native and intermediate states as functions of
time, ½N$ðtÞ and ½I$ðtÞ, respectively, for a three-state folding model
½N$ðtÞ=C1f1−m1expð−λ1tÞ− ð1−m1Þexpð−λ2tÞg [2]
½I$ðtÞ=C2f1−m2 expð−λ1tÞ− ð1−m2Þexpð−λ2tÞg: [3]
To obtain the rate constants, the fractions of the U, I, and N states averaged
over 512 MD trajectories at each time interval were fitted by Eq. 1 for a two-
state model and by Eqs. 2 and 3 for a three-state model. In other words, the
mole fractions of the native state (two-state model) and of the native and
intermediate states (three-state model) calculated from simulation data
were fitted by Eq. 1 (with C0 and λ0 as determinable parameters) and Eqs. 2
and 3 (with C1, C2, m1, m2, λ1, and λ2 as determinable parameters) (details of
all parameters, the simulation, and data analysis are in SI Appendix).
Details of the preparation of FBP28 WW mutants and of the calculated
structures are given in SI Appendix.
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8 Abbreviations and Units
A˚ A˚ngstro¨m
ACH Alpha-cyano-4-hydroxycinnamic acid
Acm Acetamidomethyl
APL Acute promyelocytic leukemia
ARE Activin response element
ARIA Ambiguous Restraints for Iterative Assignment
AU Arbitrary unit
BMP Bone morphogenetic protein
BMRB Biological Magnetic Resonance Data Bank
Boc tert-Butoxycarbonyl
BOP Benzotriazol-1-yloxytris(dimethylamino)phosphonium
hexa￿uorophosphate
BSA Bovine serum albumin
Bzl Benzyl
ºC Celsius
cam-ester Carboxamidomethyl ester
CBP Cyclic AMP response element-binding protein
cDNA Complementary DNA
CM ChemMatrix®
CNS Crystallography & NMR System
Co-SMAD Common partner SMAD
cps Counts per second
CRBPII Retinol-binding protein II
CSI Chemical shi￿ index
CSP Chemical shi￿ perturbation
CtBP C-terminal-binding protein 1
  Chemical shi￿
Da Dalton (g/mol)
DBU 1,8-Diazabicyclo[5.4.0]undec-7-ene
DCM Dichloromethane
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8 Abbreviations and Units
DIC N,N’-Diisopropylcarbodiimide
DIPEA N,N -Diisopropylethylamine
DMF N,N -Dimethylformamide
DMSO Dimethyl sulfoxide
DNA Deoxyribonucleic acid
ds DNA double-stranded DNA
DTT Dithiothreitol
E.coli Escherichia coli
EDT Ethanedithiol
EDTA Ethylenediaminetetraacetic acid
EGF Epidermal growth factor
EMSA Electrophoretic mobility shi￿ assays
EPL Expressed Protein Ligation
eq Equivalents
ESI Electrospray ionization
EVI1 Ecotropic virus integration site 1 protein homolog
ExPASy Expert protein analysis system
FBXW7 F- box/WD repeat-containing protein 7
FID Free induction decay
FM Fast/FoxH1 motif
Fmoc 9-Fluorenylmethoxycarbonyl
FPLC Fast protein liquid chromatograph
FT Fourier transform
GDF Growth and di￿erentiation factors
GST Glutathion S-transferase
GuHCl Guanidinium chloride
h Hour
HAT Histone acetyltransferase
HATU N -[(dimethylamino)-1H -1,2,3-triazolo[4,5-b]pyridin-
1-ylmethylene]-N -methylmethanaminium hexa￿uo-
rophosphate N -oxide
HBTU N -[(1H -benzotriazol-1-yl)(dimethylammo)methylene]-
N -methylmethanaminium hexa￿uorophosphate
N -oxide
HD Homeodomain
HDAC1 Histone deacetylase 1
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HEPES 2-[4-(2-Hydroxyethyl)piperazin-1-yl]ethanesulfonic
acid
HFIP 1,1,1,3,3,3-Hexa￿uoro-2-propanol
HOAt 1-Hydroxy-7-azabenzotriazole
HOBT 1-Hydroxybenzotriazole
HOOBt 3,4-Dihydro-3-hydroxy-4-oxo-1,2,3-benzotriazine
HPE Holoprosencephaly
HPLC High Performance/Pressure Liquid Chromatography
HSQC Heteronuclear Single-￿antum Correlation/Coherence
spectroscopy
IMAC Immobilised metal ion a￿nity
IPTG Isopropyl  -D-1-thiogalactopyranoside
I-SMAD Inhibitory SMAD
ITC Isothermal titration calorimetry
ivDde 1-(4,4-Dimethyl-2,6-dioxocyclohex-1-ylidene)-3-
methylbutyl
K Kelvin
KAHA ↵-ketoacid–hydroxylamine
KCL Kinetically controlled ligation
KD Dissociation constant
LB Luria broth
LC-MS Liquid Chromatography Mass Spectrometry
MALDI Matrix-Assisted Laser Desorption/Ionization
MAPK Mitogen-activated protein kinases
MCP Micro-channel plate
MCS Multiple cloning site
MeCN Acetonitrile
MESNA 2-Mercapoethanesulfonate
MH MAD homology
min Minute
MIS Muellerian inhibiting substance
MPAA 4-(Carboxymethyl)thiophenol
mRNA messenger RNA
MS Mass spectrometry
MST MicroScale￿ermophoresis
NBD 4-Chloro-7-nitrobenzofurazan
NCL Native chemical ligation
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8 Abbreviations and Units
N-CoR Nuclear receptor corepressor 1
NLS Nuclear localisation signal
NMP N -Methyl-2-pyrrolidone
NMR Nuclear magnetic resonance
NOE Nuclear overhauser e￿ect
NOESY Nuclear overhauser e￿ect spectroscopy
OD Optical density (Absorbance)
ON Overnight
Oxyma Pure Ethyl 2-cyano-2-(hydroxyimino)acetate
PAI-1 Plasminogen activator inhibitor-1
Pbf 2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl
PCR Polymerase chain reaction
PDB Protein data bank
PEG Polyethylene glycol
PHRF1 PHD and RING ￿nger domain-containing protein 1
PML Promyelocytic leukaemia protein
PMSF phenylmethanesulfonyl ￿uoride
ppm Parts per million
PS Polystyrene
PCTA PML competitor for TGIF association
PTM Post-translational modi￿cations
PyBOP® Benzotriazol-1-yloxy tris(pyrrolidino)phosphonium
hexa￿uorophosphate
RF Radio frequency
RMSD Root-mean-square deviation
RNA Ribonucleic acid
RP Reverse Phase
RPM Revolutions per minute
R-SMAD Receptor-regulated SMAD
RT Room temperature
RXRE Retinoid X receptor responsive element
SAL Sugar-assisted ligation
SARA Smad anchor for receptor activation
SBD SMAD binding domain
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis
SID SMAD interacting domain
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SIM SMAD interacting motif
SMAD Small mothers against decapentaplegic
SNR Signal-to-noise ratio
SOC Super optimal broth with catabolite repression
SPPS Solid-Phase Peptide Synthesis
ss DNA single-stranded DNA
SSH Sonic hedgehog protein
TALE ￿ree amino acid loop extension
TB Terri￿c broth
tBu tert-butyl
TCEP Tris(2-carboxyethyl)phosphine
TEV Tobacco etch virus
TFA Tri￿uoroacetic acid
TGF  Transforming growth factor- 
TGFBR TGF  receptor
TGIF1 5’-TG-3’ interacting factor 1
￿z 1,3-￿iazolidine-4-carboxo
TIPS Triisopropylsilane
TOCSY Total correlation spectroscopY
TOF Time of ￿ight
TRIS 2-Amino-2-(hydroxymethyl)propane-1,3-diol
UNRES United-residue
VA-044 2,20-azobis[2-(2-imidazolin-2-
yl)propane]dihydrochloride
vol. Volume
WT Wild type
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